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Chapter 1 
Introduction  
 
The TRP superfamily  
The Transient Receptor Potential (TRP) superfamily of proteins consists of cation-
selective ion channels with molecular structure similarities but diverse functions [1]. The 
first member of TRP family was discovered in studies that examined Drosophila 
phototransduction pathway [2], in which the photoreceptor cells of Drosophila exhibit 
sustained receptor potentials in response to continuous light exposure. Cosens and 
Manning [2-4] reported in 1969 that a group of mutant flies exhibited a transient receptor 
potential upon continuous light exposure and named it TRP. The TRP gene was cloned 
in 1989 [3] and subsequently shown to encode a Ca2+-permeable cation channel [4]. 
Since then, several channels that have sequence and structural similarities to the 
Drosophila TRP have been cloned from flies, worms, and mammals. TRP channels are 
widely expressed and have diverse functions, ranging from thermal, tactile, taste, 
osmolar and fluid flow sensing to transepithelial Ca2+ and Mg2+ transport [5-13]. 
Mutations of TRP proteins result in kidney-related diseases, including hereditary 
hypomagnesemia with secondary hypocalcemia (HSH) caused by mutations of TRPM6, 
autosomal dominant polycystic kidney disease caused by mutations of TRPP2, and focal 
segmental glomerulosclerosis caused by mutations of TRPC6 [5, 14-21]. 
 
A previous consensus report proposed a unified nomenclature for the TRP superfamily 
[22]. It classified TRP channels into TRPC, TRPV, and TRPM subfamilies on the basis of 
amino acid sequence and structural similarity. More recent classification has expanded 
TRP superfamily to include three other subfamilies, TRPP, TRPML, and TRPN [1, 22, 23]. 
Unlike most of ion channel families, the TRP superfamily is identified on the basis of 
homology only [1, 23-25]. The mode of activation and selectivity for TRP channels are 
diverse. Some TRP channels are activated by ligands, whereas others are regulated by 
physical stimuli (for instance, heat) or yet-unknown mechanisms [1, 23, 25-31]. All TRP 
channels are cation selective, but the selectivity ratio for Ca2+ versus the monovalent 
cation Na+ (PCa/PNa) varies widely [1, 23, 25-34]. Structurally, TRP channels have six 
transmembrane (TM) segments and intracellularly localized amino (N-tail) and carboxyl 
(C-tail) termini, similar to the topology of voltage-gated K+, Na+ and Ca2+ channels, cyclic 
nucleotide-gated channels and hyperpolarization-activated channels [1] (Figure 1A). The 
four subunits of TRP channels assemble as tetramers to form cation-permeable pores. In 
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the cytosolic tails, a TRP domain of a conserved 25 amino acids stretch is located in the 
C-tail, and potential regulatory sites including several ankyrin repeats and enzyme 
domains are localized in the N- and C-tails. For instance, TRPV5 and TRPV6 contain 
PDZ motifs and protein kinase C (PKC) phosphorylation sites in both N- and C-tails, 
TRPM6 and TRPM7 contain an α-kinase domain in the C-tail, and TRPM2 contains a 
phosphatase domain in its C-tail. Furthermore, between TM segment 5 and 6 there is a 
short hydrophobic stretch that forms the pore forming region of these channels. Some 
TRP channels contain potential N-linked glycosylation sites, for instance, TRPV5 and 
TRPV6 have one at the asparagine residue N358 or N357 between TM segment 1 and 2, 
respectively  [1] (Figure 1B).  
 
TRPV5 and TRPV6: unique members of the TRP superfamily  
The epithelial Ca2+ channels, TRPV5 and TRPV6, represent two highly homologous 
members within the TRP superfamily, which are mainly expressed in Ca2+-transporting 
epithelia [25, 35]. The genes of TRPV5 and TRPV6 are juxtaposed on human 
chromosome 7q35 [36-38]. The two distinct genes comprise 15 exons, encoding 
proteins of approximately 730 amino acids [28, 29, 37, 39]. TRPV5 and TRPV6 display 
30–40% homology with other members of the TRP family, and possess unique 
properties that distinguish them from other TRP channels [9, 40]. For instance, TRPV5 
and TRPV6 retain a Ca2+ over Na+ selectivity, which is much larger (PCa/PNa > 100) than 
observed for any other member of the TRP superfamily (PCa/PNa ≤ 9) [3, 25, 32-34]. 
TRPV5 and TRPV6 share 75% homology at the amino acid level, and the main 
sequence differences are located in the N- and C-tails. Electrophysiological studies 
using human embryonic kidney cells (HEK293) heterologously expressing TRPV5 or 
TRPV6, show that these channels permeate Ca2+ [25, 40, 41] and exhibit a similar ion 
permeation sequence for divalent cations (Ca2+ >Sr2+ ≈ Ba2+ > Mn2+). However, the 
relative permeability for Ba2+ in relation to Ca2+ is significantly less for TRPV6 compared 
to TRPV5. Furthermore, TRPV5 has a 100-fold higher affinity for the blocker ruthenium 
red than TRPV6 [41].  
 
The tissue distribution of TRPV5 and TRPV6 has been studied extensively by 
Northernblot, RT-PCR analysis and immunohistochemistry [28, 32, 33, 36, 38, 41-46]. In 
humans, both channels are co-expressed in the organs that mediate transcellular Ca2+ 
transport, such as small intestine, colon, kidney, bone and placenta but also in exocrine  
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 Figure1．Predicted structural organization of TRP channels. (A) Domain organization of TRP 
channels. The TRP domain is a highly conserved 25-amino acid region. The region identified as 
"TRP box" is nearly invariant. X denotes any amino acid [1]. (B) TRP channels contain a core 
domain consisting of 6 TM segments. This domain is flanked by an intracellular N- and C-tail, in 
which there contain TRP domain and potential regulatory sites including ankyrin repeats and 
enzyme domains. For instance, TRPV5 and TRPV6 contain PDZ motifs and PKC phosphorylation 
sites in their N- and C-tail, TRPM6 and TRPM7 contain an α-kinase domain in C-tail, and TRPM2 
contains a phosphatase domain in its C-tail. Furthermore, between TM segment 5 and 6 there is a 
short hydrophobic stretch that forms the pore forming region of these channels. Some TRP 
channels contain potential N-linked glycosylation sites, for instance, TRPV5 and TRPV6 have one 
at the asparagine residue N358 or N357 between TM segment 1 and 2, respectively. PKC: protein 
kinase C; PKA/cGK: cAMP- and cGMP-dependent protein kinase; CaMKII: Ca2+/calmodulin-
dependent protein kinase II, TM domain: transmembrane domain. 
 
 
 
 
 
 
 
 
tissues such as pancreas, prostate, mammary gland, sweat gland and salivary gland. 
The relative mRNA levels of TRPV5 and TRPV6 in tissues co-expressing these 
channels are different. In general, TRPV5 seems to be the major isoform in kidney, 
which is localized along the apical membrane of the epithelial cells lining the late part of 
the distal convoluted tubule (DCT2) and the connecting tubule (CNT) [45, 47]. In these 
nephron segments TRPV5 co-localizes with other proteins involved in Ca2+ transport, 
such as calbindin-D28K (CaBP28K), Na+-Ca2+ exchanger type 1 (NCX1) and plasma 
membrane Ca2+ -ATPase 1b (PMCA1b) [47]. In contrast to TRPV5, TRPV6 is abundantly 
expressed in small intestine. In the duodenum, TRPV6 protein is present in the luminal 
membrane along the villus tips [46, 47]. In addition, TRPV6 mRNA is located in the 
exocrine acinar cell of the pancreas. The expression of TRPV6 in prostate is increased 
in prostate cancer and correlates with the tumor grade [48]. 
 
The structure of TRPV5 and TRPV6 shows the typical topology features shared by all 
members of the TRP family [35] (Figure 1B). The N- and C-tails of TRPV5 and TRPV6 
contain several conserved putative regulatory sites that might be involved in regulation 
of channel activity and trafficking. For instance, the N-tails of these channels contain 
ankyrin repeats, which play a crucial role in protein–protein interactions [49]. In addition, 
the N- and C-tails of TRPV5 and TRPV6 each contain potential internal PDZ motifs, 
which can function as part of a molecular scaffold via interaction with PDZ-domain 
containing proteins, involved in membrane protein routing, trafficking and regulating 
(Figure 1B) [50, 51]. Particularly, TRPV5 and TRPV6 possess several potential 
phosphorylation sites for PKC, cAMP- and cGMP-dependent protein kinase (PKA and 
cGK) and Ca2+/calmodulin-dependent protein kinase II (CaMKII) in their N- and C-tails. 
Many of these putative phosphorylation sites are conserved among species, which 
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suggest an important role in TRPV5 and TRPV6 function (Table 1). The characteristic 
pore region of TRPV5 and TRPV6 is unique for its high Ca2+ selectivity [34, 40, 52]. A 
single aspartic residue in the pore region at position number 542 (D542) of TRPV5 is 
crucial for Ca2+ permeation, which is completely conserved in TRPV6 (D541). Mutation 
of D542 into an alanine abolishes Ca2+ permeation, but does not affect the permeation of 
monovalent cations [52].  
Table1. Number of putative phosphorylation sites in the N- and C-tails of TRPV5 and TRPV6  
 
CaMKII 
PKA/cGK 
PKC 
3 
0 
3 
5 
3 
5 
5 
0 
5 
4 
1 
4 
ND 
ND 
ND 
4 
0 
6 
5 
1 
8 
4 
1 
7 
4 
1 
7 
4 
2 
6 
ConservedHuman Mouse Rat Rabbit ConservedHumanMouse Rat Rabbit 
TRPV5 TRPV6 
 
Sequence alignment was performed with the following GenBank sequences: TRPV5: rabbit 
(Oryctolagus cuniculus AJ133128), rat (Rattus norvegicus AB032019), mouse (Mus musculus 
AF336378), human (Homo sapiens AJ271207). TRPV6: rat (R. norvegicus AF160798), mouse 
(M. musculus AB037373), human (H. sapiens AJ487964). PKC: protein kinase C; PKA/cGK: 
cAMP- and cGMP-dependent protein kinase; CaMKII: Ca2+/calmodulin-dependent protein kinase 
II; ND: not determined; Conserved: the number of conserved phosphorylation sites among all 
species. 
 
N-glycosylation of TRPV5 and TRPV6 
Protein glycosylation is the process or result of addition of saccharides to proteins. Two 
types of glycosylation exist: N-linked glycosylation to the amide nitrogen (NH2) of 
asparagine side chains and O-linked glycosylation to the hydroxyl oxygen (OH) of serine 
and threonine side chains. It has been reported that most membrane proteins of mammalian 
cells are glycoproteins (proteins containing glycans). Such glycans have two major functions. 
Inside the cell, they help proteins fold and assemble correctly in the endoplasmic reticulum 
(ER), and they might also act as a signal for the trafficking of glycoproteins. Outside the cell, 
they provide specific recognition structures for interaction with a variety of external ligands 
[53]. Protein N-glycosylation is a metabolic process that has been highly conserved in 
evolution. In all eukaryotes, N-glycosylation is obligatory for viability [54]. It functions by 
modifying appropriate asparagine residues of proteins with oligosaccharide structures, thus 
influencing their properties and bioactivities. N-glycoprotein biosynthesis involves a multitude 
of enzymes, including glycosyltransferases and glycosidases [54-56]. 
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 It has been well known that N-linked oligosaccharides arise when blocks of 14 sugars 
are added cotranslationally to newly synthesized polypeptides in the ER [57]. These 
glycans are then subjected to extensive modification as the glycoproteins mature and 
move through the ER via the Golgi complex to their final destination inside and outside 
the cell. In ER, it has been reported that N-glycans play a pivotal role in protein folding, 
oligomerization, quality control, sorting, and transport, in addition, they are used as 
universal tags that allow specific lectins and modifying enzymes to establish order [58]. 
In the Golgi complex, the glycans acquire more complex structures and new functions. 
The difference of glycan synthesis and processing between the ER and the Golgi 
complex represents an evolutionary adaptation that allows efficient adding of the 
potential oligosaccharides [57-60]. N-glycosylation of proteins is highly conserved from 
yeast to human and has a significant effect on modulating protein structure and 
localization to facilitate proper folding and trafficking of membrane proteins [59]. The 
glycosylation of proteins can be modulated by adaptations in the biosynthetic pathway. 
For instance, dietary variations and also hormones like estradiol can have a significant 
effect on the display of cell-surface carbohydrate epitopes [61]. The effects of 
cotranslational protein modification on the process of protein folding were initially poorly 
understood. Time-resolved fluorescence energy transfer has been used to assess the 
impact of glycosylation on the conformational dynamics of flexible oligopeptides [62]. 
The results showed that glycosylation causes the modified peptides to adopt different 
conformations, and for some peptides this change may lead to more compact 
conformations that better approximate the conformation of these peptides in the final 
folded protein. This result further implied that glycosylation can trigger the timely 
formation of structural elements and thus assist in the complex process of protein folding 
[62].  
The role of N-glycosylation of transmembrane proteins has received great attention, and 
it appears that in some cases it is involved in membrane targeting. To date, several 
studies have focused on the role of N-glycosylation in ion channel activity. It has been 
demonstrated that the gating and trafficking of the voltage gated K+ (Kv) channel is 
regulated by N-glycosylation. Kv1.1 and Kv1.4 channels are plasma membrane 
glycoproteins involved in action potential repolarization. It has been shown previously 
that N-glycosylation affects the gating function of Kv1.1, in addition, the cell-surface 
trafficking of Kv1.1 and Kv1.4 is influenced by glycosylation as well [63-69]. It shows that 
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prevention of N-glycosylation of Kv1.4 decreased its protein stability, induced its high 
intracellular retention, and decreased its cell-surface protein levels [70]. Understanding 
the different trafficking programs of Kv1 channels, and whether they are altered by N-
glycosylation, will highlight the different posttranslational mechanisms available to cells 
to modify their cell-surface ion channel levels and possibly their signaling characteristics. 
Furthermore, Freeman and co-workers elucidated that N-glycosylation influences gating 
and pH sensitivity of the Kv channel subunit I(sK) [71]. Pabon et. al demonstrate that N-
glycosylation of G-protein-activated inwardly rectifying K+ channel (GIRK1) at 
asparagine residue N119 and the renal outer-medullary K+ channel (ROMK1) at 
asparagine residue N117 has different consequences in K+ channel function [72]. 
Similarly, previous studies indicate that inactivation of protein N-glycosylation reduces 
Na+-pump activity [73]. The role of N-glycosylation in epithelial Na+ channel (ENaC) 
trafficking was previously obscure. All three ENaC subunits possess numerous potential 
N-glycosylation sites [74], and it is clear that all subunits are glycosylated in cells. All the 
glycosylation sites are utilized in α-ENaC, and mutating some or all of these sites does 
not seem to affect channel activity [74, 75]. It suggests that at least sugar modification of 
α-subunit does not affect proper trafficking to and insertion of the ENaC channel at the 
plasma membrane. In addition, the role of N-glycosylation in Na+-K+-2Cl- cotransporter 
(NKCC2) functional properties was assayed in one (N442Q or N452Q) or both (N442, 
N452Q) N-glycosylation mutants by Western blotting and confocal microscopy. The 
study suggested that prevention of N-glycosylation reduces NKCC2 functional 
expression by affecting insertion into the plasma membrane and the intrinsic activity of 
the cotransporter [76]. It has been thoroughly studied that the mutation of N-
glycosylation sites influences other protein activities including the gamma-aminobutyric 
acid (GABA) transporter (GAT1) [77], the voltage-gated Ca2+ channels (Cav) [78] and 
cyclic nucleotide-gated ion channel (CNG) [79]. For instance, N-glycosylation of the 
asparagine residues N136 and N184 is necessary for subunit-mediated regulation of Cav 
[78]. In addition, the mutation of the well-conserved N-glycosylation site in bovine retinal 
CNG channel affects the channel function by changing the electrostatic energy profile of 
the external vestibule near the pore [79]. 
Within the TRP superfamily, it has been demonstrated that N-glycosylation regulates 
TRPV1 channel activity [80]. However, in addition to the well-known fact that 
deglycosylation negatively regulates protein trafficking, Xu and co-workers showed that 
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deglycosylation activates TRPV4 channel in response to hypotonic stress, which is 
associated with an increase in plasma membrane targeting of TRPV4 [81]. Like other 
known TRP channels, both TRPV5 and TRPV6 channels contain a single conserved N-
glycosylation site, which is localized in the extracellular loop between TM region 1 and 2. 
This N-glycosylation site locates at the asparagine residue N358 or N357 in TRPV5 and 
TRPV6, respectively.  The studies have demonstrated that these channels are not only 
translated as core proteins, but are also complex-glycosylated resulting in higher 
molecular weight proteins ranging from 85–100 kDa [82]. The intensity of glycosylated 
TRPV5 and TRPV6 bands is reduced after incubation with endoglycosidase H (endoH), 
which hydrolyzes high mannoses. In addition, the bands completely disappear after 
treatment with peptide N-glycosidase F (endoF), which removes all types of sugars. This 
observation indicates that both epithelial channels are highly mannose- and complex-
glycosylated [82]. N-glycosylation of TRPV5 and TRPV6 may play an important role in 
protein folding, intracellular trafficking and channel regulation. 
Architecture of TRPV5 and TRPV6  
The assembly of ion channels has received a lot of attention. For instance, ENaC is 
composed of three structurally related subunits (α, β, γ) that form a tetrameric channel. It 
has been indicated that multiple domains throughout αENaC, when co-expressed with 
αβγENaC, confer a dominant negative phenotype [83]. Thus, these domains may play 
an important role in facilitating and stabilizing subunit-subunit interactions that allow for 
the proper assembly and functional expression of the heterooligomeric ENaC [83]. In 
addition, the tetrameric ROMK provides an important pathway for K+ secretion by the 
mammalian kidney. The X-ray crystal structure of KirBac1.1, a prokaryotic ortholog of 
ROMK, has suggested that channel gating involves intermolecular interactions of the N- 
and C-tail domains of adjacent subunits [84]. A considerable amount of information 
about channel subunit assembly has been accumulated by studies on Kv channels that 
are structurally related to TRP channels. Previous studies indicated that the subfamily of 
Shaker-like Kv channels possesses a T1 domain in their N-tail, which confers subfamily 
specificity and inter-subunit assembly [85]. The designated T1 domain, a highly 
conserved N-tail cytoplasmic domain (around 130 amino acids) immediately preceding 
the first putative TM helix S1, was found to form a tetrameric ring with a narrow, 
positively charged central pore [86]. This highly conserved T1 domain has been shown 
to spontaneously form tetramers in the absence of TM sequences [86, 87]. TM domain 
 - 10 - 
Chapter 1 
(TM1-3) has been implicated to be involved in Kv channel assembly [88]. Crystallization 
of T1 domain further verified the reported biochemical and functional data and implicated 
that T1 is also involved in channel gating [86, 89].  
 
Similar to Kv+ channels, it has been shown that heteromeric complex formation can 
modify the activity of the TRP channels. The Drosophila TRP and TRPL members were 
identified first to form channel hetero-multimers, which are associated with receptors and 
regulators in a signaling complex [90, 91]. Moreover, it has been shown for TRPC1 and 
TRPC3 that hetero-oligomers of these channels possess distinctive properties compared 
to the channel alone [92]. In addition, Strubing et al. [93] demonstrated that TRPC1 and 
TRPC5 are subunits of a heteromeric neuronal channel, and co-expression of these 
channels in HEK293 cells results in a novel non-selective cation channel, unlike that of 
any reported TRPC channel. Other TRPCs also exclusively assemble into homo- or 
hetero-tetramers within the confines of TRPC subfamilies, for instance, TRPC4 and 
TRPC5, TRPC3, TRPC6 and TRPC7 [94]. Recently, the oligomeric structure of another 
TRP member, TRPV1, was studied by biochemical cross-linking. The findings suggested 
the predominant existence of tetramers within the TRPV1 family [95]. 
 
D542 / D541
 Figure 2. Schematic representation of the 
tetrameric organization of the TRPV5 and TRPV6 
pore. Depicted is the cartoon view of the tetrameric 
organization of the TRPV5 and TRPV6 pore. The 
pore-forming regions of 4 monomeric TRPV5 and 
TRPV6 subunits join to form a single pore, thereby 
connecting the aspartic residues D542 / D541 into a 
negatively charged ring, which operate as a 
selectivity filter for Ca2+. 
 
 
 
 
 
 
 
Previously, Hoenderop and coworkers unraveled that TRPV5 and TRPV6 form homo- 
and hetero-tetrameric channel complexes with four subunits configured in a head-to-tail 
fashion [82] (Figure 2). Since TRPV5 and TRPV6 are co-expressed in some tissues, it 
allows oligomerization of these channels in vivo [36, 41, 43]. This study has combined 
several independent methods to demonstrate that TRPV5 and TRPV6 are functional as 
homo- and heterotetrameric Ca2+ channels with novel properties [82]. First, chemical 
cross-linking experiments revealed protein band shifts from monomeric TRPV5 and 
TRPV6 to multimeric compositions. Secondly, sucrose gradient centrifugation confirmed 
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that TRPV5 and TRPV6 channel complexes have a molecular weight in line with a 
tetrameric configuration. Thirdly, co-immunoprecipitations demonstrated that TRPV5 and 
TRPV6 subunits are physically linked to each other. Fourthly, electrophysiological 
analyses of concatemeric polypeptides revealed that all (hetero)tetrameric TRPV5 and 
TRPV6 channels are functional with differences in transport kinetics. Finally, the 
tetrameric structure was investigated in a functional assay, following a similar approach 
to that previously used to prove the tetrameric stoichiometry of the structurally related 
Shaker-like Kv+ channel [96] and cyclic nucleotide-gated channel (CNG) [97]. Detailed 
information concerning protein structure and assembly of ion channels containing six TM 
domains is available for Shaker-like Kv+ and CNG channels. The selective assembly of 
heteromeric  CNG channels requires a trimer-forming C-tail leucine zipper (CLZ) domain 
[98]. The clustering of four subunits in six TM domain channels is assumed to create an 
aqueous pore centered around the 4-fold symmetry axis [86]. It has been previously 
demonstrated that a single aspartic residue in the aqueous pore region of TRPV5 (D542) 
determines the Ca2+ permeation of the channel [52], which is completely conserved in 
TRPV6 (D541). The tetrameric architecture of TRPV5 and TRPV6 implies that four 
aspartates (TRPV5-D542 and TRPV6-D541) contribute to the selectivity filter for Ca2+, by 
analogy with the four negatively charged glutamates and/or aspartates that determine 
the Ca2+ selectivity in Cav channels [99, 100]. Although the overall structure of TRPV5 
and TRPV6 is similar to that of Cav channels, the mode of subunit assembly appears to 
be different for TRPV5 and TRPV6, since four individual TRPV5 and/or TRPV6 subunits 
have to assemble to form a functional channel, whereas functional Cav channels are 
monomeric proteins containing four homologous internal repeats. It has been shown that 
Cav channels assemble through α-interaction domain (AID), β-interaction domain (BID) 
and an extensive, conserved hydrophobic cleft (named the a-binding pocket, ABP) [101, 
102]. As TRPV5 and TRPV6 exhibit different channel kinetics, heterotetrameric TRPV5 
and TRPV6 proteins displayed properties that, depending on the subunit configuration, 
are intermediate between TRPV5 and TRPV6. An increased number of TRPV5 subunits 
in such a concatemer expresses more TRPV5-like properties, indicating that the 
stoichiometry of TRPV5 and TRPV6 heterotetramers influences the channel properties 
[82]. In addition, replacing individual TRPV5 subunits by TRPV6 subunits in a TRPV5 
tetramer has major effects on Ba2+ permeability, Ca2+-dependent inactivation and the 
block by ruthenium red. In this way, Ca2+-transporting epithelia co-expressing TRPV5 
and TRPV6 may be able to generate a pleiotropic set of functional heterotetrameric 
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channels. Variation in the individual subunits of this tetramer could provide a mechanism 
for fine tuning the Ca2+ transport kinetics in Ca2+-transporting epithelia. Consequently, it 
would be interesting to determine which molecular structures in TRPV5 and TRPV6 are 
involved in tetramerization. Hypothetically, assembly of TRPV5 and TRPV6 channels 
might involve the ankyrin repeats and the PDZ motif in the N- and C-tail [103]. The 
different characteristics of TRP channels compared to other ion channels are shown in 
Table 2, including their selectivity, localization, type of glycosylation and assembly 
domains, and so on. 
 
 
 
Table 2. The comparison of TRP channels with the other ion channels
N-gly. Tetra. Assembly 
domain 
      Channels Selectivity Renal 
localization  
Topology Reference 
 
53, 80-82,  
90-95, 108  
78, 99-102 
79, 97, 98 
63-70,  
85-89, 96 
74, 75, 83 
 
TRP Ca2+, Na+, Mg2+ Unknown Yes Yes DCT, CNT, TAL  
 
 Ca2+ ABP, AID, 
BID
Yes Yes Cav Unknown 
 
 
K+, Na+, Cl- Yes CLZ Yes Unknown CNG  
 
 K+ N-tail: T1 
TM: 1-3
Yes Yes Kv IMCD, PT 
  
 Multiple α- 
subunit 
domain 
 
Na+ Yes Yes 
 
ENaC DCT, CNT, CD 
 
K+ 72, 84 Yes Yes Yes  ROMK TAL, CD 
 
 
 
 
 
 
TRP: transient receptor potential channel; Cav: voltage-gated Ca2+ channel; CNG: cyclic nucleotide-
gated channel; Kv: voltage-gated K+ channel; ENaC: epithelial Na+ channel; ROMK: renal outer-
medullary K+ channel; N-gly.: N-glycosylation; tetra.: tetramerization; AID: α-interaction domain; BID: β-
interaction domain; ABP: α-binding pocket; CLZ: C-tail leucine zipper domain. DCT: distal convoluted 
tubule; CNT: connecting tubule; TAL: thick ascending limb of Henle’s loop; IMCD: inter modular 
collecting duct; PT: proximal tubule; CD: collecting duct; TM: transmembrane domain.  
Ankyrin repeats of TRPV5 and TRPV6 
In general, ankyrin repeats can interconnect integral membrane proteins such as ion 
channels with the spectrin-actin based cytoskeletal elements in specialized membrane 
domains, enabling protein trafficking to the plasma membrane and channel regulation 
via actin filaments [104, 105]. Ankyrin-binding proteins include the voltage-dependent 
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Na+ channel, Na+-K+-ATPase, Na+-Ca2+- exchanger, IP3 receptor and ryanodine receptor 
Ca2+ release channels. The membrane-binding domain of ankyrins is comprised of one 
or more copies of a 33-residue repeat known as the ankyrin repeat. This protein-protein 
interaction module is involved in a diverse set of cellular functions, and consequently, 
defects in ankyrin repeat proteins result in a number of human diseases [106, 107]. 
TRPV5 and TRPV6 contain several ankyrin repeat domains in their N-tails, which could 
be involved in the maintenance and targeting of these channels to specific membrane 
regions, as has been demonstrated for a neural-specific isoform of ankyrin in the 
localization of Na+ channels [105]. Interestingly, Erler et al. [108] identified a specific N-
tail domain encompassing the third ankyrin repeat being a stringent requirement for 
physical assembly of TRPV6 subunits. Deletion of this repeat or mutation of critical 
residues within this repeat renders non-functional channels that do not co-
immunoprecipitate or form tetramers. It was proposed that the third ankyrin repeat 
initiates a molecular zippering process that proceeds past the fifth ankyrin repeat and 
creates an intracellular anchor that is necessary for functional subunit assembly [108]. 
These studies provide evidence that ankyrin repeats in the N-tail of TRPV6 are essential 
for subunit assembly [108]. Importantly, it is likely that this assembly domain also exists 
in the N-tail of TRPV5, because these two channels share 75% homology at the amino 
acid level, raising the possibility that both N-tail or C-tail assemble together in order to 
form functional heterotetrameric channel complexes of TRPV5 and TRPV6 [82]. Detailed 
sequence comparison of the N- and C-tails of the TRPV5 and TRPV6 channels reveals 
significant differences, which may account for the unique electrophysiological properties 
[41, 82]. In addition, the assembly domains could differ between the two channels in 
order to specifically allow self-assembly or the formation of heterotetrameric channels 
[82]. Deleting or mutating assembly domains could cause a change in tertiary structure 
and/or prevent the interaction with auxiliary proteins, thereby affecting channel trafficking 
and activity of TRPV5 and TRPV6. 
  
The role of TRPV5 and TRPV6 in Ca2+ homeostasis  
Maintenance of body Ca2+ homeostasis is of vital importance for many physiological 
functions including intracellular signaling processes, synaptic transmission in neurons, 
neuronal excitability, muscle contraction, blood clotting, fertilization and bone formation. 
The extracellular Ca2+ concentration should, therefore, be tightly regulated. Ca2+ 
homeostasis in humans is achieved by a mechanism tightly controlling the concerted 
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actions of intestinal Ca2+ absorption, exchange the Ca2+ from the bone mass and renal 
Ca2+ reabsorption [109, 110]. There are two pathways for Ca2+ to pass through renal 
epithelium and reach the blood compartment. The major one is by passive paracellular 
transport together with Na+ in the proximal tubules and the second is by active 
transcellular Ca2+ transport in DCT and CNT tubules (Figure 3) [111]. Even though the 
distal part of the nephron is responsible for only ~15% of total renal Ca2+ reabsorption, it 
is generally regarded as the site for fine-tuning of the urinary Ca2+ reabsorption 
independently of the Na+ balance [45, 112, 113]. This transport is mediated by three 
discrete steps: (i) Ca2+ entry from the pro-urine across the apical membrane via TRPV5; 
(ii) Ca2+ buffering and intracellular diffusion from apical to basolateral membrane by 
calbindins; (iii) Ca2+ extrusion across the basolateral membrane via NCX1 and/or 
PMCA1b into the blood (Figure 3) [28, 29, 109].  
 
A B  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Localization and mechanism of epithelial Ca2+ transport. (A) Model of the nephron, the 
functional unit of the kidney, depicting the TRPV5 expressing sections in the DCT and CNT tubule. (B) 
Epithelia can absorb Ca2+ by paracellular and transcellular transport. Passive and paracellular Ca2+ 
transport takes place across the tight junctions and is driven by the electrochemical gradient for Ca2+. 
The active form of vitamin D, 1,25-dihydroxy-vitamin D3 (1,25-(OH)2D3), stimulates the individual steps 
of transcellular Ca2+ transport by increasing the expression levels of the luminal Ca2+ channels, 
calbindins, and the extrusion systems. Active and transcellular Ca2+ transport is carried out as a three-
step process. Following entry of Ca2+ through the (hetero)tetrameric epithelial Ca2+ channels, TRPV5 
and TRPV6, Ca2+ bound to calbindin diffuses to the basolateral membrane. At the basolateral 
membrane, Ca2+ is extruded via a ATP-dependent Ca2+-ATPase (PMCA1b) and a Na+/Ca2+ exchanger 
(NCX1). In this way, there is net Ca2+ absorption from the luminal space to the extracellular 
compartment. DCT: distal convoluted tubule; CNT: connecting tubule; PMCA1b: plasma membrane 
Ca2+ -ATPase 1b; NCX1: Na+-Ca2+ exchanger 1.  
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TRPV5 and TRPV6 are generally considered as the gatekeepers of transcellular Ca2+ 
transport, and therefore the regulation of Ca2+ influx across the luminal membrane 
through these channels is particularly crucial. To unravel the role of TRPV5 and TRPV6 
in maintaining the Ca2+ balance, the characterization of TRPV5 and TRPV6 knockout 
mice is instrumental. Hoenderop et al. [114] generated TRPV5 null (TRPV5-/-) mice by 
genetic ablation of TRPV5 to investigate the requirement of TRPV5 functioning in renal 
and intestinal Ca2+ (re)absorption. Interestingly, metabolic studies demonstrated that 
TRPV5-/- mice display a significant calciuresis compared to wild-type littermates 
(TRPV5+/+) while remaining normocalcemia. However, the active metabolite vitamin D 
(1,25(OH)2D3) levels in serum are significantly elevated in TRPV5-/- mice compared with 
TRPV5+/+ mice. In addition, polyuria and urine acidification were consistently observed in 
TRPV5-/- mice, which have been elucidated to reduce the potential risk of renal stone 
formation due to urine acidification [113, 115]. Micropuncture studies indicated that the 
renal Ca2+ transport defect is localized in the DCT/CNT. Furthermore, ablation of TRPV5 
in the DCT is accompanied by a concomitant decrease in calbindin-D28k and NCX1 
mRNA levels. The excessive renal Ca2+ wasting is compensated by an enhanced 
intestinal Ca2+ absorption as a result of increased TRPV6 and calbindin-D9k expression, 
explaining the normocalcemia. Moreover, the TRPV5-/- mice exhibit significant 
disturbances in bone structure, including reduced trabecular and cortical bone thickness 
compared with TRPV5+/+ mice [109]. All together, ablation of the TRPV5 gene seriously 
disturbs renal Ca2+ handling, resulting in compensatory intestinal hyperabsorption and 
bone abnormalities. Hediger and co-workers [116] addressed the functional role of 
TRPV6 in Ca2+ absorption by inactivation of the mouse TRPV6 gene. These TRPV6 null 
(TRPV6-/-) mice were placed on a Ca2+-deficient diet and subsequently applied in a 
45Ca2+ absorption assay. TRPV6-/- mice show a consistent decrease in Ca2+ absorption 
over time. From their preliminary data it was concluded that TRPV6-/- mice show a 
significant Ca2+ malabsorption, suggesting that TRPV6 is indeed the rate-limiting step in 
1,25-OH2D3-dependent Ca2+ absorption. 
 
Regulation of TRPV5 and TRPV6 
TRPV5 and TRPV6 are synthesized in the endoplasmic reticulum (ER) and are 
subsequently modified by oligosaccharide structures at appropriate asparagine residues 
through the ER to the Golgi complex, and finally transported towards their destination: 
plasma membrane. Regulation of TRPV5 and TRPV6 can, hypothetically, occur at the 
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level of (i) transcriptional and translational regulation by 1,25-dihydroxy-vitamin D3 (1,25-
(OH)2D3), dietary Ca2+, estrogen and parathyroid hormone (PTH); (ii) intracellular 
trafficking and routing regulation to the plasma membrane by S100A10/annexin 2; (iii) 
direct (in)activation of channel activity at the plasma membrane by pH, intracellular Ca2+, 
and Ca2+ sensors (calmodulin and 80K-H) (Figure 4).   
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Figure 4． Integrated model of TRPV5 and TRPV6 regulation. TRPV5 and TRPV6 is synthesized in 
the ER and is subsequently transported towards the plasma membrane. Regulation of TRPV5 and 
TRPV6 can, hypothetically, occur at the level of (1) transcriptional and translational regulation by 1,25-
(OH)2D3, dietary Ca2+, estrogen and PTH; (2) intracellular trafficking and routing of channels to the 
plasma membrane by S100A10/annexin 2; (3) direct (in)activation of channel activity at the plasma 
membrane by pH, intracellular Ca2+, and (4) Ca2+-sensors: 80K-H and calmodulin. [Ca2+]i: Ca2+ 
concentration; PTH: parathyroid hormone; 1,25-(OH)2D3: 1,25-dihydroxy-vitamin D3; CaM: calmodulin. 
A. TRPV5 and TRPV6 regulation at the transcriptional and translational level 
 
Parathyroid hormone  
Parathyroid hormone (PTH) is the calciotropic hormone controlling the Ca2+ balance [109, 
117, 118]. Early studies using micropuncture and cell preparations demonstrated that 
PTH directly stimulates active Ca2+ reabsorption in the distal part of the nephron [119, 
120]. In addition, PTH stimulates the activity of 1α-OHase, a crucial enzyme in the 
biosynthesis of 1,25-(OH)2D3 and, thereby, increases the 1,25-(OH)2D3-dependent 
absorption of Ca2+ in the small intestine [121].  Van Abel et al. [122] recently 
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demonstrated that parathyroidectomy (PTX) in rats results in decreased serum PTH 
levels and hypocalcaemia, which is accompanied by decreased TRPV5 and 
calbindinD28k mRNA levels and protein abundance [122]. Supplementation with PTH 
restores serum Ca2+ concentrations, TRPV5 and calbindinD28k abundance in kidney, 
suggesting that PTH affects renal Ca2+ handling through the regulation of TRPV5. 
 
1,25-dihydroxy-vitamin D3  
Various studies have provided evidence that the expression of TRPV5 and TRPV6 is 
tightly controlled by 1,25-dihydroxy-vitamin D3 (1,25-(OH)2D3) [42, 123-133]. In mice, a 
single dose of 1,25-(OH)2D3 up-regulates renal TRPV5 and duodenal TRPV6 mRNA 
levels, illustrating the genomic vitamin D response [126, 133]. In vitamin D receptor 
knockout (VDR-/-) mice, duodenal TRPV6 mRNA levels are significantly down-regulated 
and associated with decreased intestinal Ca2+ absorption and hypocalcemia [38, 126]. 
Targeted ablation of 1α-OHase in mice, leading to an impairment of 1,25-(OH)2D3 
biosynthesis, was shown to result in severe hypocalcemia and down-regulation of both 
renal TRPV5 and intestinal TRPV6 expression. Repletion with 1,25-(OH)2D3 restores 
Ca2+ channel expression levels and normalizes serum Ca2+ levels. Taken together, the 
transcriptional and translational levels of TRPV5 and TRPV6 is regulated by 1,25-
(OH)2D3. 
 
Estrogen and androgen 
Given the fact that the postmenopausal estrogen deficiency results in a negative Ca2+ 
balance associated with osteoporosis [134, 135] and this disturbed Ca2+ balance can be 
corrected by estrogen replacement therapy [136-139]. The effect of estrogen on the 
proteins involved in active Ca2+ (re)absorption was investigated in ovariectomized (OVX) 
1α-OHase knockout (1α-OHase-/-) mice. 17β-estradiol replacement therapy results in 
upregulation of renal TRPV5, which is accompanied by a normalization of serum Ca2+ 
levels. Furthermore, in duodenum both TRPV5 and TRPV6 mRNA levels are 
upregulated in these supplemented mice [125, 140]. Thus, TRPV5 and TRPV6 
expression is transcriptionally controlled by estrogen in a vitamin D-independent manner. 
Van Cromphaut and co-workers [141] reported that renal TRPV5 and duodenal TRPV6 
expression is reduced in estrogen receptor knockout mice and subsequently upregulated 
by estrogen treatment. In addition, Peng and co-workers [48] showed that TRPV6 
expression is particularly increased in androgen-sensitive prostate adenocarcinoma cell 
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lines as compared to androgen-insensitive cells. Dihydrotestosteron and androgen-
receptor (AR) antagonists were shown to regulate TRPV6 in these cell lines. Thus, 
besides estrogens, androgens also appear to regulate TRPV6 expression.  
 
Dietary Ca2+   
In addition to the calciotropic hormones, there are indications that Ca2+ itself can affect 
TRPV5 and TRPV6 expression. To further address this question, studies were 
performed in VDR-/- and 1α-OHase-/- mice fed with normal and high Ca2+ diets [124, 127]. 
Importantly, high dietary Ca2+ intake restores the reduced renal TRPV5 and intestinal 
TRPV6 expression in 1α-OHase-/- mice, which is accompanied by normalization of the 
serum Ca2+ concentration. In contrast, the Ca2+-enriched rescue diet increases the 
serum Ca2+ concentration, and subsequently reduces the expression of renal TRPV5 
and calbindin-D28K in wild-type mice [124, 126, 127]. Similarly, dietary rescue of the 
hypocalcemic state in VDR-/- mice amends the significantly decreased duodenal TRPV5 
and TRPV6 mRNA expression, whereas in wild-type mice high dietary Ca2+ content 
decreases TRPV5 and TRPV6 expression due to a decrease of serum 1,25-(OH)2D3 
level [126].  
Table 3. Hormonal regulation of TRPV5 and TRPV6 in the target organs  
 Kidney Duodenum Reference
 
TRPV5 TRPV6 TRPV5 TRPV6 
 ↓ 124, 126 NDHigh Ca2+ diet ↓↓
 42, 126 ↑ Wild-type+VitD ↑ ↑↑
 124, 125 ↓ 1α-OHase-/- ND UN↓ 
↑ ND 124, 125 1α-OHase-/- +VitD  ↑↑
 ND UN1α-OHase-/- +dietary Ca2+ 124, 125 ↑ ↑
 ↑ ND1α-OHase-/- +estrogen 125, 140 UN↑
 ↓ VDR-/- 38, 126 ↓↓↓ 
↑ 125, 140 OVX +estrogen ND↑ ↑ 
48  Androgen ↓ ProstateND
 48 AR+antagonist ↑ ProstateND
 
 
 
 
ND 
ND ND=
=
↑
↓PTX 
PTX+PTH 
122 ND
122 
 
 
 
 
 
↑: upregulation; ↓: downregulation; UN: undetectable; =: not changed; ND; not determined; Wild-type: 
wild-type mice; VitD: 1,25(OH)2D3; 1α-OHase-/-: 1α-OHase knockout mice; VDR-/-: vitamin D receptor 
knockout mice; OVX: ovarioectomized; AR: androgen receptor; PTX: parathyroidectomized; PTH: 
parathyroid hormone.  
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Therefore, these studies showed that Ca2+ supplementation can up-regulate TRPV5 and 
TRPV6 gene transcription in the absence of circulating 1,25-(OH)2D3. Hormonal 
regulation of TRPV5 and TRPV6 is summarized in Table 3. 
 
B. Regulation of TRPV5 and TRPV6 activity at the plasma membrane 
 
pH  
Studies using primary cultures of rabbit CNT and CCD cells indicated that acidification of 
the apical medium inhibits transcellular Ca2+ reabsorption [29, 142, 143]. In addition, pH 
directly influences TRPV5 and TRPV6 channel activity at the apical plasma membrane. 
TRPV5 expressing Xenopus laevis oocytes showed decreased 45Ca2+ uptake when the 
incubation medium is acidified and extracellular acidification significantly reduces Ca2+ 
influx through TRPV5 [144]. Extracellular pH also affects current kinetics including 
extracellular Mg2+ blockade and Ca2+ affinity. The mean current density decreases at 
acidic pH and increases at alkaline pH. Recently, Yeh and co-workers [144] showed that 
mutation of the glutamic acid (Glu) residue at position 522 to glutamine (Gln) near the 
pore helix decreases the inhibition of TRPV5 by extracellular acidification. Taken 
together, these data suggest that the luminal pH directly regulates Ca2+ entry through the 
epithelial Ca2+ channels in vivo. 
 
Ca2+-dependent feedback inhibition 
In mammalian cells, TRPV5 and TRPV6 are constitutively open at a low-intracellular 
Ca2+ concentration and a negative membrane potential [32, 145, 146].  These findings 
suggest that intracellular Ca2+ exerts a negative feedback mechanism on TRPV5 and 
TRPV6 activity [41]. Both Ca2+ channels inactivate during hyperpolarizing voltage-steps 
and this inhibition is reduced when Ca2+ is substituted for Ba2+ or Sr2+ as charge carriers. 
However, the inactivation of TRPV6 is characterized by a slow decline after an initial fast 
inactivation phase, whereas TRPV5 only shows the slow inactivation phase [145, 147]. 
In addition, the difference in Ca2+-dependent inactivation between TRPV5 and TRPV6 is 
restricted to the first intracellular loop between TM domain 2 and 3 [147]. These data 
suggested that TRPV5 and TRPV6 activity is inhibited by Ca2+ influx through the channel, 
which could be a crucial mechanism for the regulation of TRPV5 and TRPV6 at the 
plasma membrane under physiological conditions [35, 148, 149]. 
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Ca2+ sensors 
1. Calmodulin  
Calmodulin (CaM) is a ubiquitous cytosolic protein known to play a pivotal role in Ca2+-
dependent inactivation, acting as a Ca2+ sensor, thereby facilitating both activation and 
inactivation of different ion channels, including voltage- and ligand-gated Ca2+ channels 
[150], Ca2+ pumps, and other proteins in a Ca2+-dependent manner [151].  CaM consists 
of four Ca2+-binding EF-hand structures, which are localized in the N- and C-tails. Ca2+ 
binding to CaM is highly cooperative with Ca2+ binding first to the C-tail EF-hands, which 
have the highest affinity for Ca2+, followed by Ca2+ binding to lower affinity sites located 
in the N-tail [152]. CaM has been shown to modulate several other members from the 
TRP superfamily [153-163], for instance, modulation of TRPV1 and TRPC1. TRPV5 and 
TRPV6 activity is negatively regulated by the intracellular Ca2+ concentration and CaM 
could mediate the regulation of the activity of TRPV6. Niemeyer et al. showed for the 
first time that CaM binds to the C-tail of human TRPV6 in a Ca2+-dependent manner [151, 
164]. The regulation of TRPV6 by CaM was recently confirmed by Lambers et al. [165]. 
By combination of pull-down assays and co-immunoprecipitations, it was demonstrated 
that CaM binds to both TRPV5 and TRPV6 in a Ca2+-dependent fashion. The binding of 
CaM to mouse TRPV6 is localized to the TM domain and consensus CaM binding motifs 
locate in the N-tail [1–5-10 motif, TRPV6-(88-97)] and C-tail [1–8-14 motif, TRPV6-(643-
656)], suggesting a mechanism of regulation involving multiple interaction sites [165]. 
Electrophysiological measurements of HEK293 cells heterologously co-expressing Ca2+-
insensitive CaM mutants and TRPV6 revealed a significantly reduced Ca2+ inward 
current, whereas, no effect was demonstrated on currents of TRPV5-expressing cells 
[165]. This finding is remarkable given the high homology between both channels, 
similar Ca2+-dependent regulation of channel activity, and binding of CaM to both 
channels [41, 165, 166].  
 
2. 80K-H  
In an effort to identify novel regulators of Ca2+ reabsorption by TRPV5, Gkika et al. used 
cDNA microarray analysis, which identified PKC substrate 80K-H as a potential 
associated protein involved in the Ca2+-dependent control of TRPV5 [167]. This study 
reported a specific interaction between 80K-H and TRPV5 and showed that a highly 
conserved short peptide sequence (MLERK) in the TRPV5 C-tail is necessary for 80K-H 
binding [167]. Furthermore, 80K-H was shown to bind Ca2+ directly and inactivation of its 
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two EF-hand structures totally abolishes Ca2+ binding. Electrophysiological studies using 
80K-H mutants showed that three domains of 80K-H (a pair of EF-hand structures, a 
highly acidic glutamic stretch and a His–Asp–Glu–Leu sequence) are critical 
determinants for TRPV5 activity. Importantly, inactivation of the EF-hand pair reduces 
the TRPV5-mediated Ca2+ current and increases the TRPV5 sensitivity for intracellular 
Ca2+, accelerating the feedback inhibition of the channel. None of the 80K-H mutants 
alters the TRPV5 plasma membrane localization or the association of 80K-H with 
TRPV5, suggesting that 80K-H has a direct effect on TRPV5 activity at the plasma 
membrane. It was shown that both proteins co-localize in the distal part of the nephron, 
indicating that regulation of TRPV5 by 80K-H could occur in vivo. Furthermore, parallel 
transcriptional regulation of both proteins by 1,25-(OH)2D3 and dietary Ca2+ was 
demonstrated [168]. Taken together, 80K-H acts as novel Ca2+ sensor controlling 
TRPV5 channel activity at the plasma membrane. 
 
C. Regulation of trafficking of TRPV5 and TRPV6 
 
S100A10  
Directed trafficking of channels and transporters to the plasma membrane is essential for 
transcellular ion transport. Previously, an auxiliary protein of TRPV5 and TRPV6 was 
identified by screening a mouse kidney cDNA library with a yeast two-hybrid system. A 
bait was constructed with the cytoplasmic C-tail of TRPV5. This study described the 
identification of the first auxiliary protein for both TRPV5 and TRPV6, named S100A10, 
which specifically associates with the C-tail of these epithelial Ca2+ channels [169]. Van 
de Graaf et al. [169] provided the first evidence of a regulatory role for the S100A10-
annexin 2 heterotetramer in the trafficking of TRPV5 and TRPV6. S100A10 is 
predominantly present as a heterotetrameric complex with annexin 2, which has been 
implicated in numerous biological processes including endocytosis, exocytosis, and 
membrane-cytoskeleton interactions [170]. The association of S100A10 with TRPV5 and 
TRPV6 is restricted to a short conserved peptide sequence VATTV located in the C-tail 
of these channels. This stretch is conserved among all identified species of TRPV5 and 
TRPV6 [169]. The first threonine (T) of this sequence was identified as the crucial amino 
acid for binding and channel function. When this particular threonine is mutated, the 
activity of TRPV5 and TRPV6 is abolished accompanied by a major disturbance in their 
subcellular localization. This suggests that the S100A10-annexin 2 heterotetramer 
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facilitates the translocation of TRPV5 and TRPV6 channels towards the plasma 
membrane. The importance of annexin 2 in this process was demonstrated by showing 
that small interfering RNA (siRNA)-based downregulation of annexin 2 significantly 
inhibits TRPV5 and TRPV6 currents. The latter demonstrated that annexin 2 in 
conjunction with S100A10 is crucial for TRPV5 and TRPV6 activity. Taken together, 
these findings showed that the S100A10-annexin 2 complex is a significant component 
for the trafficking of ion channels to the plasma membrane in general and in particular a 
major regulator of TRPV5 and TRPV6 function and, therefore, maintenance of the Ca2+ 
balance.  
 
Goal of this thesis 
 
Ca2+ homeostasis is of utmost importance for the normal development and function of 
the body. Active transcellular Ca2+ transport involves a chain of Ca2+ transport proteins 
mediating apical Ca2+ influx, transport to the basolateral membrane and extrusion into 
the bloodstream. Regulation of the two epithelial Ca2+ channels, TRPV5 and TRPV6 that 
mediate the rate-limiting cellular Ca2+ entry steps, is pivotal to control the transcellular 
Ca2+ transport rate. In this respect, elucidation of the mechanisms underlying the 
molecular structure and regulation of TRPV5 and TRPV6 activity is instrumental to better 
comprehend the molecular nature of Ca2+ homeostasis. Although the understanding of 
function, regulation and structure assembly of the TRP family is developing rapidly, 
many aspects of TRPV5 and TRPV6 regulation remain elusive. The goal of this thesis 
was, therefore, to unravel the molecular structure and regulation mechanisms of TRPV5 
and TRPV6.   
 
In chapter 2, the assembly motif of TRPV5 forming tetrameric complexes was 
investigated. To this aim, different experimental approaches, including GST pull-down, 
co-immunoprecipitation assays were applied, by which two critical assembly domains in 
the N- and C-tail of TRPV5 were identified. At the functional level, electrophysiological 
analysis, 45Ca2+ uptake and immunocytochemical assays elucidated the pivotal role of 
TRPV5 assembly in the channel trafficking to the plasma membrane. The aim of chapter 
3 was to identify new TRPV5 or TRPV6 interacting proteins. To this end, we employed a 
yeast two-hybrid approach using the C-tail of either TRPV5 or TRPV6. The identified 
interacting protein Rab11a was subsequently characterized using biochemical, 
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histological, and functional analyses to elucidate a novel operation mode for Rab11a in 
the regulation of TRPV5 and TRPV6 trafficking to the plasma membrane. In chapter 4, 
we performed microarray analysis in TRPV5-/- mice in order to screen for genes 
encoding candidate proteins involved in Ca2+ reabsorption. Via this method, the anti-
aging hormone klotho was identified as a putative regulatory protein of TRPV5. Using 
electrophysiological analysis, 45Ca2+ uptake and cell-surface biotinylation assays to 
characterize the klotho function, this study showed for the first time a novel mechanism 
through which a glycosylated cell-surface protein, TRPV5, is regulated by the 
extracellular β-glucuronidase klotho. In chapter 5, the aim was to investigate the 
molecular mechanism of hypercalciuria observed in tissue kallikrein knockout (TK-/-) 
mice. To this end, the relation between TK expression and hypercalciuria was investigated in 
vivo using TK-/- and TRPV5-/- mice. Subsequently, the effect of TK on transcellular Ca2+ 
transport was examined in primary cultures of renal CNT and CCT cells. The signaling 
pathway through which TK acts on Ca2+ reabsorption as well as its effect on TRPV5 surface 
expression were delineated in TRPV5-expressing cells. Chapter 6 demonstrated the effect 
of different glycosidase proteins in addition to β-glucuronidase and klotho on TRPV5 
activity. Using 45Ca2+ uptake assay, our study identified another two TRPV5 stimulatory 
glycosidases: endoF and sialidase. Further, by performing cell-surface biotinylation 
assay, the mechanism of this glycosidase-mediated TRPV5 activation and the role of N-
glycosylation in TRPV5 regulation have been revealed. Moreover, to examine whether 
the klotho effect is restricted to TRPV5 or more generally applicable to other renal 
apically localized channels or transporters in DCT cells, we selected the candidates 
within the TRP channels including TRPV6, TRPV4 and TRPM6. Additionally, a Na+-Cl- 
cotransporter (NCC) was picked up as a candidate in this study. By applying 45Ca2+ and 
22Na+ uptake analyses, we demonstrated a predominantly stimulatory effect of klotho on 
the epithelial Ca2+ channels TRPV5 and TRPV6. Finally, the findings in this thesis are 
generally discussed and a summary is presented in chapter 8.  
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 The most glorious moment in your life are not the socalled days of success, 
but rather those days when out of dejection and despair you feel rise in you 
a challenge to life, and the promise of future accomplishment. (Gustave 
Flaubert) 
你的一生中，最为辉煌的一天并不是功成名就的那些天，而是从悲叹与绝望
中产生对人生的挑战和对未来辉煌的期盼的那些日子。(福楼拜 G) 
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Abstract 
 
The epithelial Ca2+ channels TRPV5 and TRPV6 mediate the Ca2+ influx in 1,25-
dihydroxy-vitamin D3-responsive epithelia, and are, therefore, essential in the 
maintenance of the body Ca2+ balance. These Ca2+ channels assemble in 
(hetero)tetrameric channel complexes with different functional characteristics regarding 
Ca2+-dependent inactivation, ion selectivity and pharmacological block. GST pull-downs 
and co-immunoprecipitations demonstrated an essential role of the intracellular N- and 
C-tails in TRPV5 channel assembly by physical interactions between N-N tails, C-C tails 
and N-C-tails. Patch-clamp analysis in human embryonic kidney (HEK293) cells and 
45Ca2+ uptake experiments in Xenopus laevis oocytes co-expressing TRPV5 wild-type 
and truncates indicated that TRPV5ΔN (deleted N-tail) and TRPV5ΔC (deleted C-tail) 
decreased channel activity of wild-type TRPV5 in a dominant-negative manner, whereas 
TRPV5ΔNΔC (deleted N-tail/C-tail) did not affect TRPV5 activity. Oocytes co-expressing 
wild-type TRPV5 and TRPV5ΔN or TRPV5ΔC showed virtually no wild-type TRPV5 
expression at the plasma membrane, whereas co-expression of wild-type TRPV5 and 
TRPV5ΔNΔC displayed normal channel surface expression. This indicates that TRPV5 
trafficking towards the plasma membrane was disturbed by assembly with TRPV5ΔN or 
TRPV5ΔC, but not with TRPV5ΔNΔC. TRPV5 channel assembly signals were refined 
between amino acid position 64-77 and 596-601 in the N-tail and C-tail, respectively. 
Pull-down assays and co-immunoprecipitations demonstrated that N- or C-tail mutants 
lacking these critical assembly domains were unable to interact with tails of TRPV5. In 
conclusion, two domains in the N-tail (64-77) and C-tail (596-601) of TRPV5 are 
important for channel subunit assembly, subsequent trafficking of the TRPV5 channel 
complex to the plasma membrane and channel activity. 
 
Introduction 
 
TRPV5 and TRPV6 constitute the Ca2+ influx pathway in 1,25-dihydroxy-vitamin D3-
responsive epithelia, including small intestine, kidney and placenta, and play a vital role 
in the process of Ca2+ (re)absorption [1-4]. Both channels belong to a distinct subfamily 
(TRPV) within the superfamily of Transient Receptor Potential channels (TRP). The TRP 
family consists of  a diverse group of non-voltage-gated cation channels, including TRPC 
(canonical), TRPM (melastatin) and TPRV (vanilloid) subfamilies, which varies 
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significantly in their selectivity and mode of activation  [5]. The understanding of the 
function, gating, regulation and structure assembly of the TRP family is developing 
rapidly. Initially, it was demonstrated that the Drosophila TRP and TRPL members form 
heteromultimeric channels associated in a supramolecular signaling complex with 
specific receptors and regulators [6]. Moreover, it has been identified that there are many 
channel compositions within the TRPC family, for instance, TRPC1 & 3, TRPC1 & 5, 
TRPC4 & 5, TRPC3 & 6 & 7 [7-9]. Within the TRPV family, the oligomeric structure of 
TRPV1 was studied by biochemical cross-linking and the predominant existence of 
tetramers was suggested [10]. More recently, it has been reported that TRPV5 and 
TRPV6 form homo- or hetero-tetramers in order to generate a pleiotropic set of 
functional channels with different Ca2+ transport [11-13]. TRPV5 and TRPV6 share 75 % 
sequence homology at the amino acid level [11-13] and display several similar functional 
properties, including the permeation profile for monovalent and divalent cations [14], and 
regulation by calciotropic hormones [15-21]. However, detailed sequence comparison of 
the N- and C-tails of the TRPV5 and TRPV6 channels reveals significant differences, 
which may account for the unique electrophysiological properties including differences of 
inactivation, kinetic properties, and affinity for the blocker ruthenium red between these 
two homologous channels [22].  
 
A considerable amount of information in channel subunit assembly has been 
accumulated by studies on voltage-gated K+ (Kv) channels that are structurally related to 
the TRP channels. Previous studies indicated that the subfamily of Shaker-related Kv 
channels possesses a T1 domain in the N-tail, which confers subfamily specificity and 
inter-subunit assembly [23]. This highly conserved T1 domain has been shown to 
spontaneously form tetramers in the absence of transmembrane sequences [24, 25]. 
Crystallization of this domain further verified the reported biochemical and functional 
data and implicated that T1 is also involved in channel gating [25, 26]. To date, no 
information is available about assembly domains in TRP proteins. Because TRPV5 
shares common structural features with Kv channels, we hypothesized that there is at 
least one assembly signal within this channel.  
 
The aim of the present study was, therefore, to identify the regions in TRPV5 involved in 
channel assembly. Using different experimental approaches, including pull-down, co-
immunoprecipitation, patch-clamp and immunocytochemical analysis, two critical 
 - 38 - 
                                                                                                                             Chapter 2 
domains in the N-tail and C-tail, were identified to be involved in TRPV5 channel 
assembly and subsequent trafficking to the plasma membrane. 
 
Material and methods 
 
DNA constructs and cRNA synthesis 
The N- and C-tail of TRPV5 were amplified and tagged with a HA or Flag tag, 
respectively, by the use of PCR on the full-length cDNA of TRPV5, and subsequently 
cloned into the pGEX 6p-2 (Amersham Pharmacia biotech) vector and the pT7Ts 
Xenopus laevis oocytes expression vector [27]. (For HA-tagged TRPV5 N-tail, forward 
primer 5’-ATGTACCCATACGACGTGCCAGACTACGCAGGGGCCTGTCCACCCAAGG-
3’, and reverse primer 5’-TTAAGGCCGCCCGTATTTCTTC-3’. For Flag-tagged TRPV5 
N-tail, forward primer 5’-
ATGGACTACAAGGATGACGATGACAAGGGGGCCTGTCCACCCAAGG-3’, and 
reverse primer 5’-TTAAGGCCGCCCGTATTTCTTC-3’. For HA-tagged TRPV5 C-tail, 
forward primer 5’-ATGTACCCATACGACGTGCCAGACTAC-
GCAGGCGACACTCACTGGCGGG-3’, and reverse primer 5’-
TCAGAAATGGTAGACTTCC-3’. For Flag-tagged TRPV5 C-tail, forward primer 5’-
ATGGACTACAAGGATGACGATGACAAGGGCGACACTCACTGGCGGG-3’, and 
reverse primer 5’-TCAGAAATGGTAGACTTCC-3’). TRPV5 truncates in which the N-tail 
(TRPV5ΔN), C-tail (TRPV5ΔC) or both tails (TRPV5ΔNΔC) were deleted, were obtained 
by PCR and cloned into the pCINeo/IRES-GFP vector and subcloned into the pT7Ts 
vector [21]. Deletion mutants of the assembly domain in the N-tail (deleted amino acids 
64-76) or the C-tail (deleted amino acids 595-600) were obtained by in vitro mutagenesis 
and subcloned into the PT7Ts vector. (For N-tail deletion, forward primer 5’-
CTGCGTCTCCTTAAGATAGCTGTGGGGGAGACGGCG-3’, and reverse primer 5’-
CGCCGTCTCCCCCACAGCTATCTTAAGGAGACGCAG-3’. For C-tail deletion, forward 
primer 5’-GTTGTGGCCACCACCGTGATGCCTCGCTTCCTGTGG-3’, and reverse 
primer 5’-CCACAGGAAGCGAGGCATCACGGTGGTGGCCACAAC-3’). pT7Ts 
constructs were linearized and cRNA was synthesized in vitro as described previously 
[21]. All constructs were verified by sequence analysis. 
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Electrophysiology  
The full-length cDNA encoding wild-type TRPV5, TRPV5ΔN, TRPV5ΔC and 
TRPV5ΔNΔC were transfected in HEK293 cells as described previously [22, 28]. 
Currents using the whole-cell configuration were measured with an EPC-9 (HEKA 
Elektronik, Lambrecht, Germany; 8-Pole Bessel filter 10 kHz). Electrode resistances 
were between 2 and 5 MΩ, capacitance and series resistance were compensated, and 
access resistance was monitored continuously. The step protocol consisted of 3 s 
voltage steps to –100 mV from a holding potential of +70 mV. The standard extracellular 
solution contained 150 mM NaCl, 1 mM CaCl2, 6 mM CsCl, 1 mM MgCl2, 10 mM glucose 
and 10 mM HEPES/CsOH (pH 7.4). Monovalent cation currents were measured in 
nominally Ca2+- and Mg2+- free solution (free Ca2+ concentration is 10 nM), and Ca2+ 
currents in 1 mM CaCl2 but Mg2+- free solutions. Monovalent cation currents were 
inhibited by replacing 150 mM NaCl with an equimolar amount of N-methyl-D-glucamine 
NMDG-Cl. The standard internal (pipette) solution contained: 20 mM CsCl, 100 mM Cs 
aspartate, 1 mM MgCl2, 10 mM BAPTA, 4 mM Na-2ATP and 10 mM HEPES / CsOH 
(pH 7.2). Cells were kept in a nominally Ca2+-free medium to prevent Ca2+ overload, and 
exposed for a maximum of 5 min to a Krebs solution containing 1.5 mM Ca2+ before 
sealing the patch pipette to the cell. All experiments were performed at room 
temperature (RT; 20–22°C).  
 
GST fusion proteins and pull-down assay 
PGEX6p-2 constructs were transformed in E.coli BL21, and GST-fused proteins were 
expressed and purified as described previously [21]. Proteins of full-length TRPV5, 
TRPV5 N-tail, C-tail or N- and C-tail deletion mutants were translated in vitro with 
[35S]methionine (Dupont/NEN Research Products, Boston, MA) for 120 min at 30°C 
using rabbit reticulocyte lysates (Promega, Madison, WI). In vitro translated proteins 
were added to purified GST-fused trunctants, immobilized on glutathione-Sepharose 4B 
beads (Amersham Pharmacia Biotech AB). After 2 h incubation at RT, the beads were 
washed extensively with pull-down buffer [20 mM Tris-HCl PH 7.4, 140 mM NaCl, 1 mM 
CaCl2, 0.2% (v/v) Triton-X-100, 0.2% (v/v) NP-40], and bound proteins were eluted with 
SDS-PAGE loading buffer and separated on SDS-polyacrylamide gels. Following 
electrophoresis, gels were analyzed by autoradiography [21]. 
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Injection of oocytes and total membrane isolation 
Xenopus laevis oocytes were prepared and injected as described previously [21]. To 
isolate total lysates, 20 oocytes were homogenized in 200 μl homogenization (HBA) 
buffer [20 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 5 mM NaH2PO4, 1 mM EDTA, 80 mM 
sucrose, 1 mM PMSF, 10 μg/ml leupeptin and 10 μg/ml pepstatin] and centrifuged twice 
at 100 g for 10 min at 4°C to remove yolk proteins. Next total lysates were taken up in 
Laemmli buffer (2 μl/oocyte) at 37°C for 30 minutes [2, 22, 29].  
 
Immunoblot analysis 
Total lysates were subjected to SDS-PAGE electrophoresis (12-16% w/v) and blotted 
onto PVDF membranes (Millipore Corp. Bedford, MA, USA). Blots were incubated with 
5% (w/v) non-fat dried milk (NFDM) in TBS-T [Tris-buffered saline (pH 7.4) containing 
0.2% (v/v) Tween-20]. Immunoblots were incubated overnight at 4°C with mouse anti-HA 
(1:4000) or mouse anti-Flag (1:8000) antibodies (Sigma chemical Co., St. Louis, MO, 
USA), in 1% or 5% (w/v) NFDM in TBS-T, respectively. After washing, immunoblots were 
incubated at RT with the corresponding secondary antibody sheep anti-mouse IgG 
peroxidase (Sigma), (1:2000) in TBS-T. For co-immunoprecipitation assays, 
immunoblots were incubated overnight at 4°C with mouse anti-Flag-peroxidase coupled 
antibody (1:2000) (Sigma), 5% (w/v) NFDM in TBS-T. Immunopositive bands were 
visualized using an enhanced chemo-luminescence system (Pierce, Rockford, IL, USA).   
 
Co-immunoprecipitation  
Twenty microliter equivalents of protein A-coupled agarose beads (Pharmacia, Uppsala, 
Sweden) were pre-incubated for 3 h at RT with 2 µl of monoclonal anti-HA antibody 
(Sigma) in 0.7 ml of IPP500 [500 mM NaCl, 10 mM Tris (pH 8.0), 0.1% (v/v) NP-40, 
0.1% (v/v) Tween-20, 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml pepstatin] and 
0.1% (w/v) bovine serum albumin. The beads were washed three times with IPP100 
[100 mM NaCl, 10 mM Tris (pH 8.0), 0.1% (v/v) NP-40, 0.1% (v/v) Tween-20, 1 mM 
PMSF, 10 µg/ml leupeptin, 10 µg/ml pepstatin]. Thirty oocytes were co-injected (each 
12.5 ng) with HA- and Flag-tagged TRPV5 N-tail or C-tail cRNA or cRNA transcribed 
form the deletion mutants. Oocytes were subsequently homogenized with 150 µl of 
solubilization buffer [20 mM Tris pH 8.0, 10% (v/v) glycerol, 5 mM EDTA, 0.5% (v/v) NP-
40, 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml pepstatin] and incubated on ice for 1 h 
and centrifuged at 16,000 g for 1 h at 4°C. The solubilized proteins were added to 
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antibody bound beads in sucrose buffer [100 mM NaCl, 20 mM Tris, pH 8.0, 5 mM EDTA, 
0.1% (v/v) Triton X-100, 10% (w/v) sucrose, 1 mM PMSF, 10 µg/ml leupeptin, 10 µg/ml 
pepstatin] and incubated o/n at 4ºC. Subsequently, the beads were washed with IPP100 
and proteins were eluted in Laemmli as described previously [29].  
 
Immunocytochemistry 
Xenopus laevis oocytes were injected with 5 ng cRNA of HA-tagged TRPV5, or co-
injected with 5 ng cRNA of HA-tagged TRPV5 and 10 ng non-tagged TRPV5 mutants 
(TRPV5ΔN, TRPV5ΔC, TRPV5ΔNΔC), respectively. Immunocytochemistry was 
performed as described previously [30, 31]   
 
45Ca2+ uptake assay 
Xenopus laevis oocytes were injected with 5 ng HA-TRPV5 cRNA only or co-injected 
with 10 ng TRPV5ΔN, TRPV5ΔC, or TRPV5ΔNΔC cRNA. Ca2+ uptake was determined 2 
days after injection as described previously [2].  
 
Plasma membrane isolation 
Xenopus laevis oocytes were injected with 5 ng HA-TRPV5 cRNA only or co-injected 
with 5 ng HA-TRPV5 and 10 ng TRPV5 truncates cRNA (TRPV5ΔN, TRPV5ΔC, or 
TRPV5ΔNΔC). After 48 h follicle membranes were manually removed and 12 oocytes 
were incubated in MBSS [20 mM 2-N-morpholino ethanesulfonic acid, 80 mM NaCl, pH 
6.0, containing 1 % (v/v) positively charged colloidal silica (Ludox Cl, Aldrich, Bornem, 
Belgium)] at 4°C for 30 min [29]. Subsequently, oocytes were washed twice in MBSS 
and incubated with 0.1 % (v/v) sodium polyacrylicacid (Aldrich) in MBSS at 4°C for 30 
min. Oocytes were homogenized in HBA buffer and plasma membranes were isolated by 
serial centrifugation at 4x 13.5g, 2x 24g and 2x 38g. One ml supernatant was exchanged 
with HBA buffer after each centrifugation step. Finally, membranes were pelleted at 
16,000 g for 30 min, dissolved in SDS sample buffer and analyzed by immunoblotting. 
 
Statistical analysis 
In all experiments, the data are expressed as mean ± SEM. Overall statistical 
significance was determined by analysis of variance (ANOVA). P values below 0.05 
were considered significant. 
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Results 
 
Pull-down assay of N-tail and C-tail of TRPV5  
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Figure 1. Pull-down analysis of N-tail and C-tail of TRPV5. GST fusion proteins containing N-tail and 
C-tail of TRPV5 were immobilized on glutathione-Sepharose 4B beads and incubated with in vitro
translated [35S]methionine full-length TRPV5, TRPV5 N-tail or C-tail. The assembly was detected 
between in vitro translated full-length of TRPV5 and GST-fused TRPV5 N-tail or C-tail (A). Furthermore, 
an interaction of the N-tail with the N-tail (B) or the C-tail with C-tail (C) was observed. Incubation of the 
GST-N-tail with both in vitro translated N-tail and C-tail indicated a preference for N-N interaction rather 
than N-C interaction (D). No binding to GST alone was detected.  
 
 
 
 
 
The role of TRPV5 N-tail and C-tail in the channel assembly was initially examined using 
pull-down assays. TRPV5 N-tail and C-tail were expressed as GST-fusion proteins and 
subsequently tested for their interaction with in vitro translated full-length of TRPV5 or 
the TRPV5 N-tail and C-tail. As depicted in Figure 1A, the GST-fused N-tail and C-tail 
associated with in vitro translated [35S]methionine-TRPV5. Moreover, pull-down analysis 
demonstrated N-tail-N-tail (Figure 1B) and C-tail-C-tail interactions (Figure 1C). To 
investigate whether the N-tail preferentially interacts with the N- or C-tail, the GST-N-tail 
was incubated with in vitro translated N- and C-tail simultaneously. This pull-down 
experiment indicated that the GST-N-tail preferentially binds the in vitro translated N-tail 
(Figure 1D). All interactions were specific, as no interaction with GST alone was 
observed.   
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Co-immunoprecipitation of N-tail and C-tail of TRPV5 
The findings from the pull-down experiments suggested that the N-tail and C-tail of 
TRPV5 contributed to channel assembly. We tested, therefore, whether the N-tail and C-
tail of TRPV5 can be co-immunoprecipitated. First, Immunoblot analysis confirmed 
expression of both tails that were specifically detected by the applied anti-HA or anti-Flag 
antibody, respectively. The anti-HA antibody specifically detected the HA-N-tail in total 
lysates from oocytes co-expressing HA-N-tail and Flag-C-tail, whereas anti-Flag 
antibody only recognized the Flag-C-tail (Figure 2A). The HA- and Flag-tagged N-tails 
(Figure 2B), HA- and Flag-tagged C-tails (Figure 2C), or HA-N-tail with Flag-C-tail of 
TRPV5 (Figure 2D) were co-expressed and subsequently immunoprecipitated using the 
anti-HA antibody. Immunoblots containing the immune complexes were probed with the 
anti-Flag antibody. Interestingly, Figure 2 showed that Flag-tagged N-tail or C-tail was 
co-immunoprecipitated with the HA-tagged N-tail or C-tail of TRPV5, demonstrating N-N, 
C-C and N-C interactions in a TRPV5 channel complex.  
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Figure 2. Co-immunoprecipitation of N-tail with C-tail of TRPV5. Xenopus laevis oocytes were co-
injected with cRNA of HA- and Flag-tagged N-tails, C-tails or HA-tagged N-tail and Flag-tagged C-tail 
of TRPV5, respectively. The cell lysates were processed for immunoprecipitation and immunoblot 
analysis. Anti-HA antibody specifically recognized HA-N-tail in total lysates from oocytes co-
expressing HA-N-tail and Flag-C-tail, whereas anti-Flag antibody only detected the Flag-C-tail (A). 
Subsequently, Oocyte lysates were subjected to immunoprecipitation using the anti-HA antibody, and 
immunoblots containing protein complexes were probed with the anti-Flag antibody. Co-
immunoprecipitations were observed between HA- and Flag-tagged N-tails (B), HA- and Flag-tagged 
C-tails (C), and HA-tagged N-tail and Flag-tagged C-tail of TRPV5 (D). 
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Functional analysis of TRPV5 channel assembly 
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Figure 3. Functional analysis of TRPV5 channel assembly. (A) 45Ca2+ uptake was measured in 
oocytes injected with TRPV5 cRNA only or co-injected with TRPV5ΔN, TRPV5ΔC or TRPV5ΔNΔC 
cRNA. (B) HEK293 cells were transfected with wild-type TRPV5 or TRPV5 truncates including 
TRPV5ΔN, TRPV5ΔC or TRPV5ΔNΔC, or co-transfected with wild-type TRPV5 and TRPV5ΔN, 
TRPV5ΔC or TRPV5ΔNΔC, and subsequently analyzed by patch-clamp analysis. Asterisk indicates 
significance compared to TRPV5 transfected cells, p<0.05). The Na+ currents in HEK293 cells 
transfected with TRPV5ΔN, TRPV5ΔC or TRPV5ΔNΔC only were not significant different from non-
transfected cells (data not shown). HA-TRPV5 and truncates were co-injected in Xenopus laevis 
oocytes. To isolate plasma membrane fractions follicle membranes were removed and plasma 
membranes were coated with silica. Plasma membrane fractions (C) or total membranes (D) were 
isolated, blotted and analyzed for TRPV5 expression using monoclonal anti-HA. 
To further elucidate the functional consequences of the observed interactions between 
N-N tail, N-C tail and C-C tail, the effect of co-expressing TRPV5 wild-type and truncates 
(TRPV5ΔN, TRPV5ΔC, or TRPV5ΔNΔC) on TRPV5 activity at the plasma membrane 
was determined in Xenopus laevis oocytes and HEK293 cells. Firstly, oocytes were 
injected with HA-TRPV5 only or co-injected with TRPV5ΔN, TRPV5ΔC, or TRPV5ΔNΔC 
cRNA. Expression of TRPV5 resulted in ~3.5-fold increase of 45Ca2+ influx compared to 
non-injected oocytes (Figure 3A). Co-expression of TRPV5ΔN significantly decreased 
the TRPV5-mediated Ca2+ influx compared to TRPV5 alone, while co-expression of 
TRPV5ΔC completely inhibited Ca2+ influx to a level that was indistinguishable from non-
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injected oocytes. In contrast, co-expression of TRPV5ΔNΔC had no significant effect on 
TRPV5 channel activity (Figure 3A). 45Ca2+ uptake in oocytes expressing only TRPV5ΔN, 
TRPV5ΔC, or TRPV5ΔNΔC was not different from non-injected oocytes (data not 
shown). Secondly, patch-clamp analysis was performed to investigate the 
electrophysiological properties of channel complexes consisting of wild-type and TRPV5 
truncates. Truncated channels, including TRPV5ΔN, TRPV5ΔC and TRPV5ΔNΔC, were 
(co)expressed with wild-type TRPV5 in HEK293 cells. As shown in Figure 3B, HEK293 
cells expressing TRPV5ΔN, TRPV5ΔC or TRPV5ΔNΔC did not yield any Na+ currents 
and were not different from non-transfected cells (data not shown). Remarkably, 
HEK293 cells co-expressing wild-type TRPV5 and TRPV5ΔN or TRPV5ΔC displayed 
significantly reduced Na+ currents compared to wild-type TRPV5 alone. Inversely, Na+ 
currents measured in HEK293 cells co-expressing wild-type TRPV5 and TRPV5ΔNΔC 
were not significantly affected, indicating that it is unlikely that the transmembrane 
domains of TRPV5 are critical determinants for subunit assembly. 
 
TRPV5 routing is disturbed by mutant channel assembly  
In order to understand the molecular mechanism underlying the dominant-negative 
effect of TRPV5 truncates (TRPV5ΔN and TRPV5ΔC) on wild-type TRPV5 channel 
activity, a biochemical and immunocytochemical approach was combined. The 
expression of HA-TRPV5 was determined by analyzing plasma membrane and total 
membrane fractions of oocytes expressing TRPV5 alone or in combination with the 
truncates. A distinct band at a molecular weight of ~85 kDa corresponding to the 
glycosylated form of TRPV5 was observed in plasma membrane fractions of TRPV5-
expressing oocytes (Figure 3C). Importantly, wild-type TRPV5 expression was 
significantly reduced or absent in plasma membrane fractions of oocytes co-expressing 
TRPV5ΔN or TRPV5ΔC, respectively. However, co-injection of TRPV5ΔNΔC had no 
effect on the plasma membrane localization of TRPV5 (Figure 3C). Importantly, total 
membrane fractions showed that TRPV5 was expressed to a similar extent in the 
absence and presence of the TRPV5 truncates (Figure 3D). These results were verified 
by immunocytochemistry to detect TRPV5 localization at the plasma membrane. In 
contrast to non-injected oocytes (Figure 4A), wild-type TRPV5 cRNA-injected oocytes 
displayed a strong immunopositive labeling along the plasma membrane, whereas the 
cytoplasm was only faintly stained (Figure 4B). Importantly, plasma membrane staining 
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of TRPV5 was significantly decreased in oocytes co-expressing HA-TRPV5 and 
TRPV5ΔN and to a lesser extent HA-TRPV5 and TRPV5ΔC (Figure 4D, E). A strong 
immunopositive staining was, however, present along the plasma membrane of oocytes 
co-injected with HA-TRPV5 and TRPV5ΔNΔC (Figure 4C). The localization of TRPV5 in 
the presence of TRPV5ΔN or TRPV5ΔC was predominantly intracellular. Together, these 
results indicated that the trafficking of HA-TRPV5 from cytosol towards the plasma 
membrane was disturbed by assembly with TRPV5ΔN or TRPV5ΔC, but not with 
TRPV5ΔNΔC, explaining the reduced channel activity. Importantly, immunoblot analysis 
demonstrated that the total expression of TRPV5 was equal under all conditions (Figure 
3D). 
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Figure 4. TRPV5ΔN and TRPV5ΔC expression impaired TRPV5 plasma membrane trafficking. 
Xenopus laevis oocytes were injected with cRNA of HA-tagged wild-type TRPV5 or co-injected with cRNA 
of HA-tagged wild-type TRPV5 and cRNA of non-tagged TRPV5ΔN, TRPV5ΔC or TRPV5ΔNΔC. 
Immunocytochemistry was performed on Xenopus laevis oocytes to investigate the effect of TRPV5 
truncates on TRPV5 localization. Oocytes injected with wild-type TRPV5 showed predominantly 
immunopositive TRPV5 staining along the plasma membrane (B), whereas TRPV5 staining in oocytes co-
expressing TRPV5ΔN (D) or TRPV5ΔC (E) was not localized at the plasma membrane, but accumulated 
intracellularly. In addition, oocytes co-injected with wild-type TRPV5 and TRPV5ΔNΔC displayed 
immunopositive staining of the channel along the plasma membrane (C). As a negative control non-
injected oocytes were treated in a similar way and devoid of any staining (A). 
Identification of the assembly signal in the N- and C-tail of TRPV5 
To gather more detailed information regarding structural requirements for channel 
subunit assembly of TRPV5, a series of deletion mutants of the N- and C-tails were 
constructed (Figure 5). Truncated forms of TRPV5 N-tail and C-tail were expressed as 
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GST-fusion proteins and subsequently tested for their interaction with in vitro translated 
TRPV5 N-tail and C-tail using pull-down assays. As depicted in Figure 5 (left part), the 
interaction between GST-fused N-tail truncations and the in vitro translated N-tail was 
abolished at amino acid position 64 and 55, whereas truncations at the positions 240 up 
to 77 associated with in vitro translated N-tail. In addition, pull-down analysis 
demonstrated that the association of the C-tail and [35S]methionine-TRPV5 C-tail 
disappeared when the tail was truncated at position 596, whereas truncations at position 
704 up to 601 did not affect the interaction (Figure 5, right part). Therefore, two critical 
regions for TRPV5 channel assembly were located between amino acid position 64-77 
(Figure 5, left part) and 596-601 (Figure 5, right part) in the N-tail and C-tail, 
respectively.  
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Figure 5. Mapping of assembly domains in TRPV5. GST fusion proteins containing different portions 
of the N-tail (left) and C-tail (right) of TRPV5 were constructed according to the schematic drawing. 
These proteins were immobilized on glutathione-Sepharose 4B beads and then incubated with in vitro 
translated [35S]methionine TRPV5 N-tail (left) or C-tail (right). Interaction of the N-tail or C-tail with the 
GST fusion proteins was determined by immunoblotting. The assembly domain in the N-tail was 
localized between 64 and 77 (left), whereas the interaction region in the C-tail (right) was observed 
between 596 and 601. GST was used as a negative control in the pull-down experiments. These 
assembly domains identified in the N- and C-tail are functionally conserved within TRPV5 and TRPV6 
members as indicated by the alignments. 
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To further elucidate the role of the assembly domains these regions were deleted in the 
N-tail (N-tailΔ64-76) and the C-tail (C-tailΔ596-600) and subsequently analyzed by pull-
downs and co-immunoprecipitations as described above. First, the N-tail and the C-tail of 
TRPV5 were expressed as GST-fusion proteins and subsequently analyzed for their 
interaction with in vitro [35S]methionine translated N-tail, C-tail and the N-tail and C-tail 
deletion mutants. In contrast to wild-type N-tail and C-tail, N-tailΔ64-76 and C-tailΔ596-
600 did not interact with the N- and C-tail (Figure 6A). Second, Xenopus laevis oocytes 
were co-injected with wild-type and mutant HA-N-tail and Flag-N-tail or HA-C-tail and 
Flag-C-tail. Co-immunoprecipitations demonstrated that assembly between HA-N-
tail/Flag-N-tailΔ64-76, HA-N-tail/Flag-C-tailΔ596-600 and HA-C-tail/Flag-C-tailΔ596-600 
was abolished, whereas binding between wild-type N- and C-tails was observed (Figure 
6B, left). Importantly, both wild-type and mutant tails were equally expressed (Figure 6B, 
right). 
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Figure 6. Pull-downs and co-immunoprecipitation assays of N- and C-tail deletion mutants of 
TRPV5. (A) GST fusion proteins containing the N-tail and C-tail of TRPV5 were immobilized on 
glutathione-Sepharose 4B beads and incubated with in vitro translated [35S]methionine TRPV5 N-tail and 
C-tail or N-tail mutant lacking amino acid residues 64-76 (N-tailΔ64-76) and C-tail mutant lacking amino 
acid residues 596-600 (C-tailΔ596-600). (B) Xenopus laevis oocytes were co-injected with HA-N-tail and 
Flag-N-tail or Flag-N-tailΔ64-76, HA-N-tail and Flag-C-tail or Flag-C-tailΔ596-600, HA-C-tail and Flag-C-
tail or Flag-C-tailΔ596-600, respectively. Cell lysates were processed for immunoprecipitation, 
immunoblotting and subsequently protein complexes were probed with the anti-Flag antibody. Both wild-
type and mutant tails were equally expressed (right). 
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Discussion  
 
In the present study molecular determinants were identified in TRPV5 that play a key 
role in the formation of the functional channel complex. Using a combined approach of 
several independent methods we conclude that at least two regions in the cytosolic tails 
of TRPV5 are important for channel assembly and subsequent routing to the plasma 
membrane. This conclusion is based on (i) pull-down assays and co-
immunoprecipitations that demonstrated physical interactions between the N-tail/N-tail, 
N-tail/C-tail and C-tail/C-tail of TRPV5; (ii) 45Ca2+ uptake measurements in oocytes and 
patch-clamp analysis in HEK293 cells that showed the dominant-negative nature of 
TRPV5 truncated channel subunits, lacking the N-tail or C-tail, on TRPV5 wild-type 
channel activity; (iii) plasma membrane fractions and immunocytochemical analysis that 
demonstrated a disturbed trafficking of TRPV5 in oocytes co-expressing TRPV5ΔC and 
TRPV5ΔN towards the plasma membrane explaining the molecular mechanism of the 
reduced channel activity; (iv) mapping assays that revealed two critical assembly 
domains located at positions 64-77 in the N-tail and 596-601 in the C-tail of TRPV5; (v) 
deletion of these assembly domains in the N-tail and C-tail that abolished the interaction 
between the tails pointing to a important role of these regions in channel assembly.    
 
By analogy with other cation channel subunits consisting of six transmembrane-spanning 
domains, TRP members are believed to assemble into homo- or heterotetrameric 
complexes. These complexes have been verified by classical methods such as co-
immunoprecipitation, crosslinking analysis or functional assays applying dominant 
negative pore mutants [7-10, 32]. Recently, we demonstrated a (hetero)tetrameric 
stoichiometry for TRPV5 and TRPV6 [32]. Heterotetrameric TRPV5 and TRPV6 proteins 
displayed properties that, depending on the subunit configuration, are intermediate 
between TRPV5 and TRPV6. Exchanging TRPV5 for TRPV6 subunits in a channel 
tetramer has major effects on Ba2+ permeability, Ca2+-dependent inactivation and the 
block by ruthenium red [32]. In this way, Ca2+ transporting epithelia co-expressing 
TRPV5 and TRPV6 may be able to generate a pleiotropic set of functional 
heterotetrameric channels. To date, little information is available about assembly 
domains in TRP proteins. 
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Our understanding of the architecture of functional TRP channels reflects only the 
endpoint of a complex and poorly understood assembly pathway. Current research is 
beginning to elucidate the intermediate steps between the synthesis and insertion of 
individual subunits into the membrane. Our data indicated N-tail-N-tail and C-tail-C-tail 
interactions within TRPV5 channel complexes. In addition, co-immunoprecipitations 
demonstrated that assembly of TRPV5 subunits occurred not only within N-tails or C-
tails, but also between the N-tail and C-tail. In order to further explore the crucial 
domains in the N-tail and C-tail for TRPV5 channel assembly, we constructed a series of 
truncated deletion mutants. Pull-down analysis indicated that a short peptide stretch at 
64-77 is necessary for N-tail/N-tail interaction, whereas the critical region for C-tail/C-tail 
interaction is located between amino acids 596 and 601. Furthermore, we demonstrated 
by pull-down assays and co-immunoprecipitations that N- and C-tail mutants lacking 
these assembly domains are not able to interact with the TRPV5 tails. These findings 
indicated that the interaction between TRPV5 channel subunits depends on assembly 
signals present in the N-tail and C-tail.  
 
It is likely that assembly also occurs within the N-tail and C-tail of TRPV6 because 
TRPV5 and TRPV6 share more than 75% homology at the amino level, raising the 
possibility that both N-tail and C-tail assembled together in order to form functional 
heterotetrameric channel complexes of TRPV5 and TRPV6 [22]. Recently, Niemeyer 
and co-workers demonstrated that the third ankyrin repeat within the N-tail of TRPV6 is 
critical for TRPV6 subunit assembly. This repeat initiates a molecular zippering process 
that proceeds past the fifth ankyrin repeat and, thereby, creates an intracellular anchor 
necessary for functional subunit assembly. In addition, deletion of this region prevented 
TRPV6-TRPV6 self association and generation of functional channels [33]. Pull-down 
mapping experiments and co-immunoprecipitations in our study identified an assembly 
domain in the N-tail of TRPV5 which is located more upstream, overlapping with the first 
ankyrin repeat. The most significant binding was found between the N-terminal regions 
64 to 77. However, a slightly stronger binding signal was observed with the truncant at 
position 162 that contains the first three ankyrin repeats [33]. These findings may 
suggest that the ankyrin repeat identified in TRPV6 could also be involved in TRPV5 
channel assembly. Ankyrin repeats have been frequently implicated in protein-protein 
interactions. In addition, structure prediction programs indicated that both assembly 
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domains identified in TRPV5 participate in a predicted α-helical structure that is often 
engaged in protein-protein interactions to form higher order structures [34]. 
 
Detailed information about the domains involved in the process of channel subunit 
assembly of TRPV5 is a prerequisite for obtaining further insight into the function and 
properties of this channel. 45Ca2+ uptake measurements demonstrated that the Ca2+ 
influx is significantly decreased or abolished in oocytes co-injected with wild-type TRPV5 
and TRPV5ΔN or TRPV5ΔC, respectively. These findings are consistent with the patch-
clamp analysis in which the Na+ currents were significantly reduced in HEK293 cells co-
expressing wild-type TRPV5 with TRPV5ΔN or TRPV5ΔC. Plasma membrane fractions 
and immunocytochemistry in oocytes demonstrated the dominant negative effect of 
TRPV5ΔN or TRPV5ΔC on trafficking of the wild-type TRPV5 channel to the plasma 
membrane. Intriguingly, TRPV5 surface expression and activity was significantly more 
reduced in cells co-expressing TRPV5ΔC compared to TRPV5ΔN. This suggests a major 
role of the N-tail domain rather than the C-tail domain in channel assembly, which was 
further substantiated by pull-down experiments in which the GST-N-tail preferentially 
binds the N-tail compared to the C-tail. Importantly, we demonstrated that the TRPV5 
channel activity was not significantly affected in cells co-expressing wild-type TRPV5 
with TRPV5ΔNΔC, which was further substantiated by a normal channel distribution at 
the plasma membrane of the oocyte underlining the specific involvement of the 
cytoplasmic tails. 
 
Our observations are in line with the structurally related K+ channels. The role of the N-
tail in the oligomerization of Shaker K+ subunits was first recognized by the laboratory of 
Jan and co-workers [35]. They identified a cytoplasmic sequence preceding the first 
transmembrane segment that was conserved among Kv1 subfamily members. In Shaker 
channels, the conserved region is found between residues 97 and 196 and named T1 
[36]. Subfamily-specific assembly is provided primarily by polar interactions encoded in a 
conserved set of amino acids at its tetramerization interface [25]. Despite the overall 
structural similarity between the various K+ channel families, there appears to be little or 
no mixing of K+ channel subunits between channel families [26, 35, 37-39]. In the Shaker 
Kv1 subfamily, the N-tail domain mediates oligomerization and prevents heteromultimer 
formation with members of other Kv subfamilies [35]. Structures of the T1 domains of 
Shaker K+ channel subfamilies provided valuable structural insights into understanding 
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both channel assembly and functional regulation of the entire channel molecule through 
conformational changes [25]. Interestingly, previous studies suggested that T1 plays a 
role not only in channel assembly, but also in channel gating, and that conformational 
changes across the buried polar interface between subunits are a crucial part of the 
gating process [40]. Further studies will address the question whether the identified 
assembly signals in TRPV5 play also a role in channel gating.  
 
In summary, both the N-tail (64-77) and C-tail (596-601) are critical for TRPV5 channel 
assembly. Truncated TRPV5 channels at the N- or C-tail oligomerize with wild-type 
TRPV5 channels leading to the formation of mutant channel complexes that do not 
reach the plasma membrane. Therefore, assembly of channel subunits is essential for 
routing of the TRPV5 channel complex and subsequent activity at the plasma membrane.  
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As fruit needs not only sunshine but cold nights and chilling showers to 
ripen it, so character needs not only joy but trial and difficulty to mellow it. 
(Hugh Black) 
水果不仅需要阳光，也需要凉夜，寒冷的雨水能使其成熟。人的性格陶冶不
仅需要欢乐，也需要考验和困难。(布莱克 H) 
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Abstract  
 
TRPV5 and TRPV6 are the most Ca2+-selective members of the Transient Receptor 
Potential (TRP) family of cation channels and play a pivotal role in the maintenance 
of body Ca2+ balance. However, little is known about the mechanisms controlling the 
plasma membrane abundance of these channels to regulate epithelial Ca2+ transport. 
In this study, we demonstrated the direct and specific interaction of GDP-bound 
Rab11a with TRPV5 and TRPV6. Rab11a co-localized with TRPV5 and TRPV6 in 
vesicular structures underlying the apical plasma membrane of Ca2+-transporting 
epithelial cells. This GTPase recognized a conserved stretch in the C-tail of TRPV5 
that is essential for channel trafficking. Furthermore, co-expression of GDP-locked 
Rab11a with TRPV5 or TRPV6 resulted in significantly decreased Ca2+ uptake, 
caused by diminished channel cell-surface expression. Together, our data 
demonstrated the important role of Rab11a in the trafficking of TRPV5 and TRPV6.  
Rab11a exerts this function in a novel fashion since it operates via direct cargo 
interaction while in the GDP-bound configuration. 
 
Introduction 
 
TRPV5 and TRPV6 form a distinct group of highly Ca2+-selective channels belonging 
to the Transient Receptor Potential (TRP) channel superfamily. This family fulfills a 
plurality of physiological functions, which vary from photo transduction, nociception, 
olfaction, heat and cold sensation to epithelial Ca2+ transport [1]. TRPV5 and TRPV6 
mediate the rate-limiting luminal influx step of transcellular Ca2+ transport [2, 3]. 
Therefore, understanding the regulation of these channels is of utmost importance for 
our insight in the Ca2+ homeostasis. TRPV5 and TRPV6 display constitutive activity 
[4], suggesting that channel abundance at the cell surface is of crucial importance for 
regulation of the Ca2+ influx via these channels. It is becoming increasingly evident 
that channel trafficking is essential in determining the activity of TRP proteins [5-9]. 
For instance, inducible vesicular translocation and plasma membrane insertion has 
been described for several TRP channels, for instance, TRPV2, TRPC3, TRPC5 and 
TRPL. This trafficking process stimulated the Ca2+ influx from the extracellular 
compartment essential to growth factor- [6, 8], carbachol- [5] or light-induced 
signaling [7]. However, little is known about the molecular mechanisms involved in 
trafficking towards the plasma membrane of TRP channels in general and in 
particular of TRPV5 and TRPV6. 
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Several protein families have been described to play key roles in cargo trafficking to 
and from specific cellular compartments, including the plasma membrane. One of 
these families consists of the Rab GTPases. The ability to act as molecular switches 
that cycle between GTP- and GDP-bound states, underlies the functionality of this 
family. Many Rab proteins show a distinct subcellular localization, making them ideal 
candidates to govern the specificity of vesicle trafficking, most likely cooperatively 
operating with other proteins [10, 11]. Further characterization of the largely elusive 
mechanism underlying the function of Rab proteins in ion channel trafficking could 
further contribute to the already enigmatic Rab-dependent regulation of cargo 
trafficking in the highly organized cellular transport machinery.  
 
The aim of this study was to identify regulatory proteins directly interacting with 
TRPV5 or TRPV6. Using biochemical, histological and functional analyses we 
demonstrate a novel operation mode for Rab11a in the regulation of TRPV5 and 
TRPV6 trafficking to the plasma membrane requiring direct interaction with these 
cargo molecules.  
 
Materials and methods  
 
DNA constructs and cRNA synthesis 
The C-tail of mouse TRPV5 and TRPV6 and deletion mutants of TRPV5 in pGEX6p-
2 were obtained as described previously [12]. A VSV tag-encoding oligo duplex 
(sense 5’-
CATGGCATACACTGATATCGAAATGAACCGCCTGGGTAAGGCGCGCCTT-3’ and 
antisense 5’-CTAGAAGGCGCGCCTTACCCAGGCGGTTCATTTCGA 
TATCAGTGTATGC-3’) was inserted into the NcoI/XbaI restriction sites of the pTLN 
oocyte expression vector. Rab11a was cloned into this construct by PCR (forward 
primer 5’- GGCGCGCCTTGGCACCCGCGACGACGAGTAC-3’ and reverse primer 
(5’-GTGAACTTGCGGGGTTTTTCAGTATCTACGA-3’) using the pACT2 construct as 
a template and subsequently subcloned into pGEX6p2 (Amersham Biosciences, 
Uppsala, Sweden) and pCB7 [13]. MluI and SalI sites were introduced into the 
lentivirus transfer vector pLV-CMV-GFP [14] by site-directed mutagenesis replacing 
the GFP stop codon.  Rab11aS25N was subsequently cloned into these sites by 
PCR using the forward primer 5’-AGCACGCGTGGCACCCGCGACGACGA-3’ and 
the reverse primer 5’-ACAGTCGACTTAGATGTTCTGACAGCACTG-3’. TRPV5 was 
cloned into eGFP-C1 (Clontech Palo Alto, CA) by PCR (forward primer 5’- 
TCCGGACGGGGGGGGATGGGGGCCTGTCCACCC-3’ and reverse primer 5’-
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CCGGTGGATCCTGATCAG-3’). The construct encoding DsRed-fused Rab11a was 
generously provided by Dr. U. Rescher (University of Muenster, Germany) and S20V 
and S25N mutants were subsequently obtained by site-directed mutagenesis. All 
constructs were verified by sequence analysis. Oocyte expression constructs were 
linearized and TRPV5, TRPV6 and Rab11a cRNA was synthesized in vitro using 
SP6 RNA polymerase as described previously [15].  
 
Yeast two-hybrid system  
Yeast was subsequently transformed with pAS-1 containing the TRPV6 C-tail, and a 
mouse kidney cDNA library (Clontech, Palo Alto, CA) present in the pACT2 vector. 
Screening of the library was performed as described previously [12]. Yeast two-
hybrid results were confirmed using purified library plasmids and negative controls 
were performed by replacing a binding partner with either a pAS-1 construct 
containing the N-tail (amino acids 1-53) of rat γENaC or the empty pACT2 vector. 
 
GST-TRPV5 and TRPV6 fusion protein and interaction assays 
pGEX6p-2 constructs were transformed in Escherichia coli BL21 and GST fusion 
proteins were expressed and purified according to the manufacturer’s protocol 
(Amersham Biosciences, Piscataway, NJ). GST-Rab proteins were prepared in GTP 
or GDP bound conformation as described [16]. Rab11a S25N was cleaved from GST 
using Precission Protease (Amersham Biosciences), concentrated using Centriprep 
YM10 (Millipore, Amsterdam, The Netherlands) and checked by SDS-PAGE. 
[35S]Methionine-labeled full-length Rab11a or TRPV5/TRPV6 protein was prepared 
using a reticulocyte lysate system (Promega, Madison, WI). HEK293 cells were 
transfected with Rab11a, Rab22b or Rab7 constructs and lysed in pull-down buffer 
[20 mM HEPES, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT, 100 μM GTP or GDP and 
0.4% (v/v) Triton X-100 (pH 7.5)]. Rab proteins, TRPV5 or TRPV6 were added to 
GST or GST-fusion proteins immobilized on glutathione-Sepharose 4B beads 
(Amersham Biosciences) in pull-down buffer and incubated for 2 h at room 
temperature. After extensive washings, bound proteins were eluted with SDS-PAGE 
loading buffer and visualized by autoradiography or immunoblotting using rabbit anti-
Rab11 (Zymed, San Fransisco, CA), monoclonal anti-VSV (Sigma, St Louis, MO, for 
Rab11 and Rab22b) or anti-myc (Santa Cruz Biotechnology, Santa Cruz, CA, for 
Rab7). The quality and quantity of GST or GST-fused proteins was routinely 
analyzed by Coomassie staining. 
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Co-immunoprecipitation 
Xenopus laevis oocytes were co-injected with 10 ng TRPV5 and 10 ng Rab11a S25N 
cRNA as described [15]. After 48 h injected oocytes were lysed in sucrose buffer 
containing 20 mM Tris pH 7.4, 5 mM EDTA, 135 mM NaCl, 0.1 % (v/v) NP-40, 0.5 % 
(w/v) sodium desoxycholate and 10 % (w/v) sucrose, centrifuged at 100 g for 5 min 
and subsequently incubated on ice for 60 min. The lysates were centrifuged for 30 
min at 16,000 g and supernatants were incubated with monoclonal anti-HA 
antibodies (Sigma, St Louis, MO) immobilized on protein A-agarose beads (Kem-En-
Tec A/S, Kopenhagen, Denmark) for 16 h at 4 °C. Immunoprecipitated proteins were 
analyzed by immunoblot analysis using rabbit anti-Rab11a antibodies. 
 
CNT and CCD primary cell culture and transepithelial Ca2+ transport 
Connecting tubules (CNT) and cortical collecting ducts (CCD) were immunodissected 
from the kidney cortex of New Zealand White rabbits (± 0.5 kg), placed in primary 
culture on permeable filters (0.33 cm2; Costar) and transepithelial Ca2+ transport was 
measured as described previously [17] in the presence or absence of 1 μM ruthenium 
red (Sigma, St Louis, MO). Cells were subsequently fixed in 3% (w/v) 
paraformaldehyde in PBS for 30 min at 4 °C.  
 
Lentiviral infection of primary CNT/CCD cells 
Third generation lentiviruses were produced by co-transfection of the packaging 
vectors pRSV-Rev, pMDL g/p RRE, and pMD2G from Tronolab (Lausanne, 
Switzerland) and the transfer vector into Human Embryonic Kidney 293T cells as 
described before [18]. The titer was determined by p24 HIV ELISA (Murex 
Diagnostics, Dartford, UK). Primary rabbit CNT/CCD cells were infected with 
lentivirus immediately before plating, in the presence of polybrene (8 μg/ml) using 1 
or 10 virus particles per cell (1 or 10 MOI). Virus was removed after 24 h. 
Transepithelial Ca2+ transport was measured 6 days post-infection in the presence of 
10 μM forskolin as described before [17].  
 
Immunofluorescence microscopy 
Immunohistochemistry on mouse kidney sections was performed as described 
previously [19] using affinity purified guinea pig antiserum against TRPV5 and rabbit 
anti-Rab11 antibodies. Serial sections were incubated with rabbit anti-TRPV6 or 
rabbit anti-Rab11a antibodies. Xenopus laevis oocytes were injected with 5 ng HA-
tagged TRPV5 cRNA or 5 ng Flag-tagged TRPV6 cRNA with or without 10 ng 
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Rab11a cRNA. Two days after injection immunocytochemistry was performed as 
described [15] using anti-HA or rabbit anti-TRPV6 (dilution 1: 400). HeLa cells were 
grown on coverslips and transfected with Effectene (QIAGEN, Valenica, CA) 
according to the manufacturer's protocol. Sixteen hours after transfection, cells were 
fixed with 4% (w/v) PFA in PBS for 10 minutes at RT, incubated with 50 mM NH4Cl in 
PBS for 5 min, washed with PBS and mounted in Mowiol containing 4% (w/v) n-
propyl-gallate as antifade agent. Cells fixed on permeable filter supports were stained 
with guinea pig anti-TRPV5 and rabbit anti-Rab11 and appropriate secondary 
antibodies coupled to Alexa 488 or 596 and mounted in Mowiol. The cell surface was 
visualized by biotinylation from the apical and basolateral compartment, followed by 
incubation with streptavidin-Oregon green 488, essentially as described [20]. This 
procedure predominantly stained the basolateral cell surface. Images were taken 
sequentially with a Biorad MRC 1024 confocal microscope or using a Zeiss LSM510 
Meta confocal microscope, emitting at 488 nm and at 543 nm using a 30 mW argon 
laser and a 1 mW helium/neon laser. Emissions were collected using a 505-530 nm 
band-pass filter or a 560 nm long-pass filter. XZ scans were constructed from 35 
confocal optical sections (0.2 μm apart). All negative controls, including non-injected 
oocytes or sections incubated with preimmune serum or conjugated antibodies alone, 
were devoid of staining. 
 
45Ca2+ uptake assay 
Xenopus laevis oocytes were co-injected with TRPV5 or TRPV6 and Rab11a cRNA. 
Ca2+ uptake was determined 2 days after injection as described previously [21].  
 
Plasma membrane isolation 
Xenopus laevis oocytes were injected with 5 ng TRPV5 cRNA only or co-injected 
with 5 ng TRPV5 and 10 ng Rab11a cRNA. After 48 h follicle membranes were 
manually removed and plasma membranes were isolated from 12 oocytes as 
described before [22]. 
 
Statistical analysis 
In all experiments, the data are expressed as mean ± SEM. Overall statistical 
significance was determined by analysis of variance (ANOVA). P values below 0.05 
were considered significant. 
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Results 
 
Identification of Rab11a as a TRPV5- and TRPV6-associated protein 
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Figure 1. Interaction of TRPV5 and TRPV6 with Rab11a. (A) The C-tail of TRPV6 or ENaC 
and full-length Rab11a were co-transformed into the Y153 yeast strain and grown on media 
without tryptophan and leucine. β-Galactosidase activity was determined in TRPV6 and 
Rab11a co-transformed yeast, γENaC and Rab11a co-transformed yeast were used as 
negative control. Two representative colonies are depicted. (B) [35S]Methionine labeled 
TRPV5 (left) or TRPV6 (right) was incubated with GST-Rab11a WT, GTP-locked mutant 
Rab11a (S20V) or GDP-locked Rab11a (S25N) or GST alone immobilized on glutathione-
Sepharose 4B beads. (C) Coomassie staining of the gels shows equal expression of GST, 
GST-fused Rab11a wild-type (WT) S20V or S25N. (D) [35S]Methionine labeled Rab11a S20V 
or Rab11a S25N was incubated with GST-TRPV5, GST-TRPV6 or GST immobilized on 
glutathione-Sepharose 4B beads. Both TRPV5 and TRPV6 strongly interacted with Rab11a 
S25N, whereas no binding to Rab11a S20V was observed. (E) Coomassie staining of the 
gels demonstrating similar amounts of GST, GST-fused to the C-tail of TRPV5 or GST-fused 
to the C-tail of TRPV6. (F, G) Xenopus laevis oocytes were injected with Rab11a S25N or co-
injected with HA-tagged TRPV5 and Rab11a S25N cRNAs. Oocytes lysates were subjected 
to immunoprecipitation using monoclonal anti-HA antibodies. The precipitated sample was 
immunoblotted for the presence of TRPV5 (F) or co-precipitated Rab11a (G). 
Using the C-tail of TRPV6 as bait to screen a mouse kidney cDNA library with the 
yeast two-hybrid technique, we isolated full length Rab11a, a member of the Rab 
family of small GTPases, as a TRPV6-interacting protein. Rab11a strongly interacted 
with TRPV6 (Figure 1A), whereas β-galactosidase activity was not observed with the 
negative control, in the absence of prey or after co-transformation of the bait with the 
empty pACT2 (prey) vector. 
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The interaction between TRPV6 and Rab11a was further substantiated using GST 
pull-down assays. In vitro translated [35S]methionine-labeled TRPV6 strongly 
interacted with Rab11a S25N, a mutant deficient in GTP binding. Binding to wild-type 
(WT) Rab11a was moderate and only minor binding to Rab11a S20V, a GTPase-
deficient Rab11a mutant [23], was observed (Figure 1B). Identical results were 
obtained with [35S]methionine-labeled TRPV5 (Figure 1B). The reverse binding 
reaction, using GST, GST-TRPV5 C-tail or GST-TRPV6 C-tail incubated with in vitro 
translated [35S]methionine-labeled Rab11a S20V or Rab11a S25N mutants, 
confirmed the TRPV5- and TRPV6-binding specificity for Rab11a S25N (Figure 1D).  
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Figure 2. (A) VSV tagged Rab11a S25N or Rab22b S19N and myc-tagged Rab7 T22N were 
transiently expressed in HEK293 cells and incubated with GST or GST fused to the C-tail of 
TRPV5 or TRPV6 and interactions were analyzed by immunoblot analysis using monoclonal 
anti-VSV or anti-Myc. (B) Coomassie staining of the precipitated GST fusion proteins 
demonstrating equal amounts of GST or GST fused to the C-tail of TRPV5 or TRPV6. (C) 
Rab11a S25N was expressed in bacteria as a GST fusion protein, GST was cleaved of using 
Precission protease and purified Rab11a S25N was incubated with immobilized and purified 
GST-TRPV5 and bound Rab11a detected by immunoblot analyses using anti-Rab11 
antibodies (left panel). The integrity and purity of Rab11a S25N was verified by Coomassie 
staining (right panel).  
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GST alone failed to show any binding in all conditions. The integrity and quantity of 
the GST-fusion proteins was analyzed by Coomassie staining and shows that 
equivalent amounts of protein were used in these assays (Figure 1C, E). In order to 
further assess the Rab11a interaction, HA-tagged TRPV5 and Rab11a S25N were 
co-expressed in Xenopus laevis oocytes and subjected to immunoprecipitation using 
monoclonal anti-HA antibodies. HA-tagged TRPV5 was specifically precipitated using 
these monoclonal antibodies, as indicated by the specific bands at ~70 kDa for the 
core TRPV5 protein and ~90 kDa for the complex-glycosylated TRPV5 (Figure 1F). 
Rab11a S25N was co-precipitated with TRPV5 from these oocytes, as represented 
by an immunopositive band of ~25 kDa (Figure 1G).  
 
Subsequently, the specificity for Rab11a was determined using distant members of 
the Rab family of GTPases. Rab22b S19N and Rab7 T22N, both GTP binding-
deficient Rab proteins, did not bind TRPV5 and TRPV6, indicating the specificity of 
the interaction of TRPV5 and TRPV6 with Rab11a (Figure 2A). GST, GST-fused 
TRPV5 and GST-fused TRPV6 were present in equal amounts, as demonstrated by 
Coomassie staining (Figure 2B). GST alone did not show any binding in these 
conditions. To investigate whether the association between Rab11a and the epithelial 
Ca2+ channels is direct, recombinant Rab11a S25N was purified as GST-fusion 
protein and subsequently cleaved from GST using Precission protease. The purity of 
recombinant Rab11a was analyzed by Coomassie staining (Figure 2C, right panel). 
Purified Rab11a S25N displayed similar TRPV5-binding efficiencies (Figure 2C), 
demonstrating that the interaction is direct and does not require additional proteins. 
 
Co-localization of Rab11a with TRPV5 and TRPV6 
Subsequently, we examined whether TRPV5 colocalized with wild-type Rab11a and 
the GTP- and GDP-locked Rab11a mutants. To this end, HeLa cells were transiently 
transfected with constructs encoding EGFP-tagged TRPV5 and DsRed-tagged 
Rab11a (WT, S20V or S25N) and the subcellular localization of TRPV5 and Rab11a 
was visualized by confocal laser scanning microscopy. TRPV5 was clearly present in 
many vesicles distributed throughout the cytoplasm where it showed prominent 
colocalization with wild-type Rab11a (Figure 3A) and to a lesser extend in the ER. 
Similarly, TRPV5 colocalized also with Rab11a S20V, the GTP-locked form of 
Rab11a, in vesicular structures, strongly resembling the pattern observed with wild-
type Rab11a (Figure 3B). Interestingly, a significant vesicular colocalization of 
TRPV5 was observed with GDP-locked Rab11a S25N (Figure 3C), opposed to the 
dispersed localization of Rab11a S25N observed previously [24, 25]. These findings 
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are in line with our GST pull-down and co-immunoprecipitation results and suggest 
that GDP-bound Rab11a is at least in part vesicle-associated in TRPV5-expressing 
cells. DsRed-fused wild-type Rab4 showed little or no colocalization with TRPV5, 
indicating that this channel is particularly enriched in the Rab11a-positive 
compartment (Figure 3D). Furthermore, YFP-fused TRPV2 did not colocalize with 
Rab11a, but showed a strong plasma membrane staining (Figure 3E). 
 
Figure 3. 
Colocalization of 
TRPV5 with Rab11a 
wild-type, S20V and 
S25N in 
cytoplasmic 
vesicles. HeLa cells 
were transiently 
transfected with 
pEGFP-TRPV5 and 
wild-type DsRed-
Rab11 (A), DsRed-
Rab11a S20V (B), 
DsRed-Rab11a 
S25N (C) or DsRed-
Rab4 (D). TRPV5 
was mainly present 
in vesicles and to a 
lesser extent in the 
ER. TRPV5 
completely 
colocalized with wild-
type Rab11a in these 
vesicles, whereas 
virtually no 
colocalization was 
observed between 
TRPV5 and Rab4 
(D). Rab11a S20V 
(B) as well as 
Rab11a S25N (C) 
both showed a 
prominent vesicular 
pattern that largely 
colocalized with 
TRPV5. Co-
expression of YFP-
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Rab11a resulted in 
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fluorescent signals 
(Bars = 5 µm). 
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 A clear plasma membrane localization of TRPV5 was not observed in either of the 
conditions, although a significant TRPV5-mediated Ca2+ influx was measured in 
TRPV5-transfected HeLa cells compared to none-transfected cells (data not shown). 
This suggests that a low number of TRPV5 channels are present at the plasma 
membrane to facilitate Ca2+ influx but prevent cytosolic overload with Ca2+. To 
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determine whether the interaction can also occur under physiological conditions the 
cellular colocalization of endogenous TRPV5 and TRPV6 with endogenous Rab11a 
was investigated. Immunopositive staining for Rab11a colocalized with TRPV5 in 
specific kidney tubules, previously identified as distal convoluted (DCT) and 
connecting tubules (CNT) [19] (Figure 4A). Furthermore, serial sections were stained 
for the presence of Rab11a and TRPV6, revealing co-expression of both proteins in 
the luminal domain of CNT and cortical collecting ducts (CCD) [26] (Figure 4B).  
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Figure 4. Co-localization of endogenous TRPV5 and TRPV6 with Rab11a. (A) Mouse kidney 
sections were co-stained with antibodies against TRPV5 and Rab11a. (B) Serial kidney sections 
were stained with antibodies against TRPV6 or Rab11a. (C, D) Immunodissected CNT and CCD 
cells were grown on permeable filter supports and double-labeled with anti-TRPV5 and anti-Rab11 
or (E) steptavidin-Oregon green to visualize the cell surface. Arrowheads indicate the positions 
utilized to render XZ projections from 35 confocal optical sections (0.2 μm apart). (F) Transcellular 
Ca2+ transport in control situations and in the presence of 1 μM ruthenium red was measured prior 
to fixation to ensure monolayer integrity and cell viability. The robust transcellular Ca2+ transport 
demonstrates the quality of the preparation. Bar denotes 100 μm (A, B) or 5 μm (* P<0.05) (C-E).  
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detailed localization studies were subsequently performed on primary cultures of 
CNT and CCD cells, immunodissected from rabbit kidney. These cells exhibited net 
apical-to-basolateral Ca2+ transport, indicating the integrity and functionality of the 
preparation. Ca2+ transport was blocked (from 63 ± 3 to 5 ± 2 nmol/cm2/h) by 
ruthenium red, a polycationic dye that blocks TRPV5 activity with an IC50 of 111 nM 
[27] (Figure 4F).  
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 Figure 5. The Rab11a binding site in TRPV5. (A) GST fusion proteins containing different portions 
of the C-tail of mouse TRPV5 were constructed according to the schematic drawing. (B) These 
proteins were immobilized on glutathione-Sepharose 4B beads and then incubated with in vitro 
translated Rab11a S25N. Interaction of Rab11a with the GST fusion proteins was determined by 
autoradiography. The region between amino acids 595 and 601 was essential for binding. Mutation of 
this region (595-5G-601) diminished the interaction with Rab11a (right panel). (C) GST or GST-
fused to the C-tail of TRPV5, immobilized on glutathione Sepharose 4B beads were incubated with in 
vitro translated Rab22b and precipitated proteins were analyzed by autoradiography. Rab22b did not 
associate with TRPV5, demonstrating the specificity of the Rab11a binding. (D) TRPV5 and TRPV6 
sequences, varying from human to zebrafish, were aligned using the Clustal method, demonstrating 
complete conservation of the Rab11a binding-site during evolution. (E) cRNA encoding full-length 
TRPV5 or TRPV6 was injected in Xenopus laevis oocytes and the localization of the channel was 
investigated by immunocytochemistry. Mutation of 5 amino acids in the Rab11a-binding region 
resulted in significantly disturbed TRPV5 and TRPV6 trafficking, resulting in a low number of 
channels at the cell surface. (F) Accordingly, TRPV5-mediated 45Ca2+ uptake was significantly 
decreased in Xenopus laevis oocytes, injected with TRPV5 595-5G-601 compared to oocytes 
injected with wild-type TRPV5. Similar functional results were obtained between wild-type and 601-
5G-607 mutant TRPV6. Bar denotes 25 μm (* P<0.05). 
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TRPV5-staining localized predominantly to the apical side of the cell and was absent 
from the basolateral membrane that is in line with its physiological function as apical 
Ca2+ influx channel (Figure 4E). Importantly, TRPV5 immunopositive staining 
overlapped with that of Rab11a in vesicular structures (Figure 4C). Analysis of z-
stacks of these cells (Figure 4D). combined with plasma membrane staining (Figure 
4E) confirmed the colocalization of Rab11a and TRPV5 in a subapical region. Thus, 
these findings further substantiate the physiological relevance of the interaction 
between the epithelial Ca2+ channels and Rab11a. 
 
Characterization of the Rab11a binding site in TRPV5 
To map the Rab11a binding site, a series of deletion mutants of the C-tail of TRPV5 
was constructed as depicted in Figure 5A. These mutants were expressed and 
purified as GST-fusion proteins and incubated with in vitro translated Rab11a S25N. 
Rab11a interacted with TRPV5 truncates up to position 601, narrowing the binding 
site to a helical region of 29 amino acids. Two truncated TRPV5 mutants, containing 
stop codons at position 596 or 591, failed to co-precipitate Rab11a (Figure 5B). 
Therefore, the region between amino acids 595 and 601 of TRPV5 is essential for 
Rab11a binding. Subsequently, this region, corresponding to the amino acid 
sequence MLERK, was mutated into glycines (595-5G-601) and the binding of 
Rab11a was re-analyzed by GST pull-down. The interaction between Rab11a and the 
mutant 595-5G-601 TRPV5 was significantly decreased, further indicating the 
relevance of this MLERK domain for Rab11a interaction (Figure 5B). 
 
Of note, the binding region for the previously identified TRPV5-interacting protein 
S100A10 is located upstream of this Rab11a binding region [12] and the T593A 
(amino acid numbering according to the mouse sequence, accession number 
NP001007573) mutation in TRPV5, which is crucial for S100A10 binding, had no 
effect on binding of Rab11a (data not shown), indicating the specificity of the 
identified region. GST alone did not bind Rab11a and in vitro translated Rab22b did 
not show any affinity for TRPV5 under these conditions (Figure 5C). Importantly, the 
diminished binding of Rab11a to the TRPV5 595-5G-601 mutant was accompanied 
by an impaired trafficking of TRPV5, as was demonstrated by immunocytochemical 
analysis of Xenopus laevis oocytes injected with TRPV5 wild-type or 595-5G-601 
mutant cRNA. Wild-type channels showed robust plasma membrane localization, 
whereas the binding-deficient mutant is mainly localized to the cytoplasm (Figure 5E).   
 We also mutated this region in TRPV6 (601-5G-607) and investigated whether 
similar trafficking defects were displayed. In line with our results with TRPV5, wild-
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type TRPV6 showed significant plasma membrane staining, whereas TRPV6 601-
5G-607 was absent from the plasma membrane but accumulated intracellularly. 
(Figure 5E). The functional role of Rab11a binding was subsequently investigated by 
45Ca2+ uptake measurements in oocytes. Expression of wild-type TRPV5 resulted in a 
~5-fold increase in the Ca2+ uptake compared to non-injected oocytes, whereas 
expression of the TRPV5 595-5G-601 mutant resulted in a Ca2+ uptake that was 
indistinguishable from non-injected oocytes (Figure 5F).  
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Figure 6. Role of Rab11a in TRPV5 and TRPV6 trafficking towards the plasma 
membrane. 45Ca2+ uptake was measured in oocytes injected with TRPV5 cRNA (A) or 
TRPV6 cRNA (B) only or co-injected with Rab11a S20V, Rab11a S25N, or Rab22b S19N 
cRNA.  Asterisk denotes significantly (P<0.05) different from non-injected oocytes. HA-
TRPV5 and Rab11a cRNA was co-injected in Xenopus laevis oocytes. Plasma membranes 
(C) or total membranes (D) were isolated and blotted for TRPV5 using monoclonal anti-HA. 
Oocytes were injected with HA-tagged TRPV5 cRNA with or without Rab11a cRNA and 
TRPV5 localization was determined by immunocytochemistry using monoclonal anti-HA (E). 
Rab11a S25N expression decreased the TRPV5 plasma membrane localization. 
Representative images of three independent experiments are shown. Bar denotes 10 μm. 
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Similar results were obtained with TRPV6 and the TRPV6 601-5G-607 mutant 
(Figure 5F). The functional significance of the identified Rab11a-binding site is 
further underscored by sequence conservation among all members of the epithelial 
Ca2+ channels TRPV5 and TRPV6 identified so far (Figure 5D), ranging from human 
to zebrafish.  
 
Rab11a S25N inhibited TRPV5- and TRPV6-mediated Ca2+ influx 
The effect of Rab11a expression on TRPV5 and TRPV6 activity at the plasma 
membrane was determined in Xenopus laevis oocytes, using a 45Ca2+ uptake assay. 
Expression of TRPV5 and TRPV6 resulted in a ~5-fold increase of Ca2+ influx 
compared to non-injected oocytes (Figure 6A, B). Co-expression of Rab11a S25N 
significantly decreased the TRPV5- and TRPV6-mediated Ca2+ influx to a level that 
was indistinguishable from non-injected oocytes (Figure 6A, B). Co-expression of 
Rab11a S20V or Rab22b S19N had no significant effect on TRPV5 and TRPV6 
activity. Ca2+ uptake in oocytes expressing only Rab11a S20V or Rab11a S25N was 
not different from non-injected oocytes (0.49 ± 0.07, 0.42 ± 0.05 versus 0.44 ± 0.04 
pmol Ca2+/oocyte/h, respectively). The effect of Rab11a S25N is consistent with a 
role for Rab11a in TRPV5- and TRPV6- targeting to the plasma membrane. 
Therefore, we investigated trafficking of TRPV5 in Xenopus laevis oocytes. A distinct 
band at the size of complex glycosylated TRPV5 [28] was observed by immunoblot 
analysis in plasma membrane preparations of TRPV5-injected oocytes (Figure 6C). 
The core TRPV5 protein was not detectable, indicating the purity of the plasma 
membrane preparation obtained by using this method [22]. Importantly, TRPV5 could 
not be detected in the plasma membrane of oocytes co-expressing TRPV5 and 
Rab11a S25N, whereas co-injection of Rab11a S20V resulted in normal plasma 
membrane localization of TRPV5 (Figure 6C). In all conditions, TRPV5 was 
produced and glycosylated to a similar extent as in the absence of mutant Rab11a 
protein (Figure 6D). These results were verified by immunocytochemical analysis of 
TRPV5- and Rab11a-expressing oocytes. Immunopositive staining for TRPV5 was 
predominantly localized along the plasma membrane (Figure 6E). Co-injection of 
TRPV5 with Rab11a S25N resulted in largely dispersed intracellular immunopositive 
staining with virtually no staining of TRPV5 at the plasma membrane, while 
expression of Rab11 S20V had no effect (Figure 6E).  
 
The role of Rab11a in the regulation of TRPV5 was further investigated using primary 
cultures of CNT/CCD cells grown to confluency on permeable filter supports. 
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Lentivirus-mediated expression of GFP-fused Rab11a S25N or GFP only was 
verified by confocal laser scanning microscopy (Figure 7A).  
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Figure 7. Rab11a S25N inhibits transcellular Ca2+ transport in primary cultures of 
CNT/CCD cells. CNT/CCD cells were immunodissected from rabbit kidney, infected with 
lentivirus and plated on permeable filter supports. Confluent monolayers of CNT/CCD cells 
were analysed six days post-infection. (A) Expression of GFP and GFP-fused Rab11a S25N 
was investigated by confocal laser scanning microscopy and localization of the GFP signal was 
compared with endogenous TRPV5. (B) Lentiviral expression of GFP or GFP-fused Rab11a 
S25N was quantified by immunoblot analysis using anti-GFP antibodies confirming the size and 
integrity of the proteins. (C) Net apical to basolateral Ca2+ transport was measured in forskolin-
stimulated (10 μM) CNT/CCD monolayers infected with lentivirus expressing either GFP alone 
or GFP-fused Rab11a S25N. Infections were performed at densities of 1 or 10 lentivirus 
particles per cell (1 or 10 MOI), showing a concentration-dependent inhibition of Ca2+ transport 
by Rab11a S25N (* p<0.05). Bar denotes 10 μm, NI; not infected. 
 
 
 
 
 
 
 
 
GFP-Rab11a S25N displayed a tubulovesicular localisation, while GFP showed a 
predominant diffuse cytosolic pattern. Rab11a S25N partially co-localized with 
endogenous TRPV5, whereas GFP alone showed no co-localization (Figure 7A), in 
line with the colocalization results obtained in HeLa cells (Figure 3). The expression 
of GFP and GFP-fused Rab11a S25N was further confirmed by immunoblot analysis 
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using anti-GFP antibodies showing single bands of comparable intensity at the 
expected height for GFP and GFP-fused Rab11a S25N (Figure 7B). Importantly, 
transcellular Ca2+ transport showed a significant and dose-dependent inhibition in 
Rab11a S25N-expressing primary CNT/CCD monolayers compared to monolayers 
expressing GFP only. Viral infections did not affect the transepithelial resistance in 
either condition confirming the integrity of the monolayer (data not shown). 
Furthermore, no differences in TRPV5 expression were observed in infected versus 
non-infected cells. Therefore, the results obtained with the renal primary cultures are 
consistent with our observations using TRPV5-expressing Xenopus oocytes and 
further substantiate the role of Rab11a in the targeting of TRPV5 to the plasma 
membrane.  
 
Discussion 
 
The present study demonstrates a novel function of Rab11a mediating trafficking of 
TRPV5 and TRPV6 towards the plasma membrane by direct cargo interaction. First, 
GDP-bound Rab11a directly and specifically binds to a conserved stretch in the C-tail 
of TRPV5 and TRPV6, demonstrating a unique interaction between a TRP channel 
and a GDP-bound Rab. Second, the epithelial Ca2+ channels colocalize with Rab11a 
in subapical vesicles present in Ca2+-transporting cells of the kidney. Third, functional 
data suggests that cargo interaction (in the GDP status) and subsequent GTP 
binding are required for Rab11a-mediated TRPV5 and TRPV6 targeting towards the 
plasma membrane. 
 
GDP-bound Rab11a as a novel TRPV5- and TRPV6-interacting protein 
Our study describes for the first time cargo proteins that interact directly with Rab11a. 
Although Rab proteins are known to interact with a large variety of effectors [10, 29, 
30], only a few studies have demonstrated direct interaction between a Rab GTPase 
and a cargo molecule [31]. Recently, it was reported that the polymeric IgA receptor 
(pIgR) interacts directly with Rab3b, controlling IgA-stimulated transcytosis [32]. The 
second example is the interaction between Rab5a and the angiotensin II type 1A 
receptor [33]. Finally, Pfeffer and coworkers were the first to demonstrate a 
mechanism in which Rab proteins interact indirectly with cargo. They showed that a 
ternairy complex of Rab9, mannose-6-phosphate receptor and the adaptor protein 
TIP47 plays a role in the vesicular transport of the mannose-6-phosphate receptor 
[34]. Direct interaction of Rabs with cargo could provide further insight into the 
mechanisms of Rab localization and function. The recruitment of Rabs to specific 
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membranes is mediated by the Rab C-tail [35]. This suggests the involvement of 
Rab-interacting proteins in the membrane localization of Rab proteins. An intriguing 
possibility is that certain Rab-accessory proteins are cargo themselves, contributing 
to the membrane localization of specific Rab proteins. As TRPV5 and TRPV6 
preferentially interacted with Rab11a in its inactive configuration, TRPV5 and TRPV6 
may support the recruitment of Rab11a to specific membrane compartments in Ca2+-
transporting epithelia. Similarly, it was suggested that the direct interaction between 
Rab3b and pIgR provides a partial explanation for the specificity of binding of Rab3b 
to pIgR-containing vesicles [32]. Furthermore, direct interaction of Rabs with cargo 
could contribute to the targeting of proteins to their proper destination. Direct 
association of TRPV5 and TRPV6 with Rab11a could support the translocation of 
these channels into recycling endosomes and thereby constitute the “delivery 
machinery” destined to transport these channels to the apical plasma membrane. 
Identification of additional novel cargo that interacts with Rab proteins could provide 
means to further dissect the mechanism of Rab activity and thus a novel insight into 
the molecular machinery of membrane traffic.  
 
Co-localization of Rab11a and TRPV5 and TRPV6 
Further evidence for a role of Rab11a in TRPV5 and TRPV6 regulation is the 
predominant co-localization of Rab11a with TRPV5 or TRPV6 along the apical 
domain of DCT, CNT and CCD, corroborating previous Rab11 localization data from 
Goldenring et al. [36]. Furthermore, Rab11a is present along the luminal membrane 
of enterocytes, where TRPV6 expression is prominent [36, 37]. The specific 
expression pattern in kidney and intestine supports a role for Rab11a in the 
regulation of TRPV5 and TRPV6. Also at the subcellular level, Rab11a shows 
significant co-localization with TRPV5 in subapical vesicular structures. Previous 
functional and histological studies have identified Rab11-positive structures as 
(apical) recycling endosomes, which are specialized compartments involved in (polar) 
sorting of endocytosed membrane proteins [23, 38-41]. Furthermore, Rab11 has 
been demonstrated to play a role in transport from the trans-Golgi network to the 
plasma membrane [42, 43]. In addition, Ang and coworkers have recently 
demonstrated a role for recycling endosomes as intermediates in the transport from 
Golgi to the plasma membrane [44]. Our study is the first to indicate that cargo 
molecules that travel via these Rab11-enriched structures can be directly bound to 
Rab11a.  
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Rab11a binding targets TRPV5 and TRPV6 towards the plasma membrane 
The unique role of Rab11a in targeting of TRPV5 and TRPV6 towards the plasma 
membrane by direct interaction to the channel was further established using 
combined biochemical, functional and immunocytochemical analyses. In order to 
identify the direct consequences of Rab11a association with the epithelial Ca2+ 
channels, we mutated the Rab11a binding site in TRPV5 and TRPV6. The interaction 
between Rab11a and TRPV5 and TRPV6 is localized to a helical stretch in the C-tail. 
A stretch of five amino acids at position 595-601 within the Rab11a binding site of 
TRPV5 was demonstrated to be required for Rab11a binding. Moreover, this region 
is conserved among all identified species of TRPV5 and TRPV6. Mutations in this 
stretch resulted in a lack of TRPV5- and TRPV6-mediated Ca2+ uptake, based on 
defective trafficking of TRPV5 and TRPV6, in line with an essential role for Rab11a in 
targeting TRPV5 and TRPV6 towards the plasma membrane. However, as this 
stretch has been implicated in the interaction of TRPV5 with 80K-H, a Ca2+-binding 
protein [45] and in TRPV5 channel assembly [46], Rab11a-independent factors can 
not be excluded to explain the impaired trafficking of this mutant. Therefore, we 
further substantiated the functional role of Rab11a in the trafficking of TRPV5 and 
TRPV6 using Rab11a mutants in Xenopus oocytes and primary cultures of Ca2+-
transporting cells from rabbit kidney. GDP-locked Rab11a expression strongly 
reduced the TRPV5- and TRPV6-mediated Ca2+ influx, resulting from a significantly 
decreased number of Ca2+ channels at the plasma membrane. This effect can be 
explained in two ways. First, in analogy with dominant negative Ras mutants [47], 
Rab11a S25N could sequester a Rab11a guanine nucleotide exchange factor (GEF) 
and thereby block the activation of Rabs. However, expression of another dominant 
negative Rab protein (Rab22b S19N) did not inhibit TRPV5 and TRPV6 activity. This 
either suggests that Rab GEF inhibition is not essential to block TRPV5 and TRPV6 
trafficking, or that Rab11a S25N associates with a specific GEF that does not bind 
Rab22b S19N. It is currently unknown which protein operates as a GEF for Rab11a 
and how promiscuous this GEF is. Rab11a S20V has a lower affinity for Rab GEFs 
[23, 48], explaining the lack of functional consequences of expression of this mutant. 
A second explanation for the dominant negative effect of Rab11a S25N is a 
competition with endogenous Rab11a for the Rab11a binding site in TRPV5 and 
TRPV6. Because Rab11a S25N can not bind GTP, it will not be activated and this 
impairs TRPV5 and TRPV6 trafficking towards the plasma membrane. Rab11a S20V 
cannot compete with endogenous Rab11a for TRPV5 and TRPV6 binding, explaining 
the lack of function of this mutant. Together, these data indicate that cargo interaction 
(in the GDP status) as well as subsequent GTP binding is required for Rab11a-
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mediated TRPV5 and TRPV6 trafficking. Our findings show a novel interaction 
between a Rab GTPase and TRP channels and point to a unique role for Rab11a in 
the regulation of TRPV5 and TRPV6 channel trafficking. We propose the following 
model for the role of Rab11a in trafficking of TRPV5 and TRPV6 (Figure 8). Initially, 
cytosolic GDP-bound Rab11a specifically interacts with TRPV5 and TRPV6 in a 
cytoplasmic compartment. Subsequently, Rab11a is docked to this compartment, 
while GDP is exchanged with GTP. At this state, Rab11a effectors will associate and  
Rab11a does no longer interact with TRPV5 and TRPV6. Finally, active GTP-bound 
Rab11a mediates transport of TRPV5 and TRPV6 containing structures to the 
plasma membrane, where membrane fusion allows Ca2+ influx.  
 TRPV5
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Rab11a-GDP Rab11a-GTP
Lumen
Tight junction
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 8. Schematic model depicting the role of Rab11a in TRPV5 and TRPV6 trafficking. 
Rab11a-GDP interacts directly with TRPV5 or TRPV6 in intracellular vesicles. Subsequently, 
Rab11a is docked at the vesicle, and GDP is exchanged for GTP. Several Rab-effectors 
stabilize Rab11a in the membrane in the GTP-bound state. At this state, Rab11a does no 
longer interact with TRPV5 or TRPV6. The vesicle is subsequently targeted to the plasma 
membrane, where its fusion enables TRPV5- and TRPV6-mediated Ca
 
 
2+ -influx. 
 
In conclusion, our data provide new insight into the molecular machinery of TRP 
channel trafficking via direct interaction between a Rab GTPase and apically targeted 
cargo. This association is involved in the physiological regulation of TRPV5 and 
TRPV6 cell-surface abundance, a critical component in Ca2+ homeostasis. The future 
challenge is to find the signals that modulate the interaction of TRPV5 and TRPV6 
and Rab11a to fine-tune cell-surface expression of these epithelial channels. 
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Why should work be such a significant source of human satisfaction. A good 
share of the answer rests in the kind of pride that is stimulated by the job, by 
the activity of accomplishing. (Leonard R.Sayles) 
为什么工作竟然是人们获得满足和快乐如此重要的源泉呢？最主要的答案就
在于，工作和通过工作所取得的成就，能极大的激发我们的自豪感。(塞尔
斯.L.R.) 
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Abstract 
 
Blood Ca2+ concentration is maintained within a narrow range despite large variations in 
dietary input and body demand. The unique Transient Receptor Potential ion channel, 
TRPV5, has been implicated in this process. We found that TRPV5 is stimulated by the 
anti-aging hormone klotho via a novel extracellular activation mechanism. Klotho, 
secreted in the pro-urine, hydrolyzes by its β-glucuronidase activity the extracellular 
TRPV5 sugar residues, entrapping the channel protein at the plasma membrane to 
maintain durable Ca2+ channel activity and membrane Ca2+ permeability in kidney. Thus, 
klotho provides a novel concept of activation of a cell-surface TRP protein by extracellular 
hydrolysis of its N-linked oligosaccharides. 
 
Materials and methods 
 
DNA constructs  
pCINeo/IRES-GFP-TRPV5, pCINeo/IRES-GFP-HA-TRPV5, pCINeo/IRES-GFP-TRPV6 
constructs were generated as described previously [1, 2]. The coding sequence of 
wild-type klotho was amplified from mouse (strain C57BL/6) kidney cDNA, cloned into the 
pGEX6p-2 vector and tagged at the N-tail with a HA-tag and subsequently subcloned into 
the pCINeo/IRES-GFP. The TRPV5 (TRPV5-N358Q) and TRPV6 (TRPV6-N357Q) 
mutants were obtained by in vitro mutagenesis in pCINeo/IRES-GFP-TRPV5 and 
pCINeo/IRES-GFP-TRPV6 cDNA, respectively. All constructs were verified by DNA 
sequence analysis. 
 
Quantitative real-time PCR analysis  
Total RNA was isolated from mouse kidney, brain, lung, muscle, heart, liver, spleen, 
duodenum, ileum and bone using TRIzol and subjected to reverse transcription as 
described [4]. The primers and probes for the real-time PCR analysis were 
5’-GCCGACCATTTCAGGGATTA-3’ and 5’-TGATCCAGTACTTGACCTGACCA-3’ and 
the probe 5’-CGAGCTCTGCTTCCGCCACTTCG-3’. Klotho expression levels were 
presented as a ratio to the expression of the housekeeping gene hypoxanthine-guanine 
phosphoribosyl transferase (HPRT) as described previously [4]. 
 
Immunohistochemistry  
Immunohistochemistry was performed as described [5]. Mouse kidney sections were 
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incubated for 16 hours at 4 ºC with affinity purified mouse anti-calbindin-D28K (1:100), 
rabbit antiserum against klotho (1:500) and guinea pig anti TRPV5 (1:200). To visualize 
the proteins corresponding secondary Alexa 488/594 conjugated antibodies (1:300) 
(Molecular Probes, Eugene, USA) were used. 
 
Collection and concentration of conditioned culture media 
HEK293 cells were transfected with 15 μg pCINeo/IRES-GFP-HA-klotho or 
pCINeo/IRES-GFP empty-vector cDNA in 85 mm petri-dishes. After 3 days of transfection, 
the conditioned culture media was collected and concentrated 10 times using the 
centriprep columns ultracel YM-30 (Millipore corporation, Bedford, MA, U.S.A.).  
 
Transfection of HEK293 cells and preparation of cell lysates 
HEK293 cells were transfected with HA-TRPV5, TRPV6, TRPV5-N358Q, TRPV6-N357Q 
and/or HA-klotho pCINeo/IRES-GFP constructs. Two days after transfection, cells were 
homogenated, centrifuged at 200 g for 10 min and subsequently eluted in Laemmli buffer 
followed by an incubated of 30 min at 37°C. For total membrane isolation of HEK293 cells, 
the cells were homogenized in HBA [20 mM Tris-HCl pH 7.4, 5 mM MgCl2, 5 mM 
NaH2PO4, 1 mM EDTA pH 8.0, 80 mM sucrose, 1 mM phenyl-methylsulfonyl fluoride 
(PMSF), 10 μg/ml leupeptin and 10 μg/ml pepstatin], and then centrifuged for 15 min, at 
4,000 g at 4°C, in addition 30 min at 13,000 rpm at 4°C. The pellet was dissolved in 30 μl 
of laemmli buffer and incubated at 37°C for 30 min. The proteins were detected by 
SDS-PAGE gel electrophoresis followed by autoradiography. 
 
Protein and immunoblot analysis 
Total protein cell lysates or total membranes were isolated from HEK293 cells as 
described above or from C57BL6 mouse kidney as described previously [6]. The samples 
were subjected to SDS-PAGE electrophoresis (6-8% w/v). Immunoblots were incubated 
overnight at 4°C with primary antibodies including mouse anti-HA (1:4000) and guinea pig 
anti-TRPV5 (1:4000), rabbit MO3 anti-TRPV6 (1:5000) and rat anti-klotho (bio-connect, 
Huissen, the Netherlands) (1:1000), in 1% (w/v) NFDM in TBS-T, respectively. After 
washing, immunoblots were incubated at room temperature with the corresponding 
secondary antibody goat anti-mouse IgG peroxidase (1:10000) (Sigma, St Louis, MO, 
USA), goat anti-guinea pig IgG peroxidase (1:10000) (Sigma), goat anti-rabbit IgG 
peroxidase (1:10000) (Sigma) or goat anti-rat IgG peroxidase (1:5000) (Sigma) in TBS-T. 
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Immunoprecipitation of klotho  
Protein A-coupled agarose beads were pre-incubated for 3 h at RT with monoclonal 
anti-HA antibody (Sigma) in PBS and subsequently washed three times with PBS. 
Culture media collected from klotho-expressing HEK293 cells (klotho-containing 
supernatant) was then added to the washed antibody-bound protein A beads (Pharmacia, 
Uppsala, Sweden) and incubated for 16 hours at 4°C. After incubation, the remaining 
supernatant was subsequently analyzed for klotho expression using the anti-klotho 
antibody and 45Ca2+ uptake in TRPV5 expressing HEK293 cells. 
 
Urine TCA precipitation 
24 hour urine was collected from mice housed in metabolic cages and centrifuged at 200 
g for 10 min at 4°C to remove debris. Proteins in the urine were precipitated using 
ice-cold trichloroacetic acid (TCA) (Ocros organics, New Jersey, USA). The urine TCA 
mixture was centrifuged at 13,000 rpm for 10 min at 4°C, and the pellet was subsequently 
washed with 300 μl acetone. Next, the pellet was air-dried (3 min), dissolved in laemmli 
buffer containing 0.1 M DTT and 150 mM Tris (pH 8.8) and analyzed by immunoblot 
analysis for the expression of klotho. 
 
Biotinylation 
HEK293 cells were transfected with 15 μg pCINEO/IRES-GFP-HA-TRPV5 or 
pCINEO/IRES-GFP empty-vector cDNA in 85 mm petri-dishes, which were coated with 
poly-L-lysine (0.1% v/v). One day after transfection, cells were incubated with conditioned 
media for 16 hours. Dishes with confluent transfected HEK293 cells were placed on ice 
and washed twice with ice-cold PBS pH 8.0 / NaOH containing 1 mM MgCl2 and 0.5 mM 
CaCl2 (PBSB). Cells were then incubated for 30 min at 4°C with NHS-LC-LC-biotin (final 
concentration 0.5 mg/ml, Pierce, Ettenleur, the Netherlands), freshly diluted in PBSB. 
Biotinylation was terminated by rinsing the dishes twice with PBSB containing 0.1% (w/v) 
bovine serum albumin and once with PBS pH 7.4 without Ca2+ or Mg2+. Cells were 
collected from plates and lysed with 1 ml lysis buffer, incubated for 60 min at 4 oC. 
Following measurement of the protein content of the cell extract, samples (900 μg of 
protein) were added to 150 μl of neutravidin beads, pre-equilibrated in the lysis buffer and 
rotated overnight at 4°C. The biotin-avidin agarose complexes were then harvested by 
centrifugation at 14,000 g for 10 min and washed four times with the lysis buffer. Finally, 
the beads were resuspended in 60 μl of 2x Laemmli buffer and incubated at 37°C for 30 
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min prior to SDS-PAGE.  
 
Electrophysiology 
To investigate the effect of klotho, HEK293 cells were transfected with HA-TRPV5 and 
incubated with culture media collected from HEK293 cells transfected with 
pCINeo/IRES-GFP (empty-vector supernatant) or pCINeo/IRES-GFP-HA-klotho 
(klotho-containing supernatant) for 16 hours. Macroscopic currents were measured in the 
whole-cell patch-clamp configuration using an EPC-9 amplifier (HEKA Elektronik, 
Lambrecht, Germany; 8-Pole Bessel filter 10 kHz) as described previously in detail [7]. 
 
45Ca2+ uptake assay 
HEK293 cells were transfected with HA-TRPV5 or co-transfected with HA-TRPV5 and 
HA-klotho pCINeo/IRES-GFP constructs. In order to investigate the effect of conditioned 
media HEK293 cells expressing TRPV5, TRPV6 or TRPV5-N358Q, TRPV6-N357Q were 
incubated for 16 hours or for the indicated time points with conditioned media. 
Subsequently, 45Ca2+ uptake was determined as described previously [2]. 
β-Glucuronidase from bovine liver and D-saccharic acid-1,4-lacton (Sigma) were used. 
 
Measurement of transcellular Ca2+ transport in primary culture of rabbit kidney 
connecting tubule and cortical collecting duct 
Rabbit kidney connecting tubules and cortical collecting ducts were immunodissected 
from kidney cortex of New Zealand White rabbits (~0.5 kg) using antibody R2G9 and then 
placed in primary culture on permeable filters (0.33 cm2; Costar, Cambridge, MA, USA) as 
described in detail previously [8]. At confluency, monolayers of rabbit connecting tubular 
and cortical collecting duct cells growing on permeable filters were washed twice and 
preincubated in PSS containing 140 mM NaCl, 2 mM KCl, 1 mM K2HPO4, 1 mM MgCl2, 1 
mM CaCl2, 5 mM glucose, 5 mM L-alanine, 5 µM indomethacin, 10 mM Hepes/Tris, pH 
7.4, for 15 min at 37°C. Subsequently, the monolayers were incubated in PSS (100 µl to 
apical and 600 μl to basolateral compartment), in the presence of empty-vector 
supernatant (apical), klotho-containing supernatant (apical), β-glucuronidase (apical) or 
10 nM PTH (basolateral, Sigma) as indicated in the text. After 90 min transepithelial Ca2+ 
transport was measured by using a colorimetric assay kit as described [8]. 
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Glucose labeling 
HEK293 cells were transfected with 2.5 μg pCINEO/IRES-GFP-HA-TRPV5 or 
pCINEO/IRES-GFP empty-vector cDNA. Cells were incubated in the presence of 4.5 
μCi/well of D-[U-14C]glucose (Amersham, Buckinghamshire, UK). 32 hour after 
transfection the cells were incubated for 16 hours with empty-vector supernatant, 
klotho-containing supernatant or β-glucuronidase. Subsequently, cells were washed and 
homogenized with 300 μl of solubilization buffer [0.5% (v/v) NP-40, 20 mM Tris pH 8.0, 
10% (v/v) glycerol, 5 mM EDTA, 1 mM PMSF, 10 μg/ml leupeptin, 10 μg/ml pepstatin] and 
incubated on ice for 1 hours, and subsequently centrifuged at 16,000 g for 1 hour at 4°C 
to pellet undissolved proteins. The solubilized proteins were diluted with 0.7 ml of sucrose 
buffer [100 mM NaCl, 20 mM Tris (pH 8.0), 5 mM EDTA, 0.1% (v/v) Triton X-100, 
10% (w/v) sucrose, 1 mM PMSF, 10 μg/ml leupeptin, 10 μg/ml pepstatin]. In the mean 
time, 20 μl equivalents of protein A-coupled agarose beads were pre-incubated for 3 
hours at room temperature with 2 μl of monoclonal anti-HA antibody (Sigma) in 0.7 ml of 
IPP500 [500 mM NaCl, 10 mM Tris pH 8.0, 0.1% (v/v) NP-40, 0.1% (v/v) Tween-20, 
1 mM PMSF, 10 μg/ml leupeptin, 10 μg/ml pepstatin] and 0.1% (w/v) bovine serum 
albumin. The beads were washed three times with IPP100 [100 mM NaCl, 10 mM Tris 
(pH 8.0), 0.1% (v/v) NP-40, 0.1% (v/v) Tween-20]. Furthermore, the cell lysates were 
added to the washed antibody-bound protein A beads and incubated for 16 hours at 4°C. 
After incubation, the beads were washed three times with IPP100, incubated in 25 μl of 
Laemmli buffer for 30 min at 37°C. The eluted proteins were subsequently subjected to 
immunoblotting and liquid scintillation counting. 
 
Statistical analysis 
In all experiments, the data are expressed as mean ± SEM. Overall statistical significance 
was determined by analysis of variance (ANOVA). P values below 0.05 were considered 
significant. 
 
Result and Discussion 
 
Ca2+ is an essential ion in all organisms, where it plays a crucial role in processes ranging 
from formation and maintenance of the skeleton to temporal and spatial regulation of 
neuronal function. Concentration of blood Ca2+ decreases with age in both men and 
women, and several studies provided evidence that this negative Ca2+ balance is linked 
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to aging-associated disorders. The Ca2+ balance is maintained by the concerted action of 
three organ systems including the gastrointestinal tract, bone and kidney. Until recently, 
the mechanism by which Ca2+ ions enter the absorptive epithelia was unknown. A major 
breakthrough in completing the molecular details of this influx pathway was the 
identification of the epithelial Ca2+ channel family consisting of two members of the 
Transient Receptor Potential (TRP) superfamily, namely TRPV5 and TRPV6 [9, 10]. 
TRPV5 comprises the Ca2+ channel predominantly involved in renal Ca2+ handling, 
whereas TRPV6 was postulated to mediate intestinal Ca2+ absorption. TRPV5 and 
TRPV6 are the most Ca2+-selective channels in the TRP superfamily. 
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Figure 1. Localization and tissue distribution of klotho. (A) Immunohistochemical analysis of 
klotho (green), TRPV5 (red) and calbindin-D28K (red) in mouse kidney sections. (B) RNA was 
extracted from several mouse tissues including kidney, brain, lung, muscle, heart, liver, spleen, 
duodenum (duod.), ileum and bone and subsequently klotho expression was determined by 
quantitative real-time PCR analysis (n=3 mice per condition). Klotho expression levels were 
presented as a ratio to the expression of the housekeeping gene hypoxanthine-guanine 
phosphoribosyl transferase (HPRT). (C) Protein lysates were prepared from mouse kidney and 24 
hour urine was collected from mice (n=3). Both samples were analyzed for the expression of klotho 
proteins by immunoblotting. Klotho-containing supernatant (klotho super) from HEK293 cells 
expressing klotho was included as a positive control. 
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Mice lacking TRPV5 display diminished renal Ca2+ reabsorption despite enhanced 
vitamin D levels, causing severe hypercalciuria [11]. In addition, compensatory 
hyperabsorption of dietary Ca2+ was measured in intestine of TRPV5 knockout mice. 
Furthermore, these mice exhibit significant abnormalities in bone structure, including 
reduced trabecular and cortical bone thickness [11]. In the process of identifying 
regulatory proteins in the maintenance of the Ca2+ balance by oligonucleotide-based 
microarray chip analysis, we identified klotho as a significantly down-regulated gene in 
kidneys of TRPV5 knockout mice. Klotho, which is a type I membrane glycoprotein of 130 
kD [12], is indeed abundantly expressed in mouse kidney as determined by quantitative 
real-time PCR analysis (Figure 1B). In all other analyzed tissues including brain, lung, 
muscle, heart, liver, spleen, duodenum, ileum and bone at least 500 times lower mRNA 
expression levels of klotho were estimated. Immunoblotting showed a clear band at ~130 
kD in mouse kidney lysates corresponding to a significant renal klotho abundance and 
accordingly klotho protein was detected in mouse urine (Figure 1C). Nabeshima and 
co-workers generated a mice strain in which the klotho gene was inactivated [12]. Klotho 
gene ablation results in a syndrome resembling human aging, including short life span, 
bone aberrations, infertility, skin atrophy and hypercalcemia together with an increased 
serum vitamin D level. Klotho exhibits a considerable homology to β-glucosidase 
enzymes of bacteria, plants and eukaryotes [13]. In general β-glucosidases participate in 
essential steps of synthesis and degradation of polysaccharides, which are involved in 
processes such as pathogen defense [14], control of signal transduction [15] and 
modification of hormones [16]. In humans, inheritable deficiencies of glycosidases are 
known to induce a large variety of impairments as lysosomal storage diseases, 
Gaucher’s and Krabbe’s disease and lactose intolerance [17]. In addition to the 
aging-associated disorders observed in the klotho null mice polymorphisms in the klotho 
gene have been linked to reduced bone mineral density in humans [18, 19]. However, the 
molecular function of klotho and the down-stream targets of this anti-aging hormone 
remain to be identified.  
 
Previous studies have indicated that the expression of both klotho and TRPV5 is tightly 
controlled by the calciotropic hormone vitamin D, which may suggest a functional link 
between these proteins in the maintenance of the Ca2+ balance [9, 20]. Based on this 
correlation and the conspicuous overlap in the pathophysiology of TRPV5 and klotho 
knockout mice, for instance, disturbed Ca2+ homeostasis and vitamin D metabolism, we 
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hypothesized that TRPV5 is a down-stream target of the anti-aging hormone klotho. To 
test this theory, we first performed detailed immunohistochemical analysis on mouse 
kidney, which demonstrated a complete co-localization of TRPV5, the vitamin D-sensitive 
Ca2+-transporting protein calbindin-D28K and the klotho protein in the distal convoluted 
(DCT) and connecting tubule (CNT), nephron segments particularly known to be 
responsible for active transepithelial Ca2+ reabsorption (Figure 1A). Despite the fact that 
klotho mutant mice show systemic aging phenotypes, only limited organs express the 
klotho gene [12].  
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Figure 2. Regulation of TRPV5 activity by klotho. (A) 45Ca2+ uptake measured in HEK293 cells 
transfected with cDNA of TRPV5, klotho, or co-transfected with both constructs. Asterisk indicates 
significant difference from TRPV5-transfected HEK293 cells. #, indicates significant difference from 
non-transfected HEK293 cells (p<0.05, n=8). An equal expression level of TRPV5 was confirmed by 
immunoblotting analysis. (B) Mock and TRPV5-transfected cells were exposed for 16 hours to 
empty-vector supernatant (empty-super) or klotho-containing supernatant (klotho-super), and 
subsequently analyzed for 45Ca2+ influx. Asterisk indicates significant difference from HEK293-TRPV5 
cells treated with empty-vector supernatant. #, indicates significant difference from mock-transfected 
HEK293 cells (p<0.05, n=6). The empty-vector supernatant or klotho-containing supernatant were then 
analyzed by immunoblotting analysis using the mouse anti-HA antibody to detect the secreted klotho. (C) 
HEK293-TRPV5 cells were treated with klotho-containing supernatant or empty-vector supernatant and 
analyzed by patch-clamp analysis. The cells treated with klotho-containing supernatant displayed 
significantly increased currents compared to the empty-vector supernatant: Na+ current at -80 mV -1526 ± 
250 pA/pF versus -299 ± 106 pA/pF (n=6, left), Ca2+ peak current -115 ± 25 versus -45 ± 10 pA/pF (n=6, 
middle) and Ca2+ current at -80 mV -88 ± 7 versus -14 ± 5 pA/pF (n=6, right), respectively. Averaged 
current responses to voltage ramps and hyperpolarizing pulses are depicted below the histograms. (D) 
HEK293-TRPV5 cells were exposed to klotho-containing supernatant for the indicated time points and 
analyzed for 45Ca2+ influx (n=3). (E) HEK293-TRPV5 cells were treated for 16 hours with β-glucuronidase 
at the indicated concentrations and subsequently analyzed for 45Ca2+ uptake (n=3). (F) HEK293-TRPV5 
cells were stimulated with klotho-containing supernatant in the presence of increasing concentrations of 
D-saccharic acid 1,4-lactone, an specific inhibitor of β-glucuronidase activity [3], (n=3). 
Subsequently, we co-expressed klotho with TRPV5 in human embryonic kidney (HEK293) 
cells. Functional studies using these cells showed a TRPV5-mediated 45Ca2+ influx that 
was significantly enhanced by co-expression of klotho (Figure 2A). Our demonstration 
that klotho is detectable in urine together with previous studies reporting that klotho is 
present in serum and cerebrospinal fluid [21], suggests that klotho operates from the 
extracellular site to regulate TRPV5 activity. To investigate this mechanism, 
HEK293-TRPV5 cells were incubated overnight (16 hours) with the culture media 
collected from klotho-expressing HEK293 cells (klotho-containing supernatant) or 
empty-vector-expressing HEK293 cells (empty-vector supernatant). Intriguingly, TRPV5 
activity was significantly increased by klotho-containing supernatant, whereas no effect 
was observed with empty-vector control supernatant (Figure 2B). Klotho protein with a 
molecular weight of 130 kDa was clearly detectable in supernatant obtained from 
HEK293-klotho cells, whereas no specific band was noticeable in the empty-vector 
control supernatant (Figure 2B). Klotho did not alter TRPV5 expression (data not shown) 
suggesting a specific effect on channel kinetics or trafficking towards the plasma 
membrane. HEK293-TRPV5 cells were treated overnight (16 hours) with 
klotho-containing supernatant or empty-vector supernatant, and subsequently analyzed 
by whole cell patch-clamp analysis. Both the Na+ and Ca2+ currents were significantly 
stimulated by klotho treatment (Figure 2C). Measurements in divalent free solution 
(EDTA 0.1 mM) revealed a significant increase in channel activity (Figure 2C, left). 
Application of a hyperpolarizing voltage step from a holding potential of +70 to -100 mV 
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showed an increased Ca2+ peak current, whereas no significant differences on the 
Ca2+-dependent inactivation behavior of the channel was observed (Figure 2C, middle). 
By applying a voltage ramp to cells perfused with a solution containing 10 mM Ca2+ a 
significant rise in current amplitude was obtained (Figure 2C, right). Together with the 
fact that TRPV5 is a constitutive active Ca2+ channel with an open probability close to 
100% [22], these findings imply an increased channel abundance at the plasma 
membrane due to the incubation with extracellular klotho. The stimulatory effect of klotho 
on TRPV5 activity was maximal at 16 hours of incubation, but a significant increase in 
channel activity was already apparent after 2 hours (Figure 2D). Since it has been 
demonstrated that klotho exhibits β-glucuronidase activity [3], we examined whether 
purified β-glucuronidase from bovine liver (EC 3.2.1.31) could mimic the stimulatory effect 
of klotho on TRPV5 channel activity. To this end, HEK293-TRPV5 cells were incubated 
for 16 hours with increasing concentrations of β-glucuronidase. Remarkably, 
β-glucuronidase mimicked the effect of the klotho-containing supernatant on TRPV5 
channel activity with a maximal stimulation at 250 μg/ml (Figure 2E). To further 
characterize whether the β-glucuronidase activity of klotho is responsible for the 
stimulatory action, we studied the effect of the potent klotho inhibitor D-saccharic acid 
1,4-lactone [3]. As shown in Figure 2F, the klotho-mediated increase of TRPV5 activity 
was dose-dependently inhibited by this blocker with an apparent IC50 of 0.5 μM 
demonstrating that the stimulatory action of klotho can be attributed to its β-glucuronidase 
activity. Subsequently, klotho was immunoprecipitated from the klotho-containing 
supernatant and the remaining fluid was indeed depleted of klotho and importantly failed 
to increase TRPV5 channel activity (Figure 2G). Together, these findings demonstrated 
that klotho via its β-glucuronidase activity directly activates TRPV5.  
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 Figure 2. Regulation of TRPV5 activity by klotho. (G) Klotho was immunoprecipitated from the 
klotho-containing supernatant (klotho-super) and the remaining fluid was analyzed for klotho 
expression (depleted klotho-super). HEK293-TRPV5 cells were stimulated with depleted and normal 
klotho-containing supernatant and subsequently analyzed for 45Ca2+ influx. Asterisk indicates 
significant difference from HEK293-TRPV5 cells (p<0.05, n=3). 
 
 
 
 
 
Next, the effect of klotho and β-glucuronidase was evaluated in kidney primary cultures. 
These primary cultures of rabbit distal convoluted and connecting tubules form confluent 
monolayers that exhibit many characteristics of the original polarized epithelium, 
including PTH- and vitamin D-stimulated transepithelial Ca2+ transport [8]. Apical addition 
of klotho-containing supernatant or β-glucuronidase significantly stimulated transcellular 
Ca2+ transport in these primary kidney cells, whereas the control supernatant did not 
affect the transport process (Figure 3).  
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Figure 3. Transepithelial Ca2+ transport is 
stimulated by klotho. Monolayers of rabbit 
connecting tubules and cortical collecting 
ducts primary cell cultures were apically 
treated with the klotho-containing supernatant 
(klotho super) or empty-vector supernatant 
(empty super) for 16 hours. Net apical to 
basolateral Ca2+ transport was measured in 
the presence of empty-vector supernatant 
(apical), klotho-containing supernatant 
(apical), 250 μg/ml β-glucuronidase (Glu, 
apical) or 100 μM parathyroid hormone (PTH, 
basolateral). Asterisk indicates significant 
difference from cell cultures treated with 
empty-vector supernatant (p<0.05, n=6). 
To elucidate the molecular mechanism underlying the stimulatory effect of extracellular 
klotho on TRPV5 channel activity, we studied the role of glycosylation in this process. 
Heterologous expression of TRPV5 in HEK293 cells and subsequent immunoblot 
analysis of cell lysates revealed specific bands of TRPV5 with a molecular size ranging 
from 75 to 90-100 kDa (Figure 4A). These bands were not detected in 
empty-vector-transfected cells. The immunoreactive protein bands at 75 kDa reflect the 
core TRPV5 protein, while the 90-100 kDa band represents the complex glycosylated 
TRPV5 product [23]. Sequence analysis predicts a N-glycosylation site (N358) positioned 
between transmembrane segment 1 and 2. The functional role of glycosylation in 
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klotho-mediated TRPV5 stimulation was investigated by mutating the asparagine residue 
in this putative glycosylation site into a glutamine (TRPV5-N358Q), which prevented 
TRPV5 glycosylation upon expression in HEK293 cells. These cells showed normal Ca2+ 
influx that was not significantly different from cells expressing wild-type TRPV5 channels 
(Figure 4A). Interestingly, the klotho and β-glucuronidase-stimulatory effect on TRPV5 
was abolished in the HEK293 cells expressing this TRPV5-N358Q mutant, whereas 
HEK293-TRPV5 cells showed an increased Ca2+ influx activity (Figure 4A). These 
results indicated that abolishment of the glycosylation by mutagenesis of the 
N-glycosylation site prevents accumulation of TRPV5 at the plasma membrane. This 
suggests that the klotho-mediated TRPV5 accumulation is due to the specific hydrolysis 
of extracellular sugar residues from the channel protein. Next, we showed that klotho also 
augments the activity the highly homologues TRPV6 channel, while the 
glycosylation-deficient TRPV6 (N357Q) mutant failed to respond to klotho and the 
β-glucuronidase (Figure 4B).  
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Thus, klotho stimulates TRPV channel activity by sugar hydrolysis at the conserved 
glycosylation site between transmembrane segment 1 and 2. To investigate 
klotho-mediated hydrolysis of the glycosylated TRPV5 protein, HEK293 cells transiently 
expressing the channel were labeled for 48 hours with D-[U-14C]glucose.  
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Figure 4. Molecular mechanism of 
klotho-stimulated TRPV5 channel activity. (C) 
HEK293-TRPV5 cells were labeled for 48 hours with 
D-[U-14C]glucose. After 32 hours cells were treated 
with klotho-containing supernatant (klotho-super), 
empty-vector supernatant (empty-super) or 250 
μg/ml β-glucuronidase (Glu) and subjected to 
immunoprecipitation using the guinea pig 
anti-TRPV5 antibody. Precipitated 
D-[U-14C]glucose-TRPV5 was eluted from the beads 
and processed for liquid scintillation counting. 
Asterisk indicates significant difference from 
HEK293-TRPV5 cells treated with empty-vector 
supernatant (p<0.05, n=6). 
Figure 4. Molecular mechanism of klotho-stimulated TRPV5 channel activity. HEK293 cells 
expressing TRPV5 or TRPV5-N358Q (A), TRPV6 or TRPV6-N357Q (B) were exposed to 
klotho-containing supernatant (klotho-super) or 250 μg/ml β-glucuronidase (Glu) for 16 hours and 
subsequently assayed for 45Ca2+ uptake. Asterisks indicate significant difference from 45Ca2+ influx in 
HEK293-TRPV5 cells or in HEK293-TRPV6 cells, respectively (p<0.05, n=4). TRPV5 and TRPV6 
expression was analyzed in the cell lysates and total membrane fractions indicating that glycosylation 
was impaired in the mutant TRPV5-N358Q and TRPV6-N357Q, respectively. 
Figure 4. Molecular mechanism of klotho-stimulated TRPV5 channel activity. (D) HEK293 cells 
were transfected with TRPV5 and incubated for 16 hours with klotho-containing supernatant 
(klotho-super), empty-vector supernatant (empty-super) or 250 μg/ml β-glucuronidase (Glu). TRPV5 
expression was determined by immunoblotting in total cell lysates to demonstrate equal expression 
(left). Cell-surface proteins were biotinylated extracellularly, precipitated with neutravidin-agarose 
beads and immunoblotted for TRPV5 (middle: low exposure, right: high exposure). As a negative 
control biotine was omitted in the procedure. 
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After 32 hours of D-[U-14C]glucose labeling the cells were incubated for 16 hours with 
klotho-containing supernatant, empty-vector control supernatant or β-glucuronidase and 
subsequently TRPV5 was immunoprecipitated. Incubation of the HEK293-TRPV5 cells 
with klotho-containing supernatant or β-glucuronidase showed a decrease in 
D-[U-14C]glucose-labeled TRPV5 precipitate indicating extracellularly cleaved 14C-sugars 
compared to the empty-vector control supernatant (Figure 4C). These data demonstrate 
that klotho exhibits β-glucuronidase activity by hydrolysing sugars from glycosylated 
TRPV5 channels. To obtain insight into the functional consequences of the klotho action 
on TRPV5, the plasma membrane expression of TRPV5 was examined in klotho- and 
control-treated HEK293-TRPV5 cells by plasma membrane surface biotinylation which 
demonstrated that the klotho-containing supernatant enhanced the plasma membrane 
TRPV5 expression explaining the observed increase in channel activity (Figure 4D, 
middle: low exposure, right: high exposure). Treatment of the cells with empty-vector 
supernatant had no effect on cell-surface expression indicating the specificity of the 
klotho action. Total expression of TRPV5 in cell lysates was equal in all conditions 
(Figure 4D, left). The klotho-mediated increase in channel abundance was fully 
mimicked by the addition of 250 μg/ml β-glucuronidase indicating that extracellular 
hydrolysis of TRPV5 associated carbohydrates and consequent plasma membrane 
gathering depends on the glucuronidase activity of the klotho protein. 
 
N-glycosylation of proteins is highly conserved from yeast to human and has a significant 
stabilizing effect on large regions of the backbone protein structure to facilitate proper 
folding and trafficking of membrane proteins. Protein glycosylation has been implicated in 
cellular functions such as modulating protein structure and localization, cell-cell 
recognition, and signaling in multicellular systems. The glycosylation of proteins can be 
modulated by adaptations in the biosynthetic pathway. For instance, dietary variations 
and also hormones like estradiol can have a profound effect on the display of cell-surface 
carbohydrate epitopes [24]. The present study now demonstrates that glycosylated 
cell-surface proteins are extracellularly controlled by glucuronidases to regulate their 
biological function. Thus, we provide a new concept of a regulatory mechanism by 
glycosylation in which the secreted urinary β-glucuronidase klotho hydrolyzes the 
N-linked oligosaccharides of TRPV5 to entrap channels at the plasma membrane. Since 
klotho and TRPV5 co-localize in the distal part of the nephron, klotho could exert its 
stimulatory effect via an auto- and/or paracrine mechanism. Furthermore, TRPV5 and 
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klotho are both positively regulated by the biosynthetic vitamin D pathway. This 
concomitant control will ensure high Ca2+ transport capacity and reduce Ca2+ excretion to 
preserve normal blood Ca2+ levels during periods of dietary Ca2+ insufficiency. 
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The ideals that have lighted my way, and time after time have given me new 
courage to face life cheerfully, have been kindness, beauty and truth. (Albert 
Einstein)  
有些理想曾为我们引过道路，并不断给我新的勇气以欣然面对人生，那些理
想就是--真、善、美。 (爱因斯坦. A.) 
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Abstract  
 
The Transient Receptor Potential Vanilloid 5 (TRPV5) channel determines urinary Ca2+ 
excretion and is therefore critical for Ca2+ homeostasis. Interestingly, mice lacking the 
serine protease tissue kallikrein (TK) exhibit robust hypercalciuria comparable to the 
Ca2+ leak in TRPV5 knockout mice. Here, we delineated the molecular mechanism 
through which TK stimulates Ca2+ reabsorption. Using TRPV5-expressing primary 
cultures of renal Ca2+-transporting epithelial cells, we showed that TK activates Ca2+ 
reabsorption. The stimulatory effect of TK was mimicked by bradykinin (BK) and could 
be reversed by application of JE049, a BK receptor type 2 (B2R) antagonist. A cell 
permeable analog of diacylglycerol (DAG) increased TRPV5 activity within 30 minutes 
via protein kinase C activation of the channel, since mutation of TRPV5 at the putative 
PKC phosphorylation sites S299 and S654 prevented the stimulatory effect of TK. Cell-
surface labeling revealed that TK enhanced the amount of wild-type TRPV5 channels, 
but not of the TRPV5 S299A and S654A mutants, at the plasma membrane by 
delaying its retrieval. In conclusion, TK stimulates Ca2+ reabsorption via the BK-
activated PLC/DAG/PKC pathway and the subsequent stabilization of the TRPV5 
channel at the plasma membrane. 
 
Introduction 
 
The overall Ca2+ balance is regulated by a homeostatic mechanism tightly controlling 
the concerted actions of intestinal Ca2+ absorption, exchange of Ca2+ from bone and 
renal Ca2+ reabsorption. In kidney, Ca2+ can cross the epithelial cells and reach the 
blood compartment via two pathways: passive (paracellular) and active (transcellular) 
Ca2+ reabsorption. Active Ca2+ reabsorption takes place in the distal convoluted (DCT) 
and the connecting (CNT) tubules [1]. Although it accounts only for ~15% of total renal 
Ca2+ reabsorption, it is generally considered the site for fine-tuning of urinary Ca2+ 
excretion. Furthermore, active Ca2+ reabsorption is the primary target for regulation by 
calciotropic hormones, including 1,25-dihydroxyvitamin D3 and parathyroid hormone 
(PTH), enabling the organism to regulate Ca2+ reabsorption to the body’s demand.  
 
The Transient Receptor Potential Vanilloid 5 (TRPV5) channel is expressed along the 
apical membrane of DCT and CNT and represents the rate-limiting step in renal 
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transcellular Ca2+ reabsorption [1]. Inactivation of TRPV5 in mice (TRPV5-/-) abolishes 
active Ca2+ reabsorption in kidney resulting in severe hypercalciuria [2]. To 
compensate this renal Ca2+ leak, TRPV5-/- mice exhibit intestinal Ca2+ hyperabsorption. 
In addition, the bone structure of these mice is significantly disturbed as illustrated by a 
reduced trabecular and cortical bone thickness [2]. Hence, these data demonstrate the 
key function of TRPV5 in active Ca2+ reabsorption and its essential role in the body 
Ca2+ homeostasis.  
 
Interestingly, hypercalciuria was recently observed in tissue kallikrein-deficient (TK-/-) 
mice [3]. TK is a serine protease produced in CNT [4], where it co-localizes with 
TRPV5 [2]. Proteolytic enzymes such as TK are synthesized as inactive precursors or 
zymogens, to prevent protein degradation and to enable spatial and temporal 
regulation of enzymatic activity. The precursor of TK is converted to the mature active 
form before entering the luminal tubular compartment. Trypsin, plasma kallikrein, 
plasmin and thermolysin can cleave in vitro the TK precursor, but the endogenous 
activator is still unknown [5]. Once activated, TK is excreted and can process low 
molecular weight kininogen to release kinin which acts through kinin receptors such as 
the bradykinin (BK) 2 receptor (B2R) [6]. Remarkably, recent studies show that TK can 
directly activate the B2R independently of BK release [7]. However, the molecular 
events that link TK to Ca2+ balance are at present unknown.  
 
The aim of this study was, therefore, to elucidate the molecular mechanism of 
hypercalciuria observed in TK-/- mice. To this end, the relation between TK expression 
and hypercalciuria was investigated in vivo using TK-/- and TRPV5-/- mice. 
Subsequently, the effect of TK on transcellular Ca2+ transport was examined in primary 
cultures of renal CNT/cortical collecting duct (CCD) cells. Finally, the signaling 
pathway through which TK acts on Ca2+ reabsorption and its effect on TRPV5 surface 
expression were delineated in TRPV5-expressing cells.  
 
Material and methods 
 
Animal experiments 
TK-/- mice were produced as previously described [3, 8] and fed ad libitum two Na+ 
diets containing 0.3% w/w or 3% w/w for 14 days. Subsequently, 24 hour urine was 
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collected from TK-/- and TK+/+ mice housed in metabolic cages and blood was obtained 
by orbital puncture. Measurements of biological parameters in the animals plasma and 
urine were performed as previously described [3]. Urinary Na+, Ca2+ and Mg2+ 
excretion was expressed as ratios to urinary creatinine excretion to take into account 
the variations in urine collection. TRPV5-/- mice were generated as described 
previously [2]. At the age of 4 weeks, mice were fed ad libitum two diets containing 
0.02% w/w or 2% w/w Ca2+ for 5 weeks and were subsequently placed in metabolic 
cages. 24 hour urine samples were collected and subjected to TCA precipitation. The 
animal ethics board of the Radboud University Nijmegen approved all animal 
experimental procedures. 
 
Urine protein precipitation by TCA 
10% v/v of the 24 hour urine volume collected of TRPV5-/- mice was centrifuged at 200 
g for 10 minutes at 4°C to remove cell debris. Proteins in the urine were precipitated 
using ice-cold TCA (Acros organics, New Jersey, USA). The TCA mixture was 
centrifuged at 13,000 g for 10 minutes at 4°C, and the pellet was subsequently washed 
with 300 μl acetone. Next, the pellet was air-dried for approximately 3 minutes, 
dissolved in Laemmli buffer containing 0.1 M DTT and 150 mM Tris (pH 8.8) and 
analyzed by immunoblot analysis for the expression of TK using a rabbit anti-TK 
antibody (Calbiochem, San Diego, CA, USA). Immunopositive bands were scanned 
using an imaging densitometer to determine pixel density (Molecular Analyst Software, 
BioRad Laboratories, Hercules, CA). 
 
DNA constructs and cell culture 
The pCINeo/IRES-GFP-TRPV5 and pCINeo/IRES-GFP-HA-TRPV5 constructs were 
generated as described previously [9]. Single and combined PKC mutants were 
generated by alanine substitution of the six putative phosphorylation sites of TRPV5 
(S144A, S299A, S316A, S654A, S664A, S698A) using in vitro mutagenesis 
(QuickChange Site-Directed Mutagenesis kit, Stratagene, La Jolla, CA, USA). The 
B2R pcDNA3 was a kind gift from Prof G. Erdös, MD (Department of Pharmacology, 
University of Illinois, Chicago, USA). HEK293 cells were transfected at 70% of 
confluency using polyethylenimine (Polysciences, Inc., Warrington, USA) or 
Lipofectamin 2000 (Invitrogen Life Technologies, Breda, The Netherlands). After 48-60 
hours, cells were used for 45Ca2+ uptake assays, patch-clamp and/or biotinylation 
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experiments. Prior to the assays, cells were incubated for 1 hour in serum-free 
medium containing the particular compound.  
 
Transcellular Ca2+ transport in renal primary cultures  
CNT/CCD tubules were immunodissected from kidney cortex of New Zeeland White 
rabbits (~0.5 kg) using antibody R2G9 and then placed in primary culture on 
permeable filters (0.33 cm2; Costar, Cambridge, MA, USA) as described before [10]. At 
confluence, monolayers were used for the transepithelial Ca2+ transport assay as 
previously described [10]. Transepithelial potential difference and resistance were 
checked before and after transport measurement to confirm the integrity of the 
monolayer.  
 
45Ca2+ uptake assay 
HEK293 cells were transfected with pCINeo/IRES-GFP-HA-TRPV5 or pCINeo/IRES-
GFP empty-vector cDNA. Ca2+ uptake was determined in uptake medium (110 mM 
NaCl, 5 mM KCl, 1.2 mM MgCl2, 0.1 mM CaCl2, 10 mM Na-acetate, 2 mM NaH2PO4, 
20 mM HEPES-Tris, pH 7.4 supplemented with 10 µM felodipine, 10 µM methoxy-
verapamil, 1 mM BaCl2 and 1 µCi/ml 45CaCl2) for 10 minutes at room temperature (20–
25°C). Each well was washed extensively with stop buffer (110 mM NaCl, 5 mM KCl, 
1.2 mM MgCl2, 0.5 mM CaCl2, 1.5 mM LaCl3, 10 mM Na-acetate, 20 mM HEPES-Tris, 
pH 7.4) at 4 °C, incubated with 0.05 % w/v SDS and the lysates were counted for 
radioactivity using liquid scintillation.  
 
Electrophysiology and solutions 
Patch-clamp experiments were performed as described previously [11] in the tight seal 
whole-cell configuration at room temperature using an EPC-9 patch-clamp amplifier 
computer controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany). 
Two voltage protocols were used: a ramp, to establish the I-V relation in nominally 
DVF or in 10 mM Ca2+-containing extracellular solutions and a hyperpolarizing step 
protocol to measure the Ca2+-dependent inactivation. Na+ current densities were 
calculated from the current at -80 mV during the ramp protocols, while the Ca2+ 
currents were calculated from the current at -80 mV during the ramp protocols or from 
Ca2+ peak values were extracted from the current at -100 mV during the step protocol. 
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The analysis and display of patch-clamp data were performed using Igor Pro software 
(WaveMetrics, Lake Oswego, USA).  
 
Cell-surface labeling with biotin 
Human Embryonic Kidney (HEK293) cells were transfected with 15 µg pCINeo/IRES 
GFP-HA-TRPV5, pCINeo/IRES-GFP-TRPV5-S299A, pCINeo/IRES-GFP-TRPV5-
S654A or pCINeo/IRES-GFP empty-vector cDNA in poly-L-lysine (Sigma, St Louis, 
MO, USA) coated 88 mm dishes. 48 hours after transfection, cells were incubated for 1 
hour with 100 nM TK and 1 μM JE049. The biotinylation assay was performed, cells 
were homogenized in 1 ml lysis buffer as described previously [12] using the NHS-LC-
LC-biotin (Pierce, Etten-Leur, The Netherlands). Finally, biotinylated proteins were 
precipitated using neutravidin-agarose beads (Pierce). TRPV5 expression was 
analyzed by immunoblot for the precipitates (plasma membrane fraction) and for the 
total cell lysates using the guinea pig anti-TRPV5 antibody [13]. For the biotinylation 
assay determining TRPV5 cell-surface turnover, the biotinylation experiment was 
pursued as described above. For time point 0 hour, cells were collected from plates 
and lysed, immediately after biotinylation. Other plates of cells were further cultured 
after biotinylation for 1, 3, 6 or 12 hours, then washed once with ice-cold PBS (pH 7.4), 
and subsequently homogenized in lysis buffer. All samples were processed as 
described above.  
 
Compounds 
TK, BK, PMA and OAG were purchased from (Sigma, St Louis, MO, USA). U73122 
and U73343 were purchased from Upjohn Laboratories (Kalamazoo, MI, USA). JE049, 
formerly known as icatibant or HOE140, which was a kind gift of Dr. J. Pünter (Aventis 
Pharma Deutschland GmbH, Frankfurt, Germany).  
 
Statistical analysis 
In all experiments, the data is expressed as mean ± S.E.M. Overall statistical 
significance was determined by analysis of variance (ANOVA). In case of significance, 
differences between the means of two groups were analyzed by unpaired t-test, while 
multiple comparisons between groups were performed by Bonferroni post-hoc tests. 
p<0.05 were considered significant. The statistical analyses were performed using the 
SPSS software (SPSS Inc, Chicago, Illinois, USA).  
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Result 
 
TK expression levels inversely correlate with urinary Ca2+ excretion  
The relation between urinary TK expression and urinary Ca2+ excretion was 
investigated by using wild-type (TK+/+) and TK-/- mice fed a 0.3 % w/w (normal) and 3 
% w/w (high) Na+ diet. Urinary Ca2+ excretion was significantly increased in TK+/+ mice 
on high Na+ diet compared to mice on normal diet (p<0.05, n=12 mice) (Figure 1A). 
Conversely, Ca2+ excretion in TK-/- mice on normal Na+ diet was significantly higher 
(140 ± 13 %) than in TK+/+ mice (p<0.05, n=12 mice), but remained constant on a high 
Na+ diet (p>0.2, n=12 mice) (Figure 1A). On the high Na+ diet there was no significant 
difference in urinary Ca2+ excretion between TK+/+ and TK-/- mice. Body weight, food 
intake, urinary creatinine as well as plasma values of Ca2+, creatinine and protein 
concentrations did not differ between mice genotypes on either diet (Table 1).  
 
Table 1. Phenotypic characterization of TK+/+ and TK-/- mice on 0.3 % w/w and 3 % w/w Na+ diets.  
   
   0.3 % w/w Na+                                                  3 % w/w Na+ 
                                                       TK+/+              TK-/-                            TK+/+             TK-/- 
Weight (g)                                 23.8±1.0        24.5±0.8                     24.6±1.0      23.8±0.4 
Food intake (g/24h)                  2.68±0.64       2.09±0.5                    1.91±0.32    2.18±0.34 
Plasma values                           
      Total Ca2+ (mM)                  2.05±0.06     1.96±0.07                    2.01±0.08     2.07±0.08 
      Creatinine (μM)                   10.5±1.0       9.3±0.9                        9.5±2.1         9.0±2.2 
      Protein (g/L)                        46.3±0.9       44.9±0.9                      49.3±1.0       44.8±1.0 
Urine values  
       Volume (ml/24h)                 1.47±0.20      1.36±0.26                   3.47±0.89     2.18±0.34   
Creatinine excretion           4.94±0.42      4.56±0.37                   4.79±0.39     4.71±0.38 
        (μmol/24h)      
UNa+/Ucr                           39.6±2.5          33.9±2.4                    292.5±38.8    223.2±23.8 
       (mmol/mmol) 
 
 
*p< 0.05 versus same genotype on 0.3 % w/w Na+ diet (n=12 mice). 
 
TK is up-regulated in TRPV5-/- mice 
The amount of TK excreted in the urine was determined by trichloroacetic acid (TCA) 
protein precipitation of 24 hour urine collected from wild-type (TRPV5+/+) and TRPV5-/- 
mice fed either a 0.02 % w/w (low) or a 2 % w/w (high) Ca2+ diet. Immunoblot analysis 
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of the TCA-precipitate showed the specific TK band migrating at ~40 kDa (Figure 1B). 
Semi-quantitative densitometry of the TK corresponding protein band demonstrated 
that urinary TK excretion increased in TRPV5-/- mice compared to TRPV5+/+ littermates 
on low Ca2+ diet, whereas the high Ca2+ diet did not affect TK excretion between 
TRPV5-/- and TRPV5+/+ genotypes (Figure 1C). 
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Figure 1. TK expression in relation to Ca2+ excretion. (A) 24 hour Ca2+ excretion normalized for 
creatinine excretion (UCa2+/UCr) in wild-type (TK+/+, closed bars) and knock-out (TK-/-, open bars) mice 
fed a 0.3 % w/w or 3 % w/w Na+ diet. Data are expressed as means ± S.E.M. (n=12 mice). *p<0.05 
versus TK+/+ mice on 0.3 % w/w diet. (B) Immunoblotting of urinary TK in wild-type (TRPV5+/+) and 
knock-out (TRPV5-/-) mice fed a 0.02 % or a 2 % w/w Ca2+ diet. Each lane represents the protein TCA-
precipitate of 24 hour urine from one individual mouse. (C) The intensity of the immunopositive bands 
was quantified by densitometry and TK expression was depicted as a percent ratio to TRPV5+/+ mice 
(closed bars) fed with 0.02 % w/w Ca2+ diet. Data are expressed as means ± S.E.M. (n=4 mice). 
*p<0.05 versus TRPV5+/+ mice on the same diet. 
 
TK stimulates Ca2+ transport in renal primary cell cultures 
The effect of TK on transcellular Ca2+ transport was evaluated in primary cultures of 
renal CNT/CCD cells. Application of 100 nM TK to the apical side of the monolayer 
significantly stimulated Ca2+ transport compared to non-treated monolayers, while no 
effect was observed when TK was added to the basolateral side only (Figure 2A). 
Importantly, apical addition of TRPV5 channel blocker ruthenium red (10 µM) 
completely inhibited baseline transepithelial Ca2+ transport and abolished the 
stimulatory effect of TK (Figure 2A). TK action was mimicked by apical addition of 100 
nM trypsin, which like TK displays serine protease activity (Figure 2B), as well as 1 
µM BK (Figure 2C). Interestingly, the stimulatory effect on Ca2+ reabsorption of both 
BK and TK was inhibited by apical application of 1 µM JE049, a B2R antagonist 
(Figure 2C). Basolateral treatment of trypsin, BK or JE049 did not affect transcellular 
Ca2+ transport across the monolayer (data not shown). 
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TK enhances TRPV5 channel activity 
The stimulatory effect of TK on Ca2+ transport was further examined in TRPV5-
transfected HEK293 cells. Incubation of these cells with TK concentrations ranging 
from 0.05 to 5,000 nM enhanced 45Ca2+ influx in a dose-dependent manner with a 
maximal stimulation at 500 nM and an EC50 of 6.00 ± 0.04 nM (Figure 3A), whereas 
no effect was observed in mock-transfected cells (data not shown).  
 
150
100
50
0
150
100
50
0
*
* #
A B C
C
a2
+
tra
ns
po
rt 
(%
 o
f C
TR
L)
C
a2
+
tra
ns
po
rt 
(%
 o
f C
TR
L)
C
a2
+
tra
ns
po
rt 
(%
 o
f C
TR
L)* * *
150
100
50
0
**
C
TR
L
TK
 a
pi
ca
l
TK
 b
as
ol
at
er
al
TK
 b
ot
h
C
TR
L
TK B
K
C
TR
L
TK
Tr
yp
si
n
C
TR
L-
R
R
TK
 a
pi
ca
l-R
R
C
a2
+
tra
ns
po
rt 
(%
 o
f C
TR
L)
C
a2
+
tra
ns
po
rt 
(%
 o
f C
TR
L)
C
a2
+
tra
ns
po
rt 
(%
 o
f C
TR
L)
C
TR
L
TK
 a
pi
ca
l
TK
 b
as
ol
at
er
al
TK
 b
ot
h
C
TR
L
TK B
K
C
TR
L
TK
Tr
yp
si
n
C
TR
L-
R
R
TK
 a
pi
ca
l-R
R
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Stimulatory effect of TK on active Ca2+ reabsorption. (A) Monolayers of rabbit primary 
cultures of CNT/CCD cells were incubated with 100 nM TK for 90 minutes at the apical, basolateral 
or both sides. In one condition cell monolayers were incubated for 90 minutes in the presence of the 
TRPV5 blocker ruthenium red (RR, 10 µM, apical side) in the presence or absence of TK (100 nM, 
apical side). Vehicle-treated cells were used as control (CTRL) and net apical to basolateral Ca2+ 
transport was measured. Data are expressed as means ± S.E.M. (n=6 wells). *p<0.05 versus CTRL, 
#p<0.05 versus TK-treated. (B) Primary cells were treated apically with 100 nM trypsin or 100 nM 
TK. (C) 1 µM BK and 100 nM TK were applied at the apical side of the monolayers in the presence 
(open bars) or absence (closed bars) of 1 µM JE049, a B2R antagonist. In all experiments vehicle-
treated cells were used as control (CTRL) and net apical to basolateral Ca2+ transport was 
measured. Data are expressed as means ± S.E.M. (n=4 wells). *p<0.05 versus CTRL. 
 
 
 
 
 
 
 
Further, TK action on TRPV5 channel activity was investigated by the whole-cell 
patch-clamp technique in TRPV5-expressing HEK293 cells. Pre-incubation with 100 
nM TK increased the inward Ca2+ current in response to the step protocol, but the 
Ca2+-dependent inactivation of the TRPV5 currents remained unchanged (Figure 3B). 
The current-voltage (I-V) relation of the currents in response to a voltage ramp did not 
alter after pre-incubation with 100 nM TK (Figure 3C), but the inward Ca2+ current at -
80 mV increased by 167 ± 14 % compared to non-treated, control (CTRL) cells 
(p<0.05, n=15 cells) as depicted in Figure 3D. Likewise, in divalent free (DVF) solution 
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a significant increase of 149 ± 17 % in Na+ inward currents at -80 mV (p<0.05, n=15 
cells) was observed, while the I-V relation remained unchanged (Figure 3E-F). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TK increases TRPV5-mediated currents via the B2R 
Since BK mimicked the TK action on Ca2+ transport in primary cultures of CNT/CCD 
cells, the effect of BK on TRPV5-expressing HEK293 cells was further studied. First, 
the expression of the B2R in HEK293 cells was confirmed by immunoblot analysis. 
B2R-transfected HEK293 cells were used as a positive control. In both mock and B2R-
transfected HEK293 cells, the receptor was detected as a single immunopositive band 
of ~69 kDa (Figure 4A), confirming the presence of the endogenous B2R in this cell 
line. Subsequently, TRPV5-transfected HEK293 cells were incubated for 1 hour with 1 
µM BK and functionally characterized by patch-clamp measurements in comparison to 
Figure 3. Effect of TK on TRPV5-
transfected HEK293 cells. (A) HEK293 
cells were transfected with TRPV5 and 
treated for 1 hour with TK in 
concentrations ranging from 0.05 to 
5,000 nM and finally 45Ca2+ uptake was 
measured. Values are expressed as 
means ± S.E.M. (n=6 wells). (B) 
Averaged Ca2+ currents measured with 
10 mM Ca2+ in the extracellular solution 
during a 3 seconds step to -100 mV from 
holding potential of +70 mV in TRPV5-
transfected HEK293 cells treated (dotted 
trace) or non-treated (solid trace) with 
100 nM TK. (C) Current-voltage relations 
measured from 450 milliseconds voltage 
ramps in 10 mM Ca2+-containing 
extracellular solution from non-treated 
control (CTRL) (solid trace) or TK treated 
(dotted trace) TRPV5-expressing 
HEK293 cells. (D) Average density of the 
Ca2+ current measured as in (C), was 
400 ± 56 pA/pF (n=15 cells) for TK 
treated cells compared to 240 ± 33 pA/pF 
(n=15 cells) for control (CTRL) cells. (E) 
rrent-voltage relations measured from 
450 milliseconds voltage ramps in 
nominally DVF solution in TRPV5-
transfected HEK293 cells treated (dotted 
trace) or non-treated (solid trace) with 
TK. (F) Average Na+ current density at -
80 mV in nominally DVF solution were 
745 ± 85 pA/pF (n=15 cells) for TK 
treated cells compared to 500 ± 55 pA/pF 
for control (CTRL) cells (n=15 cells). 
*p<0.05 versus CTRL. 
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non-treated (CTRL) cells. Interestingly, BK treatment resulted in a significant increase 
of in both Ca2+ (Figure 4D) and Na+ (Figure 4F) currents (p<0.05, n=12 cells) 
compared to CTRL cells, without affecting the Ca2+-dependent inactivation (Figure 4B) 
or the I-V relation of the currents (Figure 4C and 4E).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Because the different treatments of TRPV5-expressing HEK293 cells affected both 
Ca2+ and Na+ current amplitudes leaving unaffected the other current properties, only 
the Ca2+ currents were depicted to demonstrate the effect of particular compounds. 
Figure 4. TK stimulation of TRPV5 
activity is mediated by B2R. (A) B2R 
transfected and mock cells were lysed 
and calibrated for equally protein 
loading on gel. Immunoblot analysis of 
the samples shows the B2R expression.  
(B) Inward Ca2+ currents in TRPV5-
transfected HEK293 cells treated 
(dotted trace) or non-treated (solid 
trace) with 1 µM BK for 1 hour 
measured with the step protocol as in 
Figure 3B. (C) Current-voltage relations 
measured from 450 milliseconds 
voltage ramps in 10 mM Ca2+-
containing extracellular solution from 
non-treated control (CTRL) (solid trace) 
or BK (dotted trace) treated TRPV5-
expressing HEK293 cells. (D) Amplitude 
of Ca2+ current for BK treated cells was 
363 ± 45 pA/pF and for control cells 240 
± 30 pA/pF (n=12 cells for each 
condition). (E) Current-voltage relations 
measured from voltage ramps in 
nominally DVF extracellular solution 
m non-treated control (solid trace) 
d BK (dotted trace) treated TRPV5-
expressing HEK293 cells. (F) Average 
Na+ current for cells treated with BK 
was 615 ± 49 pA/pF and for control 
(CTRL) cells 460 ± 46 pA/pF. (G) 
Inward Ca2+ currents measured with 10 
mM Ca2+ in the extracellular solution 
during the voltage step to -100 mV of 
control non-treated cells (solid trace), 
ls treated with TK (dotted trace), and 
cells treated with both TK and 1 µM of 
the B2R antagonist JE049 (dashed 
trace). Inactivation of currents remained 
unchanged. (H) Average peak Ca2+ 
current of cells treated with TK and 
JE049 was 285 ± 45 pA/pF and for 
control (CTRL) cells 300 ± 50 pA/pF 
compared to 500 ± 55 pA/pF measured 
from TK treated cells. *p<0.05 versus 
CTRL. #p<0.05 versus TK treated cells. 
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Chapter 5 
Incubation of TRPV5-transfected cells with 1 μM JE049 reversed the stimulatory effect 
of TK on TRPV5-mediated currents. The Ca2+-dependent inactivation of Ca2+ currents 
remained unchanged for cells treated with TK or TK and JE049 (Figure 4G). Ca2+ 
current amplitudes measured from the step protocol were significantly lower, 285 ± 50 
pA/pF, for the JE049-treated cells (p<0.05, n=11 cells) compared to TK-treated cells 
(Figure 4H). 
 
TK stimulates TRPV5-mediated currents via the PLC-dependent PKC pathway  
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Figure 5. TK action is mediated by 
the DAG/PKC-dependent PLC 
signalling pathway. TRPV5 
expressing cells were incubated for 1 
hour with 100 nM TK and 
subsequently treated as described 
below. (A) 10 minutes incubation 
with 10 μM of the PLC inhibitor 
U73122 reverted the average Ca2+ 
currents amplitude of the TK treated 
cells to values similar to control 
(CTRL) cells, contrary to its inactive 
form U73343 which let the TK effect 
unaltered (n=10 cells). (B) Ca2+ 
current of cells pre-treated for 1 hour 
with 10 μM OAG Ca2+ currents was 
355 ± 30 pA/pF and for control 
(CTRL) cells 191 ± 25 pA/pF. (C) 
Time-course of TRPV5 current 
stimulation by OAG. Points represent 
Ca2+ peak current measured at -100 
mV using the step protocol from cells 
pre-treated with 10 µM OAG for 15, 
30 and 60 minutes or non-treated 
cells. *p<0.05 versus non-treated 
cells at 0 minutes. (D) Average Ca2+ 
currents for cells expressing TRPV5 
mutated for all its six PKC 
phosphorylation sites were 123 ± 36 
pA/pF and TK treated cells were 113 
± 25 pA/pF (n=10 cells for each 
condition). (E) Point mutation of the 
PKC phosphorylation sites S299 and 
S654 did not affect Ca2+ currents in 
comparison with the other four PKC 
mutants upon TK treatment.  Data 
are expressed as percentage of Ca2+ 
currents measured of cells 
expressing PKC-TRPV5 point 
mutants treated with 100 nM TK 
normalized to non-treated control 
(CTRL) cells (n=12 cells for each 
mutant).  
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Figure 5. (F) Incubation with 1 μM PMA for 24 hours was used to down-regulate the PMA-sensitive 
PKC isoforms in TRPV5-transfected cells. In both cases, non-treated (NT), or incubation  with PMA 
for 24 hours, TK (black bars) was still able to significantly increase TRPV5-mediated Ca2+ currents 
compared to control cells (white bars) (n=14 cells for each condition) *p<0.05 versus CTRL cells.  
 
To elucidate in detail the mechanism through which TK enhances TRPV5 activity, the 
following strategies were followed. First, pre-treatment with 10 μM of the PLC inhibitor 
U73122 for 10 minutes abolished the TK stimulatory effect on TRPV5-mediated Ca2+ 
currents, whereas 10 μM of its inactive analogue U73343 had no effect (p<0.05, n=10 
cells) (Figure 5A). Then, TRPV5-transfected cells were incubated for 1 hour with 10 
μM 1-oleoyl-acetyl-sn-glycerol (OAG), a synthetic diacylglycerol (DAG) analogue. OAG 
mimicked the stimulatory effect of TK on TRPV5-mediated Ca2+ currents (p<0.05, n=10 
cells) (Figure 5B). The stimulatory effect of OAG was observed within 30 minutes after 
addition (Figure 5C). Next, the effect of TK on the sextuple PKC phosphorylation-
deficient mutant was tested. In HEK293 cells expressing this mutant, the stimulatory 
effect of TK was abolished (Figure 5D). Subsequently, the PKC phosphorylation sites 
were individually mutated into an alanine residue. TK increased Ca2+ currents of all 
single PKC mutants, except of S299A and S654A (p<0.05, n=12 cells) (Figure 5E).  
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Figure 6. B2R confers specificity to TK-dependent stimulation of TRPV5 activity. (A) 
Averaged Ca2+ currents measured with 10 mM Ca2+ in the extracellular solution during a 3 
seconds step to -100 mV from a holding potential of +70 mV in TRPV5-transfected HEK293 cells 
treated with 1 mM ATP (dotted trace), treated with 1 mM ATP and 1 µM of the B2R antagonist 
JE049 (dashed line) or non-treated control (solid trace). (B) Current-voltage relationships 
measured from 450 milliseconds voltage ramps in 10 mM Ca2+-containing solution in TRPV5-
transfected HEK293 cells treated with ATP (dotted trace), treated with ATP and JE049 (dashed 
trace) or non-treated (solid trace) with ATP. (C) Average density of the Ca2+ peak current 
measured as in (B), was 300 ± 54 pA/pF for ATP-treated cells and 322 ± 65 pA/pF for ATP and 
JE049, compared to 190 ± 23 pA/pF (n=15 cells) for control (CTRL) cells. *p<0.05 versus CTRL.
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Furthermore, to determine which PKC isoforms are involved in this process, cells were 
incubated for 24 hours with 1 μM of phorbol ester (phorbol 12-myristate 13-acetate-
PMA) to down-regulate the PMA-sensitive PKC isoforms expressed in HEK293 cells 
as previously described [14]. Then, these PMA-pretreated cells were treated as 
aforementioned with 100 nM TK for 1 hour. TK was still able to significantly increase 
(164 ± 14% of control, p<0.05, n=14 cells) the TRPV5-mediated Ca2+ currents (Figure 
5F). Vehicle-incubated (NT) cells were used as control for the effect of PMA on TRPV5 
currents and PMA incubation left TRPV5-mediated currents unaffected.  
 
Subsequently, the possible involvement of other G-protein coupled receptors in 
addition to the B2R was investigated. To this end, purinergic receptors were activated 
by the addition of extracellullar ATP (1 mM for 1 hour) to TRPV5-expressing HEK293 
cells. Indeed, as shown in the Figure 6, ATP treatment enhanced the inward Ca2+ 
currents in these cells, while leaving the I-V relationship and Ca2+-dependent 
inactivation unchanged. Moreover, after pre-treatment with the B2R antagonist JE049, 
ATP was still able to stimulate the TRPV5 currents, indirectly demonstrating the 
specificity of TK stimulation via the B2R. 
 
TK increases cell-surface expression of TRPV5 by delaying channel retrieval  
 
 
 
 
 
 
  
Figure 7. TK affects the plasma 
membrane expression of 
TRPV5. (A) TRPV5-transfected 
HEK293 cells were treated with 
100 nM TK with or without 1 μM 
JE049. Cells were subjected to 
cell-surface biotinylation and after 
lysis precipitated with neutravidin-
agarose beads. TRPV5 
expression was analyzed by 
immunoblot for the plasma 
membrane fraction (left panel) 
and for the total cell lysates (right 
panel). As negative controls, 
mock cells were used and biotin 
was omitted in the procedure. 
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The effect of TK on the amount of TRPV5 channel expressed at the plasma membrane 
was investigated in HEK293 cells. TRPV5-transfected cells were incubated with 100 
nM TK alone or in combination with 1 μM JE049 for 1 hour and then subjected to cell-
surface biotinylation. Biotinylated cell lysates were precipitated with neutravidin-
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agarose beads and immunoblotted for TRPV5. Mock-transfected and non-biotin-
treated cells were used as negative controls. TK treatment enhanced TRPV5 
expression in the biotinylated fraction, whereas JE049 abolished this effect (Figure 7A, 
left panel). Importantly, TRPV5 was equally expressed in total cell lysates of all tested 
conditions (Figure 7A, right panel). The observed increase in cell-surface expression 
of TRPV5 by TK could be due to either an enhanced trafficking from the Golgi 
apparatus to the cell surface or a reduction in channel retrieval from the plasma 
membrane. The kinetics of cell-surface retrieval was measured in HEK293 cells using 
cell-surface biotinylation. After a 1 hour TK treatment, the retrieval of TRPV5 channel 
from the plasma membrane was decreased by 71, 46, and 17 % (p<0.05, n=3 blots) at 
the time points of 1, 3 and 6 hours, respectively (Figure 7B). TRPV5 expression in cell 
lysates was identical in all tested conditions (Figure 7C). These results suggested that 
TK increases cell-surface expression of TRPV5 by delaying channel retrieval from the 
plasma membrane. 
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Figure 7. TK affects the 
plasma membrane 
expression of TRPV5. (B, C) 
TK treated or non-treated 
TRPV5-transfected cells were 
subjected to biotinylation. Cells 
were immediately homogenized 
(time point 0), or further 
cultured for 1, 3, 6, 12 hours. 
Subsequently, the cells were 
lysed, following 
immunoprecipitation with 
neutravidin-agarose beads and 
TRPV5 expression of plasma 
membrane (B) and total lysates 
(C) was visualized by 
immunoblot analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
TRPV5 PKC mutants S299A and S654A are insensitive to TK treatment 
The effect of TK on the TRPV5 PKC mutants S299A and S654A was investigated in 
HEK293 cells by biotinylation analysis. TRPV5 wild-type (WT), S299A and S654A 
transfected cells were incubated with or without 100 nM TK for 1 hour and then the 
kinetics of cell-surface retrieval was measured in HEK293 cells using cell-surface 
biotinylation. Without TK treatment (Figure 8A), the plasma membrane expression of 
TRPV5 WT, S299A and S654A was decreased at the similar extent at the time points 
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of 1, 3, 6 and 12 hours. Interestingly, with TK treatment (Figure 8B), the retrieval of 
TRPV5 WT channel from the plasma membrane was decreased, but retrieval of 
S299A and S654A was not altered. TRPV5 WT, S299A and S654A expression in cell 
lysates was identical in all tested conditions (data not shown). These results indicated 
that the TK effect of delaying channel retrieval from the plasma membrane was 
abolished in TRPV5 PKC mutants S299A and S654A. 
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Figure 8. TK does not affect the plasma membrane expression of TRPV5 PKC mutants S299A 
and S654A. TRPV5 wild-type (WT), S299A and S654A-transfected HEK293 cells were treated for 1 
hour without (A) or with (B) 100 nM TK, and subjected to cell-surface biotinylation. Subsequently, 
cells were immediately homogenized (time point 0), or further cultured for 1, 3, 6, 12 hours. Then, 
the cells were lysed, following immunoprecipitation with neutravidin-agarose beads and TRPV5 
expression of plasma membrane was visualized by immunoblot analysis. The expression of TRPV5 
in the cell lysates was similar in the various conditions (data not shown). 
 
 
 
 
 
 
Discussion 
 
The present study showed that extracellular TK stimulates TRPV5-mediated Ca2+ 
reabsorption by activating the B2R and subsequently the DAG/PKC pathway resulting 
in accumulation of TRPV5 channels at the cell surface. This conclusion is based on 
the following experimental observations: (i) Urinary Ca2+ excretion in mice is inversely 
related to the expression of TK; (ii) TK stimulates Ca2+ reabsorption in primary cultures 
of renal CNT/CCD cells, which can be blocked by the B2R antagonist JE049; (iii) the 
stimulatory effect of TK is mediated by the PLC/DAG/PKC-pathway and requires the 
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two conserved PKC sites S299 and S654 in TRPV5; (iv) TK enhances Ca2+ transport 
by increasing TRPV5 abundance at the plasma membrane.  
 
TK stimulated TRPV5-mediated Ca2+ transport via the B2R receptor. The physiological 
relevance of this latter finding is substantiated by the co-localization of B2R with TK 
[15] and TRPV5 [2] in DCT and CNT. B2R belongs to the seven-transmembrane 
domain G protein-coupled receptor superfamily [16] and signals via Gq protein with 
consequent activation of PLC. PLC catalyzes the hydrolysis of phosphatidylinositol-
4,5-biphosphate (PIP2) in inositol trisphosphate (IP3) and DAG [17]. Commonly, IP3 
releases Ca2+ from the endoplasmic reticulum stores, while DAG activates PKC [17]. 
Certainly, our results show that TRPV5 activation requires PIP2 breakdown following 
B2R stimulation and relies on DAG as a down-stream effector. Subsequently, DAG 
increases TRPV5 activity via PKC phosphorylation of the channel since potential PKC 
phosphorylation deficient mutants of TRPV5 at positions S299 and S654 lack the TK 
effect. This is the first study demonstrating that TRPV5 is activated through its PKC 
phosphorylation sites. Among the six predicted phosphorylation sites in the TRPV5 
sequence, two serines, S299 and S654 are critical for TRPV5 activation by TK. 
Importantly, TRPV5 closest homologue, TRPV6, did not respond to TK (data not 
shown). Since the second serine (S654) is not conserved in TRPV6, both serines are 
apparently critical for stimulation of TRPV5 by TK. In addition, pre-incubation with PMA 
for 24 hours down-regulates α, β, and ε isoforms of PKC, but not PKC [18]. This latter 
PKC isoform is presumably involved in TK increase of TRPV5 currents since the 
stimulatory effect of PKC was similar in PMA-pretreated and control cells. Interestingly, 
stimulation of active Ca2+ transport in primary cultures of renal CNT/CCD also involves 
PMA-insensitive PKC isotypes [19] among which the isotype PKC can be activated by 
B2R [20]. However, B2R knockout mice (B2R-/-) mice showed no change in urine Ca2+ 
excretion [3], in contrast with TK-/- mice, suggesting that compensation mechanisms 
could mask the TK effect on the Ca2+ balance in these knockout mice. For instance, it 
has been shown that in these knockout mice a compensatory induction of the B1 
receptor occurs that could theoretically be a new target for TK (Duka et al., 2001). 
Alternatively, TK exerts its in vivo effect via a mechanism independent of the B2R.  
 
Previous studies showed that TRP channels can be activated by different signaling 
molecules of the PLC pathway. For example, the three canonical TRP members 
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TRPC3, 6 and 7 are characterized by their sensitivity to DAG [21]. Alternatively, the 
vanilloid and melastatine members of TRP family, TRPV1 [22], TRPV5 [23], TRPM4 
[24], TRPM5 [25], TRPM7 [26] and TRPM8 [27] can be directly regulated by PIP2. 
Thus, in vivo TRPV5 activation by PIP2 [23] or DAG/PKC could adjust TRPV5 activity 
in response to physiological fluctuations. In addition, Ca2+ entering the cell through 
TRPV5 could prevent the electrostatic interaction between the negatively charged PIP2 
and the channel by screening the negative charge on the lipid head group, as 
proposed for Mg2+ and TRPM7 [28].  
 
Stimulation of Ca2+ transport through TRPV5 upon TK action could be the result of an 
increase in either open probability of the channel or in expression of TRPV5 at the 
plasma membrane. Surface biotinylation analysis showed that TK increases the 
amount of TRPV5 channels at the plasma membrane. Thus, PKC activation of TRPV5 
following the TK application would regulate the balance between constitutive 
exocytosis and endocytosis in favor of the former leading to the accumulation of 
TRPV5 at the cell surface. Similarly, the epidermal growth factor (EGF) prevents the 
internalization of plasma membrane TRPC3 [29]. The role of the cytoskeleton in this 
translocation process is presently unknown. It is possible that PKC-dependent 
phosphorylation of TRPV5 leads to activation of motor proteins that transport the 
channels towards the plasma membrane. This process could involve the FKBP52 
protein, characterized previously as a TRPV5 regulatory protein [30], since FKBP52 is 
known to interact with the motor protein dynein [31, 32]. Interestingly, TRPM7 
associates to the actomyosin cytoskeleton upon BK stimulation regulating cell 
adhesion [33]. Remarkably, the protein synaptotagmin has been proposed to regulate 
the exocytosis of TRPC5 [34]. However, the cytoskeletal elements and the motor 
proteins participating in the incorporation of TRPV5 at the plasma membrane remain to 
be identified. Furthermore, accumulation of channels at the cell surface can also occur 
by increased incorporation into the plasma membrane. Indeed, PKC potentiation of 
TRPV1 promotes the recruitment of a channel vesicular pool to the cell surface [35]. 
This exocytosis process of TRPV1 is dependent on the soluble N-ethylmaleimide-
sensitive-factor attachment proteins receptor (SNARE) [35], known to act as 
membrane recognition molecules and acceptors for vesicle trafficking, docking and 
fusion [36]. It would be interesting to investigate the role of similar scaffold proteins in 
the assembly of TRPV5 and PKC upon TK treatment, considering that such signaling 
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pathways are currently indicated to function in spatially distinct microdomains [37]. For 
instance, the A-kinase-anchoring protein, AKAP, has been described to coordinate the 
subcellular localization of second messenger-regulated enzymes, such as PKC in 
order to modulate the activity of K+ channel, KCNQ/M, upon agonist stimulation via Gq-
coupled pathway [38]. 
 
The aforementioned data is in support of plasma membrane recycling of TRPV5 
protein as mechanism of channel regulation. A tight control of TRPV5 activity is of 
primordial importance for body Ca2+ homeostasis, since TRPV5 constitutes the fine-
tuned Ca2+ entry step in active Ca2+ reabsorption [1]. Besides the hormonal regulation 
of TRPV5, accessory proteins play a role in modulating channel trafficking and activity 
[9, 39]. Together with a recent report on the β-glucuronidase klotho [12], our study 
introduces a new mechanism of TRPV5 regulation which is based on extracellular 
enzymatic activation. TK and klotho co-localize with TRPV5 in the distal part of the 
nephron where they activate the channel from the luminal side. A comparable 
enzymatic regulation is described for the epithelial Na+ channel, ENaC, present in CNT, 
by the channel activating proteases, CAP-1, CAP-2 and CAP-3 [40]. Unlike the 
protease CAP and the β-glucuronidase klotho, TK stimulates TRPV5 indirectly via 
activation of the B2R that then induces a redistribution of TRPV5 channels towards the 
plasma membrane. On the contrary, CAPs which are membrane-bound serine 
proteases, act directly on the channel gating by enhancing the open probability of 
ENaC [41] to stimulate epithelial Na+ absorption. Likewise, klotho directly activates 
TRPV5 by enzymatic modification of the N-glycan to stabilize TRPV5 channels at the 
plasma membrane [12].  
 
Interestingly, we showed that an increase in Na+ supply induced a Ca2+ wasting in WT 
mice. It is well know that a high Na+ diet increases the plasma volume that triggers the 
renin-angiotensin-aldosterone system (Nijenhuis et al., 2005). These hormones will 
reduce the reabsorption of Na+ and consequently Ca2+ in the proximal tubules as a 
negative feedback response. Ultimately, this will increase the urinary excretion of Ca2+. 
However, the anticipated calciuria was not observed in TK-/- mice, possibly these mice 
can not further increase their urinary Ca2+ excretion. In addition, the rates of urinary 
Ca2+ excretion in WT and TK-/- mice were similar on a high Na+ diet, whereas they 
markedly differed on a normal Na+ diet. This strongly supports the fact that TK 
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participates in the renal response to a high Na+ diet and to the attendant decrease in 
urinary Ca2+ reabsorption. 
 
 
 
 
 
Figure 9. Schematic diagram of TK stimulatory effect on TRPV5. TK activates the B2R and 
subsequently PLC, leading to the hydrolysis of PIP2 in IP3 and DAG. DAG induces subsequently the 
phosphorylation of TRPV5 through PKC-dependent mechanism with consequent stabilization of 
TRPV5 channel at the plasma membrane. The increased number of channels at the plasma 
membrane is the result of delayed channel retrieval ensuing enhanced Ca2+ transport through 
TRPV5. 
Here, we demonstrated that TK displays autocrine or paracrine stimulation of active 
Ca2+ reabsorption in a dose-dependent manner. As shown in the mice models, 
reduction in TK expression increases urinary Ca2+ excretion due to impaired tubular 
Ca2+ reabsorption.  Conversely, genetic ablation of TRPV5 doubled the renal 
expression of TK possibly due to counterbalance the significant Ca2+ wasting observed 
in the TRPV5-/- mice by maximally stimulating the process of Ca2+ reabsorption. Indeed, 
an increase in dietary Ca2+ intake as an alternative manoeuvre to offset the renal Ca2+ 
loss in TRPV5-/- mice prevented the compensatory increase in TK expression. These 
results underline the role of TK during Ca2+ restriction. It is, therefore, interesting to 
study the Ca2+ excretion in humans with a genetically reduced TK activity. In this 
respect, a loss-of-function polymorphism of the TK gene in which the active-site 
arginine at position 53 is changed into a histidine (R53H), reduces by 50-60% TK 
activity is interesting [42]. Partial genetic deficiency in TK activity of the R53H subjects 
is associated with a form of arterial dysfunction [43]. TK is well known as a vasodilator 
factor of renal cortical blood vessels through BK production, while abnormalities of TK 
levels has long been documented in the pathogenesis of hypertension [44]. It is 
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therefore tempting to speculate that TK stimulation of TRPV5-mediated Ca2+ 
reabsorption plays a role in TK hypotensive action, since urinary Ca2+ leak has been 
correlated with higher baseline systolic and diastolic blood pressures [45].  
 
In conclusion, our data demonstrated that TK reduces urinary Ca2+ excretion by an 
autocrine and paracrine stimulation of TRPV5-mediated Ca2+ reabsorption explaining 
the hypercalciuria in TK-/- mice. Figure 9 illustrates the molecular pathway linking TK to 
stimulation of TRPV5, as elucidated in the present study. TK activates the B2R and 
through the PLC derived-messenger DAG initiates the phosphorylation of the TRPV5 
PKC sites S299 and S654. Subsequently, Ca2+ influx through TRPV5 is enhanced by 
the accumulation and stabilization of the channel at the plasma membrane. Thus, TK-
directed translocation of TRPV5 channels constitutes a mechanism by which renal 
cells can fine-tune the Ca2+ reabsorption. 
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Happiness, I have discovered, is nearly always a rebound from hard work. 
(David Grayson) 
我发现，辛勤工作的报酬几乎总是幸福。(格雷森.D.) 
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Abstract 
Transient Receptor Potential Vanilloid 5 (TRPV5) constitutes the gatekeeper of 
transepithelial Ca2+ reabsorption and plays, therefore, an essential role in the 
maintenance of the Ca2+ balance. TRPV5 is complex glycosylated containing a N-linked 
glycan located at the asparagine residue N358. Here, we report that TRPV5 channel 
activity is stimulated by the glycosidases: sialidase that hydrolyzes sialic acid residues 
and peptide N-glycosidase F (endoF) that removes the entire N-glycan. These two 
glycosidases activate TRPV5 by enhancing channel expression at the plasma 
membrane via hydrolysis of the TRPV5 extracellular N-glycan, similar to the recently 
reported glycosidases β-glucuronidase and klotho. In contrast, β-glucosidase, β-
galactosidase and endoglycosidase H (endoH) did not exhibit this stimulatory effect on 
TRPV5 activity. Furthermore, cell-surface biotinylation was employed to determine the 
channel turnover at the plasma membrane. It showed that β-glucuronidase delays 
TRPV5 retrieval at the cell surface. Finally, we demonstrated that the TRPV5 
glycosylation-deficient mutant TRPV5-N358Q has a reduced retrieval rate at the plasma 
membrane compared to the wild-type channel. These data suggest that N-glycosylation 
plays a crucial role in TRPV5 retrieval and glycosidase-mediated channel activation. 
 
Introduction 
Ca2+ is an essential ion in all organisms, where it plays a pivotal role in processes 
ranging from formation and maintenance of the skeleton to temporal and spatial 
regulation of neuronal function. The Ca2+ balance is tightly controlled by the concerted 
action of three organ systems - the gastrointestinal tract, bone and kidney. A major 
breakthrough in the mechanism by which Ca2+ ions enter the absorptive epithelia was 
the identification of two epithelial Ca2+ channels TRPV5 and TRPV6 that are the most 
Ca2+-selective channels within the Transient Receptor Potential (TRP) superfamily [1, 2]. 
TRPV5 is essential for renal Ca2+ handling, whereas TRPV6 is postulated to mediate 
intestinal Ca2+ absorption. 
 
In the process of identifying regulatory proteins of TRPV5 and TRPV6 by 
oligonucleotide-based microarray chip analysis, we previously discovered klotho as a 
significantly down-regulated gene in kidneys of the mice lacking TRPV5 (TRPV5-/- mice ) 
[3]. Klotho, which is a type I membrane glycoprotein of 130 kD, exhibits a considerable 
homology to β-glucosidase enzymes of bacteria, plants and eukaryotes [4]. Klotho gene 
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ablation results in a syndrome resembling human aging, including short life span, bone 
aberrations, infertility, skin atrophy and hypercalcemia together with increased vitamin D 
serum levels [4]. In contrast, klotho extends the life span when overexpressed in mice [5], 
by regulating the insulin / insulin-like growth factor 1 (IGF1) signaling pathway. To date, 
the elucidation of the physiological functions of klotho is developing rapidly. Previous 
studies indicated that klotho may function as ligand, co-receptor, and enzyme, and in 
addition the protein is secreted in serum, cerebrospinal fluid and urine [3, 6]. Klotho has 
been implicated in the maintenance of the Ca2+ and phosphate balance [7]. 
 
The molecular action of klotho in maintaining the Ca2+ balance was observed in a recent 
study showing that klotho enhances TRPV5 activity [3]. We demonstrated by 
immunohistochemistry on kidney sections a co-localization of klotho with TRPV5 in the 
renal distal convoluted (DCT) and connecting tubules (CNT) [3]. Functional analysis 
using human embryonic kidney (HEK293) cells showed that TRPV5 activity is 
significantly enhanced by extracellularly secreted klotho, which can be mimicked by β-
glucuronidase. Intriguingly, the stimulatory effect of klotho or β-glucuronidase on TRPV5 
was abolished in HEK293 cells expressing the TRPV5 glycosylation-deficient mutant 
TRPV5-N358Q, indicating that N-glycosylation plays a crucial role in the TRPV5 
activation. N-glycosylation of proteins is highly conserved from yeast to human and has 
a significant effect on modulating protein structure and localization to facilitate 
appropriate folding and trafficking of membrane proteins [8]. To date, considerable 
studies have demonstrated that prevention of N-glycosylation negatively influences 
trafficking and activity of many transporters or channels [9-13]. It has been thoroughly 
studied that gating, cell-surface trafficking and pH sensitivity of the voltage gated K+ (Kv) 
channels are regulated by N-glycosylation [14-16]. Furthermore, within the TRP 
superfamily, N-glycosylation influences also TRPV1 and TRPV4 channels [17, 18]. 
These data point to a potential function of N-glycosylation influencing trafficking, gating 
and activity across diverse members of membrane proteins. 
 
However, up to date, the exact role of N-glycosylation in the klotho-mediated TRPV5 
regulation is elusive. Based on a previous study, we hypothesized that other 
glycosidases may mimic the stimulatory effect of klotho. Therefore, the current study 
aims to investigate the molecular mechanism underlying the klotho-mediated TRPV5 
activation as well as the specificity of this effect. To this end, we investigated the effect of 
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diverse members of the glycosidase superfamily, to which β-glucuronidase and klotho 
belong, namely β-glucosidase, β-galactosidase, sialidase, endoglycosidase H (endoH), 
and peptide N-glycosidase F (endoF). These glycosidases hydrolyze various sugar 
residues including glucuronic acid, glucoses, galactoses, sialic acid, high mannoses and 
the entire N-glycan. New enzymes in the glycosidase family that activate TRPV5 activity 
have been discovered using 45Ca2+ uptake analysis in HEK293 cells expressing the 
channel. Subsequently, the molecular mechanism through which klotho stimulates 
TRPV5 was delineated by cell-surface biotinylation experiments that address channel 
turnover at the plasma membrane.  
 
Material and methods 
 
DNA constructs 
pCINeo/IRES-GFP-TRPV5, pCINeo/IRES-GFP-HA-TRPV5 [19], and pCINeo/IRES-
GFP-HA-klotho [3] constructs were generated as described previously. The TRPV5 
mutant (TRPV5-N358Q) was obtained by in vitro mutagenesis in pCINeo/IRES-GFP-
TRPV5 cDNA. All constructs were verified by DNA sequence analysis. 
 
Collection and concentration of conditioned culture media 
HEK293 cells were transfected with 15 μg pCINeo/IRES-GFP-HA-klotho or 
pCINeo/IRES-GFP empty-vector cDNA in a 85 mm petri-dish. After 3 days of 
transfection, the conditioned culture media was collected and concentrated 10 times 
using the centriprep columns ultracel YM-30 (Millipore corporation, Bedford, MA, U.S.A.).  
 
Transfection of HEK293 cells and preparation of total cell membrane 
HEK293 cells were transfected with 2 μg pCINeo/IRES-GFP-HA-TRPV5 or 
pCINeo/IRES-GFP empty-vector cDNA in a 6-well plate. Two days after transfection, the 
cells were homogenized in HBA buffer [20 mM Tris (pH 7.4 / HCl), 5 mM MgCl2, 5 mM 
NaH2PO4, 1 mM EDTA (pH 8.0 / NaOH), 80 mM sucrose, 1 mM phenyl-methylsulfonyl 
fluoride (PMSF), 10 μg/ml leupeptin and 10 μg/ml pepstatin], and then centrifuged for 15 
min at 4,000 g at 4°C, followed by 30 min spin down at 16,000 g at 4°C. The pellet was 
dissolved in 30 μl of laemmli buffer and incubated at 37°C for 30 min. The proteins were 
detected by SDS-PAGE gel electrophoresis followed by autoradiography. 
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Enzymatic treatment of HEK293 cells 
HEK293 cells were transfected with 2 μg pCINeo/IRES-GFP-TRPV5-N358Q or 
pCINeo/IRES-GFP-HA-TRPV5 or pCINeo/IRES-GFP empty-vector cDNA in a 6-well 
plate. Two days after transfection, cells were homogenized for total membrane isolation 
as described above. Subsequently, the total membrane fraction was dissolved in DMEM 
medium (Cambrex Bio Science, Verviers, Belgium). Culture media collected from klotho-
expressing HEK293 cells (klotho-containing supernatant), β-glucuronidase from bovine 
liver (Sigma, St. Louis, MO, U.S.A.), β-glucosidase (Sigma), β-galactosidase (Promega, 
Madison, WI, U.S.A.), endoH, endoF (New England Biolabs, Ipswich, MA, U.S.A), or 
sialidase (Calbiochem, San Diego, CA, U.S.A.) was added to the medium at 37oC for 1 
hour. The final concentration of β-glucuronidase is 310 U/ml, β-glucosidase or β-
galactosidase is 27 U/ml, endoH or endoF is 10,000 U/ml, and sialidase is 27 mU/ml, 
respectively. In addition, laemmli buffer was added to the medium after glycosidase 
treatment, and incubated for 30 min at 37oC. The protein was detected by SDS-PAGE.  
 
45Ca2+ uptake assay 
HEK293 cells were transfected with 2 μg pCINeo/IRES-GFP-TRPV5-N358Q, 
pCINeo/IRES-GFP-HA-TRPV5 or pCINeo/IRES-GFP empty-vector cDNA in a 6-well 
plate. One day after transfection, HEK293 cells expressing HA-TRPV5 or TRPV5-N358Q 
were incubated for 16 hours with klotho-containing supernatant, β-glucuronidase, β-
glucosidase, β-galactosidase, endoH, endoF or sialidase in 300 μl DMEM medium at 
37°C with 5% (v/v) CO2. The final concentration of β-glucuronidase is 310 U/ml, β-
glucosidase or β-galactosidase is 27 U/ml, endoH or endoF is 10,000 U/ml, and sialidase 
is 27 mU/ml, respectively. Subsequently, 45Ca2+ uptake was determined as described 
previously [3, 19]. 
 
Biotinylation 
HEK293 cells were transfected with 15 μg pCINeo/IRES-GFP-TRPV5-N358Q, 
pCINeo/IRES-GFP-HA-TRPV5 or pCINeo/IRES-GFP empty-vector cDNA in a 85 mm 
petri-dish, which were coated with 0.1% (v/v) poly-L-lysine. One day after transfection, 
cells were incubated with klotho-containing supernatant or the investigated glycosidases 
at 37°C with 5% (v/v) CO2 for 16 hours. Dishes with transfected confluent HEK293 cells 
were subsequently processed for the biotinylation assays as described previously [3].  
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Biotinylation assay to determine TRPV5 cell-surface turnover 
HEK293 cells were transfected with 15 μg pCINeo/IRES-GFP-HA-TRPV5 or 
pCINeo/IRES-GFP-TRPV5-N358Q in a 85 mm petri-dish, which were coated with poly-L-
lysine (0.1% v/v). One day after transfection, cells were incubated with 310 U/ml β-
glucuronidase for 16 hours at 37°C with 5% (v/v) CO2. The day after incubation, the 
biotinylation assay was pursued as described previously [3]. For time point 0 hour, cells 
were collected from plates and lysed with 1 ml lysis buffer immediately after biotinylation. 
The cells were further cultured in DMEM medium for 1, 3, 6 and 12 hours at 37°C with 
5% (v/v) CO2, subsequently washed with ice-cold PBS, and homogenized in 1 ml lysis 
buffer, followed by immunoprecipitation using neutravidin beads.  
 
Immunoblot analysis 
Total membrane isolation or biotinylation assay was performed in HEK293 cells as 
described above. The samples were subjected to SDS-PAGE electrophoresis (8% w/v). 
Immunoblots were incubated overnight at 4°C with guinea pig anti-TRPV5 (1:4,000) in 
1% (w/v) non-fat dried milk (NFDM) in TBS-T [Tris-buffered saline (TBS) buffer (150 mM 
NaCl, 10 mM Tris pH 7.4 / HCl) containing 0.2% (v/v) Tween-20]. After washing, 
immunoblots were incubated at room temperature with goat anti-guinea pig IgG 
peroxidase (1:10,000) (Sigma, St. Louis, MO, U.S.A.) in TBS-T. 
 
Statistical analysis 
In all experiments, the data are expressed as mean ± SEM. Overall statistical 
significance was determined by analysis of variance (ANOVA). P values below 0.05 
were considered significant. 
 
Results 
 
EndoF and sialidase stimulate TRPV5 activity 
The effect of different glycosidases on TRPV5 activity was determined in HEK293 cells 
expressing TRPV5 using a 45Ca2+ uptake assay. These cells were incubated for 16 hours 
with various members of the glycosidase superfamily, including β-glucosidase, β-
galactosidase, sialidase, endoH and endoF. Klotho-containing supernatant and β-
glucuronidase were used as positive controls. HEK293 cells expressing TRPV5 showed 
an increase in Ca2+ influx (~2 fold) compared to empty-vector (mock)-transfected HEK 
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cells (Figure 1A). Remarkably, incubation with sialidase or endoF significantly enhanced 
the TRPV5-mediated Ca2+ influx, same as the klotho-containing supernatant or β-
glucuronidase incubation. However, cells incubated with β-glucosidase, β-galactosidase 
or endoH showed a Ca2+ influx indistinguishable from vehicle treated TRPV5-expressing 
cells. Importantly, sialidase and endoF did not stimulate Ca2+ influx in mock-transfected 
HEK293 cells (Figure 1A).  
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Figure 1. Stimulation of TRPV5 activity by endoF and sialidase. (A) 45Ca2+ uptake was measured in 
HEK293 cells transfected with cDNA of TRPV5 or mock. Subsequently, the cells were exposed for 16 
hours to different members of the glycosidase superfamily including β-glucuronidase, klotho-containing 
supernatant, sialidase, endoF, endoH, β-glucosidase and β-galactosidase. After 16 hours of incubation, 
the cells were analyzed for 45Ca2+ influx analysis. Sialidase and endoF incubated mock-transfected 
HEK293 cells were used as control. Asterisk indicates significant difference from HEK293-TRPV5 cells. 
#, indicates significant difference from mock-transfected HEK293 cells (p<0.05, n=6). (B) HEK293-
TRPV5 cells were treated with different glycosidases as described above and analyzed by 
immunobloting analysis. 
Effect of glycosidases on TRPV5 N-glycosylation 
Heterologous expression of TRPV5 in HEK293 cells and subsequent immunoblot 
analysis of total cell membrane isolation revealed two specific bands of TRPV5 with 
molecular sizes of 70-75 and 85-100 kDa. The band of 70-75 kD reflected the core 
TRPV5 protein, whereas the band of 85-100 kD represented the complex glycosylated 
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form (Figure 1B). The complex-glycosylated TRPV5 band disappeared after endoF 
treatment, but was not altered by the other investigated glycosidases (Figure 1B). 
Importantly, total expression of TRPV5 was identical in all conditions.  
 
75
100
50
75
100
50
M
oc
k
TR
PV
5
kDa kDa
BA
no
 b
io
tin
β-g
lu
cu
ro
ni
da
se
TR
PV
5
kl
o-
su
pe
r
TR
PV
5
si
al
id
as
e
TR
PV
5
en
do
F
TR
PV
5
TR
PV
5
M
oc
k
TR
PV
5
no
 b
io
tin
β-g
lu
cu
ro
ni
da
se
TR
PV
5
kl
o-
su
pe
r
TR
PV
5
si
al
id
as
e
TR
PV
5
en
do
F
TR
PV
5
TR
PV
5
M
oc
k
TR
PV
5
no
 b
io
tin
β-g
lu
cu
ro
ni
da
se
TR
PV
5
kl
o-
su
pe
r
TR
PV
5
si
al
id
as
e
TR
PV
5
en
do
F
TR
PV
5
TR
PV
5
M
oc
k
TR
PV
5
no
 b
io
tin
β-g
lu
cu
ro
ni
da
se
TR
PV
5
kl
o-
su
pe
r
TR
PV
5
si
al
id
as
e
TR
PV
5
en
do
F
TR
PV
5
TR
PV
5
 
 
 
 
 
 
 
 
 
Figure 2. Enhancement of TRPV5 expression at the cell surface by klotho, β-glucuronidase, 
sialidase and endoF. HEK293 cells were transfected with TRPV5 and incubated for 16 hours with β-
glucuronidase, klotho-containing supernatant, sialidase and endoF. (A) Cell-surface proteins were 
biotinylated, precipitated with neutrovidin-agarose beads and immunoblotted for TRPV5. (B) TRPV5 
expression was determined by immunoblotting in total cell lysates to demonstrate equal expression. As a 
negative control biotin was omitted in the procedure.
Klotho, β-glucuronidase, sialidase and endoF enhance TRPV5 expression at the 
plasma membrane 
To address the molecular mechanism of glycosidase-mediated TRPV5 activation, cell-
surface protein biotinylation assays were performed with TRPV5-expressing HEK293 
cells treated with the various glycosidases. Cell-surface protein labeling indicated that 
channel expression at the plasma membrane is significantly increased by enzymatic 
treatment with endoF, sialidase, klotho or β-glucuronidase (Figure 2A). Importantly, 
immunoblot analysis showed that the total membrane expression of TRPV5 was equal in 
all conditions (Figure 2B). The intensity of complex-glycosylated band of TRPV5 
reduced upon the endoF treatment in both plasma membrane and total membrane 
fractions.  
 
β-glucuronidase increases channel activity by delaying TRPV5 retrieval at the 
plasma membrane 
The retrieval of TRPV5 from the plasma membrane to the cytosol was measured using 
metabolic labeling in combination with cell-surface biotinylation. Channel abundance of 
wild-type TRPV5 at the plasma membrane decreased by 41% (p<0.05, n=3) within 1 
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hour due to protein retrieval (Figure 3A). However, this apparent retrieval process was 
delayed by 98%, 85% and 77% (p<0.05, n=3) after the exposure to β-glucuronidase at 1, 
3 and 6 hours, respectively (Figure 3B). Importantly, total expression of TRPV5 was not 
altered by β-glucuronidase treatment (data not shown). Semi-quantification of the 
immunoblot demonstrated significantly delayed retrieval kinetics of TRPV5 in HEK293 
cells treated with β-glucuronidase, compared to non-treated cells (Figure 3C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retrieval of the TRPV5 glycosylation-deficient mutant is delayed at the plasma 
membrane 
To elucidate the molecular mechanism responsible for the delay in klotho-mediated 
TRPV5 retrieval, we studied the role of N-glycosylation in this process. Sequence 
analysis predicted a conserved N-glycosylation site (N358) positioned between TM 
segment 1 and 2 of TRPV5. The functional role of N-glycosylation in klotho-mediated 
TRPV5 stimulation was investigated by mutating the asparagine residue in this putative 
Figure 3. TRPV5 retrieval at the plasma membrane is delayed by β-glucuronidase. HEK293 cells 
were transfected with TRPV5 and incubated for 16 hours with β-glucuronidase. TRPV5 cell-surface 
expression was determined by biotinylation for 30 min, and the amount of TRPV5 channels at the 
plasma membrane with (B) or without (A) β-glucuronidase treatment was analyzed by immunoblotting 
analysis at the different time points as depicted. (C) Semi-quantification of the immunoblot indicated the 
significantly different retrieval process with or without β-glucuronidase treatment. 
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glycosylation site into a glutamine (TRPV5-N358Q) [3]. Immunoblot analysis showed that 
N-glycosylation is impaired in TRPV5-N358Q, since the upper complex-glycosylated 
TRPV5 band of this mutant was not detectable (Figure 4C) [3]. HEK293 cells expressing 
TRPV5-N358Q exhibited wild-type TRPV5 Ca2+ influx (Figure 4A) [3]. The apparent 
retrieval process of TRPV5 was decreased in the TRPV5-N358Q mutant by 100%, 60%, 
53% and 45% (n=3) at 1, 3, 6 and 12 hours, respectively (Figure 4B). Total expression 
of TRPV5 and TRPV5-N358Q was similar in all conditions (Figure 4C).  
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Figure 4. Molecular mechanism of klotho-mediated TRPV5 activation and retrieval kinetics of 
TRPV5-N358Q. (A) HEK293 cells expressing TRPV5 or TRPV5-N358Q were exposed to β-
glucuronidase for 16 hours and subsequently assayed for 45Ca2+ uptake. Asterisks indicate significant 
difference from HEK293-TRPV5 cells. #, indicates significant difference from mock-transfected HEK293 
cells (p<0.05, n=4). (B) HEK293 cells were transfected with TRPV5 or TRPV5-N358Q. TRPV5 cell-
surface expression was determined by biotinylation for 30 min, and the amount of TRPV5 channels at 
the plasma membrane was analyzed by immunoblotting analysis at the different time points as depicted. 
(C) Total TRPV5 expression was determined by immunoblotting in cell lysates to demonstrate equal 
expression. Immunoblot analysis indicated that N-glycosylation was impaired in the TRPV5-N358Q 
mutant.   
 
β-glucuronidase does not change the retrieval kinetics of TRPV5-N358Q  
To address the functional consequences of β-glucuronidase action on TRPV5-N358Q, 
HEK293 cells expressing TRPV5 or TRPV5-N358Q were treated for 16 hours with β-
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glucuronidase. 45Ca2+ uptake and cell-surface biotinylation assays were subsequently 
performed. 45Ca2+ uptake analysis demonstrated that TRPV5-N358Q expressed a 
comparable Ca2+ influx to wild-type TRPV5, which was not enhanced by β-glucuronidase 
treatment (Figure 4A). Furthermore, cell-surface biotinylation showed that β-
glucuronidase is not able to change the retrieval kinetics of TRPV5-N358Q at the plasma 
membrane (Figure 5B), whereas wild-type TRPV5 retrieval was significantly delayed by 
this enzyme (Figure 5A). Importantly, total expression of TRPV5 and TRPV5-N358Q 
was equal in all conditions (Figure 5C, D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
 
Here we identified, in addition to klotho and β-glucuronidase, sialidase and endoF as 
novel glycosidases stimulating TRPV5 activity by hydrolyzing the N-oligosaccharides of 
the channel, resulting in stabilization of TRPV5 at the plasma membrane. This 
conclusion is based on the following experimental observations: (i) sialidase, endoF, 
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Figure 5. Retrieval kinetics of TRPV5-N358Q are not affected by β-glucuronidase. HEK293 cells 
were transfected with TRPV5 or TRPV5-N358Q, and subsequently exposed to β-glucuronidase for 16 
hours. TRPV5 cell-surface expression was determined by biotinylation for 30 min, and the amount of 
TRPV5 channels at the plasma membrane with or without β-glucuronidase treatment was analyzed by 
immunoblotting analysis at the different time points as depicted (A, B). Total TRPV5 expression was 
determined by immunoblotting to demonstrate equal expression (C, D). 
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klotho and β-glucuronidase enhanced TRPV5 channel abundance at the plasma 
membrane, resulting in increased TRPV5-mediated Ca2+ influx. In contrast, β-
glucosidase, β-galactosidase and endoH did not exhibit this stimulatory effect on TRPV5 
activity. (ii) β-glucuronidase stabilized TRPV5 at the cell surface by delaying channel 
protein retrieval. (iii) the glycosylation-deficient mutant TRPV5-N358Q showed delayed 
retrieval kinetics compared to the wild-type channel. (iv) β-glucuronidase did not affect 
TRPV5-N358Q retrieval due to absence of the entire N-glycan.  
 
In general glycosidases participate in essential steps of synthesis and degradation of 
polysaccharides, which are involved in processes such as pathogen defense [21], 
control of signal transduction [22] and modification of hormones [23]. At present, the 
biological function of glycosidases remains scarce. So far, some studies suggested that 
sialidase and endoF can regulate ion channel activity [24]. In support of the previous 
findings, our data show that sialidase and endoF activate TRPV5, substantially 
extending the members of glycosidases extracellularly modulating TRPV5 activity 
besides klotho and β-glucuronidase [3]. Sialidase is known to hydrolyze sialic acid 
residues from glycosylated proteins [25]. A novel mechanism has been described 
through which hydrolysis of surface sialic acids by sialidase or removal of the complete 
surface N-glycan of voltage-gated Na+ channel (Nav) can directly modulate channel 
gating, and therefore affect cardiac, skeletal muscle, and neuronal excitability [24]. 
Moreover, it has been described that Kv1.1 channels contain significant amounts of sialic 
acids, which appear to be the negative charges at the channel surface sensitive to Ca2+. 
The data suggested that sialidase treatment modifies Kv1.1 function by influencing the 
channel voltage dependence of activation [26]. EndoF is a well-known glycosidase, 
which removes the entire N-glycan of proteins. Glycans participate in many key 
biological processes including cell adhesion, molecular trafficking, receptor activation, 
signal transduction, and endocytosis [27]. It has been reported that N-glycans could 
serve as a signal for degradation by the SCF(Fbx2) ubiquitin ligase complex [28]. The F-
box protein Fbx2 binds specifically to proteins attached to N-linked high-mannose 
oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated 
proteins. These studies highlight the role of N-glycans in protein degradation besides its 
typical role in protein folding, quality control, sorting, transport and channel activity [29]. 
Interestingly, the complex-glycosylated TRPV5 band of 85-100 kDa disappeared after 
endoF treatment, but was not changed by the other investigated glycosidases. It 
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indicated that klotho and sialidase only hydrolyze specific N-oligosaccharides of TRPV5, 
not detectable as a shift in molecular weight of the channel by SDS-PAGE. However, 
this hydrolysis can already activate TRPV5. In addition, based on the result that β-
glucosidase, β-galactosidase and endoH did not increase TRPV5-mediated Ca2+ influx, 
our data revealed that these specific N-oligosaccharides, responsible for the channel 
activation, are β-glucuronic acid and sialidic acid, hydrolyzed by β-glucuronidase and 
sialidase, respectively. 
 
Stimulation of Ca2+ influx through TRPV5 upon glycosidase treatment could be the result 
of an increase in either open probability of the channel or in expression of TRPV5 at the 
plasma membrane. Cell-surface biotinylation analysis showed that sialidase, endoF, 
klotho and β-glucuronidase increase TRPV5 channel abundance at the plasma 
membrane. Thereby, TRPV5 activation following the glycosidase application might be 
due to either an enhanced trafficking from the Golgi apparatus to the cell surface or a 
reduction in channel retrieval from the plasma membrane. Metabolic labeling in 
combination with cell-surface biotinylation subsequently revealed that the apparent 
retrieval process of TRPV5 is significantly delayed upon exposure to β-glucuronidase, 
indicating that β-glucuronidase increases TRPV5 activity by stabilizing the channel at the 
plasma membrane. Most likely, this also applies to sialidase and endoF-mediated 
increase in TRPV5 activity.  
 
To further clarify the molecular mechanism underlying the N-glycan-mediated TRPV5 
retrieval, we investigated the retrieval kinetics of the TRPV5 glycosylation-deficient 
mutant (TRPV5-N358Q). Our result corroborates the importance of N-glycosylation in 
TRPV5 stability at the cell surface, since TRPV5-N358Q showed a low turnover 
compared to wild-type channels. In addition, β-glucuronidase did not further delay the 
TRPV5-N358Q retrieval due to absence of the entire N-glycan of this mutant, confirming 
that N-glycosylation plays a key role in the retrieval process of TRPV5, and therefore 
glycosidase-mediated channel activation. N-glycosylation of proteins is highly conserved 
from yeast to human and has a significant effect on protein structure and localization to 
facilitate proper folding and trafficking of membrane proteins [8]. To date, considerable 
studies have conclusively demonstrated that prevention of N-glycosylation negatively 
influences gating, cell-surface trafficking and activity of many channels or transporters, 
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for example, the γ-aminobutyric acid (GABA) transporter (GAT1) [9], voltage-gated Ca2+ 
channels (Cav) [10], cyclic nucleotide-gated ion channel (CNG) [11], Na+-K+-2Cl- 
cotransporter (NKCC2) [13], G-protein-activated inwardly rectifying K+ channel (GIRK1), 
renal outer-medullary K+ channel (ROMK1) [12], and the Kv channels [14-16]. In addition, 
the human ether-à-go-go-related gene (HERG) channel without N-glycosylation 
degrades more rapidly than the glycosylated channel, resulting in a reduced cell-surface 
stability [30]. However, in addition to the well-known fact that deglycosylation negatively 
influences protein trafficking, stability and activity, Xu and co-workers showed that 
deglycosylation activates TRPV4 channel [18]. They demonstrated that the TRPV4 
mutant (TRPV4-N651Q) is not glycosylated. HEK293 cells expressing TRPV4-N651Q 
display an enhanced Ca2+ entry resulted from an increased plasma membrane 
abundance of TRPV4-N651Q compared to the wild-type channel. This finding supports 
the present study showing that deglycosylation of TRPV5 increases channel expression 
at the cell surface. Furthermore, our data add a new dimension to the traditional effect of 
N-glycosylation on ion channel trafficking and degradation by showing that 
deglycosylation delays TRPV5 retrieval to increase channel stability. Future studies 
should investigate whether the same mechanism applies to other TRP channels.  
 
Together with a recent report on a serine protease, tissue kallikrein (TK) [31], our study 
introduces a new mechanism through which Ca2+ reabsorption can be stimulated via 
extracellular urinary enzymes. To date, there is only limited information about 
extracellular regulation of ion channels and transporters. It has been  previously 
described that epithelial Na+ channel (ENaC) is extracellularly regulated by the channel 
activating proteases CAP-1, CAP-2 and CAP-3 [32]. CAPs, which are membrane-bound 
serine proteases, act directly on channel gating by enhancing the open probability of 
ENaC to stimulate epithelial Na+ absorption [33]. Unlike CAPs, TK stimulates TRPV5 
indirectly via activation of the bradykinin (BK) 2 receptor (B2R), which then induces a 
redistribution of TRPV5 channels towards the plasma membrane [31]. Sialidase, endoF, 
klotho and β-glucuronidase, directly activate TRPV5 by enzymatic modification of the N-
glycan to stabilize TRPV5 channels at the plasma membrane. Klotho and TK co-localize 
with TRPV5 at the apical membrane of the distal part of the nephron. Of particular 
interest is that these two proteins are secreted into the pro-urine from which they activate 
the TRPV5 channel, and therefore Ca2+ reabsorption. Thus, it would be tempting to 
explore additional urinary proteins extracellularly regulating TRPV5. Urinary secreted 
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glycosidases could be potential candidates crucial in maintaining the Ca2+ balance. 
Unraveling the molecular mechanisms by which extracellular calciotropic factors control 
the activity of TRPV5 is essential in keeping Ca2+ levels within a healthy range.  
 
In conclusion, our data demonstrated that sialidase and endoF together with klotho and 
β-glucuronidase stimulate TRPV5-mediated Ca2+ influx by the hydrolysis of the N-glycan 
of the channel, resulting in an increased channel abundance at the plasma membrane 
by a reduced retrieval rate. 
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Abstract 
The klotho gene encodes a single-pass transmembrane protein and functions as an 
aging-suppressing hormone. It was recently demonstrated that klotho plays a pivotal role 
in the maintenance of Ca2+ homeostasis via regulation of the Transient Receptor 
Potential (TRP) ion channel TRPV5, the gatekeeper of renal active Ca2+ reabsorption. 
Klotho stimulates TRPV5 activity by hydrolysis of N-oligosaccharides, resulting in 
stabilization of the channel at the plasma membrane. To further investigate whether the 
action of klotho can be extended to other renal apically localized channels or 
transporters in distal convoluted tubules (DCT), four different proteins were selected 
including TRPV4, TRPV6, TRPM6 and the thiazide-sensitive Na+-Cl- co-transporter 
(NCC). 45Ca2+ uptake assays in human embryonic kidney (HEK293) cells expressing the 
proteins of interest demonstrated that TRPV6-mediated Ca2+ influx is significantly 
increased by klotho or β-glucuronidase. However, β-glucuronidase did not enhance the 
Ca2+ influx mediated by TRPV4 and TRPM6. In addition, 22Na+ uptake analysis in 
mammalian kidney cortical collecting duct (mpkCCD) cells showed that thiazide-
sensitive Na+ uptake mediated by NCC is not influenced by β-glucuronidase. Thereby, 
our data revealed that the stimulatory effect of klotho is predominantly applicable to the 
epithelial Ca2+ channels TRPV5 and TRPV6, but not to TRPV4, TRPM6 and NCC. 
 
Introduction 
The klotho gene was originally identified as a gene mutated in a mouse strain that 
develops multiple aging-like phenotypes [1]. Mice defective in klotho expression (klotho-/- 
mice) exhibit a syndrome resembling human aging, including short life span, hypoactivity, 
muscle atrophy, skin atrophy, osteopenia, vascular calcification, abnormality in 
phosphate and Ca2+ metabolism [1]. Conversely, overexpression of the klotho gene 
extends the life span in mice, by regulating the insulin / insulin-like growth factor 1 (IGF1) 
signaling pathway [2]. These observations suggest that klotho may function as an aging-
suppressor and be involved in the regulation of aging and age-related diseases. The 
klotho gene encodes a single-pass transmembrane protein. The extracellular region of 
the protein is composed of two domains, each having a homology to β-glucosidase of 
bacteria and plants. In addition, β-glucuronidase activity is detected when artificial 
substrates are added to the extracellular domain of klotho [3]. The extracellular domain 
of klotho is secreted into serum, urine and cerebrospinal fluid [4, 5]. Intriguingly, klotho is 
only mainly expressed in the renal DCT cells and the choroid plexus in the brain, but 
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multiple aging-like phenotypes of klotho-/- mice are involving almost all organ systems. 
Therefore, klotho itself may function as a humoral factor. 
 
To date, the identification of the physiological functions of klotho is developing rapidly. It 
has been demonstrated that klotho regulates the insulin / IGF1 [2] and fibroblast growth 
factor (FGF23) signaling pathway [6]. More recently, it was shown that klotho plays a 
crucial role in the maintenance of Ca2+ and phosphate balance. Appealing evidence of 
the involvement of klotho in Ca2+ homeostasis came from the study showing that klotho 
activates the epithelial Ca2+ channel TRPV5 [4]. TRPV5 functions as the gatekeeper of 
renal transcellular Ca2+ reabsorption, and is regulated at multiple levels including 
transcription, translation, intracellular trafficking and channel activity at the plasma 
membrane [7]. We demonstrated [4] by functional analysis using HEK293 cells that 
TRPV5 activity is significantly enhanced by secreted klotho, which can be mimicked by 
β-glucuronidase. Intriguingly, the stimulatory effect of klotho or β-glucuronidase on 
TRPV5 was abolished in HEK293 cells expressing the TRPV5 glycosylation-deficient 
mutant TRPV5-N358Q, indicating a pivotal role of N-glycosylation in the TRPV5 
activation. Since klotho co-localizes with TRPV5 in renal DCT cells where it activates the 
channel from the pro-urine [4], it is tempting to explore whether the activities of other 
renal apically localized channels or transporters could be influenced by klotho. 
 
The aim of the present study was, therefore, to examine whether the klotho effect is 
restricted to TRPV5 or more generally applicable to other renal apically localized 
proteins in DCT cells. To this end, we selected candidates within the TRP channels 
including TRPV4, TRPV6 and TRPM6. These channels have structural similarities with 
TRPV5 and are permeable to Ca2+. Additionally, the thiazide-sensitive Na+-Cl- 
cotransporter (NCC) was selected as a candidate in this study. Peptide N-glycosidase F 
(endoF) that removes the entire N-glycan was applied to elucidate the role of N-
glycosylation in the regulation of the investigated proteins. By using 45Ca2+ and 22Na+ 
uptake analyses, we demonstrated that β-glucuronidase does not activate TRPV4, 
TRPM6 and NCC, but only stimulates TRPV5 and TRPV6. Thereby, a unique 
stimulatory effect of klotho on the epithelial Ca2+ channels TRPV5 and TRPV6 was 
discovered.   
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Material and methods 
DNA constructs 
pCINeo/IRES-GFP-HA-TRPV5, pCINeo/IRES-GFP-TRPV6 [8], pCINeo/IRES-GFP-
TRPV4 [9], pCINeo/IRES-GFP-HA-TRPM6 [10], pCB6-Flag-NCC [11] and pCINeo/IRES-
GFP-HA-klotho [4] constructs were generated as described previously. All constructs 
were verified by DNA sequence analysis. 
 
Collection and concentration of conditioned culture media  
HEK293 cells were transfected with 15 μg pCINeo/IRES-GFP-HA-klotho or 
pCINeo/IRES-GFP empty-vector cDNA in a 85 mm petri-dish. Three days after 
transfection, the conditioned culture media was collected and concentrated 10 times 
using the centriprep columns ultracel YM-30 (Millipore corporation, Bedford, MA, U.S.A).  
 
Transfection of HEK293 cells and preparation of total cell membrane 
HEK293 cells were transfected with 2 μg pCINeo/IRES-GFP-HA-TRPV5, pCINeo/IRES-
GFP-TRPV6, pCINeo/IRES-GFP-HA-TRPM6, pCINeo/IRES-GFP empty vector, or 0.5 
μg pCINeo/IRES-GFP-TRPV4 cDNA in a 6-well plate. MpkCCD cells were transfected 
with 2.5 μg pCB6-Flag-NCC or pCB6 empty vector cDNA in a 6-well plate [11]. Two 
(TRPV4, TRPV5 and TRPV6) or three days (TRPM6 and NCC) after transfection, the 
cells were homogenized in HBA buffer [20 mM Tris (pH 7.4 / HCl), 5 mM MgCl2, 5 mM 
NaH2PO4, 1 mM EDTA (pH 8.0 / NaOH), 80 mM sucrose, 1 mM phenyl-methylsulfonyl 
fluoride (PMSF), 10 μg/ml leupeptin and 10 μg/ml pepstatin], and then centrifuged for 15 
min, at 4,000 g at 4°C, in addition to 30 min at 16,000 g at 4°C. The pellet was dissolved 
in 30 μl of laemmli buffer and incubated at 37°C for 30 min. The proteins were detected 
by SDS-PAGE gel electrophoresis followed by autoradiography. 
 
45Ca2+ uptake assay  
HEK293 cells were transfected with 2 μg pCINeo/IRES-GFP-HA-TRPV5, pCINeo/IRES-
GFP-TRPV6, pCINeo/IRES-GFP-HA-TRPM6, pCINeo/IRES-GFP empty-vector, or 0.5 
μg pCINeo/IRES-GFP-TRPV4 cDNA in a 6-well plate. HEK293 cells expressing TRPV4, 
TRPV5, TRPV6, or TRPM6 were incubated for 16 hours with klotho-containing 
supernatant, 310 U/ml β-glucuronidase (Sigma, St. Louis, MO, U.S.A), or 10,000 U/ml 
endoF (New England Biolabs, Ipswich, MA, U.S.A) in 300 μl DMEM medium (Cambrex 
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Bio Science, Verviers, Belgium) at 37°C with 5% (v/v) CO2, respectively. Subsequently, 
45Ca2+ uptake was determined as described previously [4]. For the 45Ca2+ uptake in 
TRPV4, TRPV5 and TRPV6, the depletion buffer was KHB buffer (pH 7.4 / 1 M Tris) 
containing 110 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 10 mM Na-acetate, 2 mM NaH2PO4, 
20 mM HEPES, 4 mM L-lactate, 10 mM D-glucose and 1 mM L-alanine. The uptake 
buffer was 45CaCl2 (1 μCi/ml) in KHB buffer with 0.1 mM Ca2+, 4 mM L-lactate, 10 mM D-
glucose, 1 mM L-alanine and voltage-gated Ca2+ channel inhibitors (10 μM felodipine, 10 
μM verapamil, and 1 mM BaCl2). The stop buffer contained 110 mM NaCl, 5 mM KCl, 
1.2 mM MgCl2, 10 mM Na-acetate, 20 mM HEPES, 0.5 mM CaCl2 and 1.5 mM LaCl3. 
For 45Ca2+ uptake in TRPM6, the depletion buffer (pH 7.4 / 1 M Tris) contained 110 mM 
NaCl, 5 mM KCl, 10 mM Na-acetate, 20 mM HEPES, 4 mM L-lactate, 10 mM D-glucose 
and 1 mM L-alanine. The uptake buffer was 45CaCl2 (1 μCi/ml) in depletion buffer with 
0.1 mM CaCl2, 4 mM L-lactate, 10 mM D-glucose, 1 mM L-alanine, 10 μM felodipine and 
10 μM verapamil. The stop buffer was depletion buffer with 1.5 mM LaCl3 and 0.5 mM 
CaCl2. 
 
22Na+ uptake  
For 22Na+ uptake experiments, mpkCCD cells were transfected with 2.5 μg pCB6-Flag-
NCC or pCB6 empty-vector cDNA in a 6-well plate as described previously [11]. 
MpkCCD cells expressing Flag-NCC were incubated for 16 hours with 310 U/ml β-
glucuronidase or 10,000 U/ml endoF at 37°C with 5% (v/v) CO2 after two days of 
transfection. The cells were subsequently washed and performed with 22Na+ uptake 
measurement as previously described [11]. 
 
Cell culture 
MpkCCD cells were derived from a 1-month-old SV-PK/Tag transgenic mouse [11]. Cells 
were cultured in defined medium consisting of a 1:1 mixture of DMEM:Ham's F-12 
(Invitrogen, Breda, the Netherlands), supplemented with 2% (v/v) heat-inactivated fetal 
calf serum, 5 μg/ml insulin (Sigma, St. Louis, MO, U.S.A), 1 nM dexamethasone (Sigma), 
90 nM sodium selenate (Sigma), 5 μg/ml transferrin (Sigma), 10 ng/ml EGF (Sigma), 4.5 
mM glutamine (Gibco-BRL, Breda, the Netherlands), 0.2% (w/v) D-glucose (Sigma), 30 
μg/ml gentamicin and 20 mM HEPES (Gibco-BRL), equilibrated with 5% CO2–95% air at 
37°C.  
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Protein and immunoblot analysis 
Total membranes were isolated from HEK293 or mpkCCD cells. The samples were 
subjected to SDS-PAGE electrophoresis (6% w/v or 8% w/v). Immunoblots were 
incubated overnight at 4°C with primary antibodies including guinea pig anti-TRPV5 
(1:4,000), mouse anti-HA (1:4,000), rabbit anti-TRPV4 (1:5,000), rabbit anti-TRPV6 
(1:2,000) in 1% (w/v) non-fat dried milk (NFDM), or rabbit anti-NCC A857 (1:10,000) [11] 
in 5% (w/v) NFDM in TBS-T [Tris-buffered saline (TBS) buffer (150 mM NaCl, 10 mM 
Tris pH 7.4 / HCl) containing 0.2% (v/v) Tween-20]. After washing, immunoblots were 
incubated at RT with the corresponding secondary antibody including goat anti-guinea 
pig IgG peroxidase (1:10,000) (Sigma, St. Louis, MO, U.S.A), sheep anti-mouse IgG 
peroxidase (1:10,000) (Sigma), or goat anti-rabbit IgG peroxidase (1:5,000) (Sigma) in 
TBS-T. 
 
Statistical analysis 
In all experiments, the data are expressed as mean ± SEM. Overall statistical 
significance was determined by analysis of variance (ANOVA). P values below 0.05 
were considered significant. 
 
Results  
 
The β-glucuronidase klotho or endoF stimulates TRPV5 activity 
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Figure 1. Stimulation of TRPV5 activity by klotho, β-glucuronidase or endoF.   (A) HEK293 cells 
were transfected with TRPV5 or empty vector (mock) cDNA. Then, the cells expressing TRPV5 were 
exposed for 16 hours to β-glucuronidase (β-Glu), klotho-containing supernatant (klo-super) or endoF, 
and subsequently analyzed for 45Ca2+ influx analysis. Asterisk indicates significant difference from 
HEK293-TRPV5 cells. #, indicates significant difference from mock-transfected HEK293 cells (p<0.05, 
n=6). (B) HEK293 cells expressing TRPV5 were treated with klotho-containing supernatant, β-
glucuronidase or endoF, and analyzed by immunobloting analysis. 
The effect of klotho, β-glucuronidase or endoF on TRPV5 activity was determined in 
HEK293 cells expressing the channel using a 45Ca2+ uptake assay. The TRPV5-
transfected HEK293 cells were incubated for 16 hours with culture media collected from 
klotho-expressing HEK293 cells (klotho-containing supernatant), β-glucuronidase or 
endoF. 45Ca2+ uptake assay demonstrated that the expression of TRPV5 resulted in a ~2 
fold increase of Ca2+ influx compared to cells transfected with empty-vector (mock) 
cDNA (Figure 1A). Pre-incubation with klotho-containing supernatant, β-glucuronidase, 
or endoF significantly enhanced the TRPV5-mediated Ca2+ influx. The complex-
glycosylated TRPV5 band of 85-100 kDa disappeared after endoF treatment, but was 
not noticeably altered by klotho-containing supernatant or β-glucuronidase (Figure 1B). 
Importantly, total expression of TRPV5 was equal in all conditions. 
 
The β-glucuronidase klotho enhances TRPV6-mediated Ca2+ influx 
 
Because TRPV6 is a close homologue of TRPV5, we subsequently tested the klotho 
effect on TRPV6. TRPV6-transfected HEK293 cells were incubated for 16 hours with 
klotho-containing supernatant or β-glucuronidase. 45Ca2+ uptake analysis showed that 
TRPV6 expressing cells display a ~1.5 fold increase of Ca2+ influx compared to mock 
transfected cells (Figure 2A). Incubation with klotho-containing supernatant or β-
glucuronidase for 16 hours resulted in a significantly enhanced Ca2＋ influx mediated by 
TRPV6. Total expression of TRPV6 in all conditions was similar. In addition, endoF 
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inhibited complex glycosylation of TRPV6 as indicated by immunoblot showing that the 
upper complex-glycosylated band of TRPV6 disappeared after endoF treatment. 
However, the glycosylation was not changed by incubation with klotho-containing 
supernatant or β-glucuronidase (Figure 2B).  
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Figure 2. Activation of TRPV6 channel by β-glucuronidase or klotho. (A) HEK293 cells were 
transfected with TRPV6 and incubated for 16 hours with β-glucuronidase (β-Glu) and klotho-containing 
supernatant (klo-super). The cells were subsequently analyzed for 45Ca2+ influx. Asterisk indicates 
significant difference from HEK293-TRPV6 cells. #, indicates significant difference from mock-
transfected HEK293 cells (p<0.05, n=6). (B) HEK293-TRPV6 cells were treated with klotho-containing 
supernatant, β-glucuronidase or endoF, and subsequently analyzed by immunobloting analysis. 
 
 
Regulation of TRPV4 activity by β-glucuronidase or endoF 
 
To test whether TRPV4 activity is regulated by β-glucuronidase or endoF, 45Ca2+ uptake 
assays were performed. TRPV4-transfected HEK293 cells displayed a ~2-3 fold 
increased Ca2+ influx compared to mock transfected cells. TRPV4-mediated Ca2+ influx 
was not influenced by β-glucuronidase, but significantly increased by endoF (Figure 3A). 
The intensity of the complex-glycosylated band of TRPV4 was reduced by endoF 
treatment (Figure 3B), whereas the total expression of TRPV4 was the same in all 
conditions.  
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Figure 3. Regulation of TRPV4 by endoF or β-glucuronidase. (A) HEK293 cells were transfected with 
TRPV4 and incubated for 16 hours with β-glucuronidase (β-Glu) or endoF. TRPV4 activity was determined 
by 45Ca2+ uptake assay. (B) The total expression of TRPV4 channels with or without β-glucuronidase and 
endoF treatment was analyzed by immunoblotting. Asterisk indicates significant difference from HEK293-
TRPV4 cells. #, indicates significant difference from mock-transfected HEK293 cells (p<0.05, n=6). 
β-glucuronidase treatment does not stimulate TRPM6 activity  
The effect of β-glucuronidase on TRPM6 channel was examined by 45Ca2+ uptake 
experiments. Our functional analyses demonstrated that TRPM6 transfected cells exhibit 
a ~1.5 fold increase of Ca2+ influx compared to mock-transfected cells. However, β-
glucuronidase incubation for 16 hours did not enhance the Ca2+ influx mediated by 
TRPM6.  
Mock TRPM6
0
40
80
120
TRPM6
β-Glu
#
#
45
C
a2
+
up
ta
ke
 (%
)
45
C
a2
+
up
ta
ke
 (%
) Figure 4. TRPM6 channel isinsensitive to β-glucuronidase 
treatment. HEK293 cells 
expressing TRPM6 were 
exposed to β-glucuronidase (β-
Glu) for 16 hours and 
subsequently assayed for 45Ca2+ 
uptake. #, indicates significant 
difference from mock-
transfected HEK293 cells 
(p<0.05, n=6).  
  
  
 
 
 
 
- 152 -
                                           Chapter 7 
NCC activity is insensitive to β-glucuronidase or endoF treatment 
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Figure 5. β-glucuronidase 
or endoF is unable to 
stimulate NCC cotrans-
porter. (A) mpkCCD cells 
were transfected with Na+-
Cl- cotransporter (NCC) 
cDNA. Two days after 
transfection, the cells were 
exposed to β-glucuronidase 
(β-Glu) or endoF for 16 
hours. Subsequently, NCC 
activity was determined by 
22Na+ uptake assay. 100 μM 
hydrochlorothiazide 
(thiazide) was added to the 
cells to examine the 
specificity of Na+ transport 
by NCC. #, indicates 
significant difference from 
mock-transfected HEK293 
cells (p<0.05, n=6). (B) The 
effect of endoF or β-
glucuronidase on N-
glycosylation of NCC was 
analyzed by immunoblotting.
 
 
 
 
 
 
 
 
 
22Na+ uptake experiments demonstrated that the Na+ influx in NCC transfected mpkCCD 
cells was significantly increased as compared to mock transfected cells (Figure 5A). 
Hydrochlorothiazide (thiazide) reduced the 22Na+ influx in NCC expressing mpkCCD cells, 
indicating that the NCC-expressing cells displayed a thiazide-sensitive Na+ uptake. 
Furthermore, the thiazide-sensitive Na+ uptake was not influenced by β-glucuronidase or  
endoF treatment. The complex-glycosylated band of NCC of 115 kDa completely 
disappeared after endoF treatment (Figure 5B). Importantly, total expression of NCC in 
all conditions was similar. 
  
Discussion 
Based on the fact that klotho co-localizes with TRPV5 in the renal DCT cells where it is 
secreted and activates the channel from the pro-urine [4], we explored whether the 
activities of other renal apically localized channels or transporters in DCT cells (including 
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TRPV4, TRPV6, TRPM6 and NCC) can also be extracellularly influenced by klotho. Our 
data discovered a predominant effect of klotho on the epithelial Ca2+ channels TRPV5 
and TRPV6. This conclusion is substantiated by the following experimental observations: 
(i) klotho and β-glucuronidase stimulated TRPV5- or TRPV6-mediated Ca2+ influx. (ii) 
TRPV4- or TRPM6-mediated Ca2+ influx was not enhanced by β-glucuronidase. (iii) β-
glucuronidase did not increase the thiazide-sensitive Na+ influx displayed in NCC 
transfected mpkCCD cells. 
 
TRPV5 and TRPV6 represent two highly homologous members within the TRP 
superfamily [12, 13] constituting a distinct class of highly Ca2+-selective channels [14, 15], 
which are mainly expressed in Ca2+-transporting epithelia. TRPV5 shares 75% homology 
with TRPV6 at the amino acid level [16], and these two channels have similar molecular 
structures, electrophysiological features, and the unique pore characteristics [17]. By 
using 45Ca2+ uptake experiments, we were able to demonstrate that incubation with 
klotho-containing supernatant or β-glucuronidase for 16 hours results in a significantly 
enhanced Ca2+ influx mediated by TRPV6. The immunoblot showed identical total 
expression of TRPV6 in all conditions, indicating that klotho or β-glucuronidase 
increases either open probability of the channel or TRPV6 abundance at the plasma 
membrane. The latter is most likely, since a cell-surface biotinylation assay has shown a 
significantly increased TRPV5 expression at the plasma membrane by klotho [4]. The 
present study further substantiates klotho as a regulator of both TRPV5 and TRPV6 
channels. The tissue distribution of TRPV5 and TRPV6 in humans indicates that both 
channels are co-expressed in several organs that mediate transcellular Ca2+ transport 
[18], such as duodenum, colon, and kidney, but also in pancreas, prostate, mammary, 
sweat and salivary glands. Klotho is predominantly expressed in the renal DCT cells and 
the choroid plexus in the brain, and the extracellular domain of klotho is secreted into  
serum, urine and cerebrospinal fluid [4, 5]. Therefore, the secreted klotho may function 
as a humoral factor extracellularly modulating TRPV5 and TRPV6 activity in various 
target organs where these two epithelial Ca2+ channels are expressed. Both TRPV5 and 
TRPV6 channels contain a conserved N-glycosylation site at the asparagine residue 
N358 (TRPV5) or N357 (TRPV6) in the extracellular loop between TM region 1 and 2, 
respectively [4]. Immunoblot analysis showed that the intensity of the complex-
glycosylated TRPV5 and TRPV6 bands is reduced after incubation with endoglycosidase 
H (endoH) hydrolyzing N-linked high mannoses [19]. These bands disappear after 
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treatment with endoF removing the entire N-glycan, indicating that both epithelial 
channels are similarly complex glycosylated [19]. N-glycosylation plays a crucial role in 
TRPV5 regulation by klotho [4]. Likely, a comparable function applies to N-glycosylation 
of TRPV6 in the klotho-mediated channel stimulation 
 
Furthermore, we investigated whether β-glucuronidase activates two other members of 
TRP superfamily, TRPV4 and TRPM6, which share similar molecular structures with 
TRPV5 and TRPV6. TRPV4 and TRPM6 are Ca2+-permeable cation channels [20, 21], 
localized in the renal DCT cells. In general, TRPV4 plays a key role in cell volume 
regulation [22], and is widely expressed including in lung, spleen, kidney, testis, fat, brain, 
cochlea, skin, smooth muscle, liver, and vascular endothelium [23]. TRPM6 has a more 
restricted expression pattern being predominantly present in absorbing epithelia [24], 
and plays a potential role in the maintenance of Mg2+ balance [25]. Our results showed 
that β-glucuronidase incubation does not simulate TRPV4 and TRPM6 channel activity. 
Presumably, the N-oligosaccharides pivotal for TRPV5 and TRPV6 activation, which are 
hydrolyzed by β-glucuronidase, are not present in TRPV4 and TRPM6. Alternatively, 
hydrolysis of the N-oligosaccharides is not involved in the regulation of TRPV4 and 
TRPM6. A consensus N-glycosylation motif was identified at the asparagine residue 
N651 within the pore-forming loop between the fifth and sixth TM segments of TRPV4 [26, 
27]. Mutation of this residue results in a glycosylation-deficient mutant TRPV4-N358Q, 
which displays an increased Ca2+ entry resulted from the enhancement of TRPV4 
expression at the plasma membrane [26]. Since deglycosylation increases TRPV4 
channel activity [26], we applied endoF to remove TRPV4 N-glycosylation in order to 
study the role of N-glycosylation in the channel regulation. The results showed that 
endoF treatment enhances TRPV4-mediated Ca2+ influx. It supports the previous study 
that deglycosylation activates TRPV4 channel, indicating a key role of N-glycosylation in 
TRPV4 regulation. Up to date, detailed information regarding TRPM6 N-glycosylation 
remains elusive. Therefore, comprehensive studies about N-glycosylation and N-glycan 
structure of TRPM6 are a prerequisite to further understand TRPM6 regulation. 
 
To substantiate the applicability of the effect of β-glucuronidase on other transporters 
besides TRP channels, we investigated whether the thiazide-sensitive NCC can be 
activated by β-glucuronidase. NCC is mainly expressed in the apical membrane of  DCT, 
where it is responsible for the reabsorption of 10% of the filtered NaCl load [28, 29]. 
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Interestingly, mutations in NCC have been implicated in the autosomal recessive renal 
tubular disorder Gitelman syndrome, characterized by hypokalemic metabolic alkalosis, 
hypomagnesemia, and hypocalciuria [30]. Our results demonstrated that the thiazide-
sensitive Na+ influx mediated by NCC is not influenced by β-glucuronidase or endoF 
treatment. Detailed sequence analysis showed that rat NCC contains two potential N-
glycosylation consensus sites, at the asparagine residue N404 and N424. Functional 
expression of NCC in Xenopus laevis oocytes revealed that the glycosylation-deficient 
mutants NCC-N404Q and NCC-N424Q display drastically decreased thiazide-sensitive 
22Na+ uptake, resulting from reduced plasma membrane expression [31]. This 
observation suggests that N-glycosylation is essential for optimal function and cell-
surface expression of NCC [31]. It may suggest a different role of N-glycosylation in 
NCC regulation compared to TRPV5 and TRPV6, explaining why NCC is insensitive to 
β-glucuronidase or endoF treatment.  
In conclusion, a predominantly stimulatory effect of klotho has been discovered in the 
present study, which is only applicable to the epithelial Ca2+ channels TRPV5 and 
TRPV6, but not to TRPV4, TRPM6 and NCC. This may result from diverse functions of 
N-glycosylation or various N-glycan structures of the investigated proteins. Therefore, 
detailed studies concerning the N-glycosylation and N-glycan structures of TRPV4, 
TRPV5, TRPV6, TRPM6 and NCC are warranted in the near future.      
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Almost any situation---good or bad ---is affected by the attitude we bring to. 
(Lucius Annaus Seneca) 
差不多任何一种处境——无论是好是坏——都受到我们对待处境的态度的影
响。(西尼加 L A) 
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Introduction 
The Transient Receptor Potential (TRP) superfamily of proteins consists of ion channels 
with molecular structure similarities [2]. TRP channels are extensively expressed and 
have diverse functions [3-11]. They are all cation selective, but the selectivity ratio for 
Ca2+ and  the monovalent cation Na+ varies widely [2, 12-22]. The TRP superfamily is 
identified on the basis of homology only [2, 12, 13, 23], since the mode of activation and 
ion selectivity are diverse.  Mutations of TRP proteins result in kidney-related diseases, 
including hereditary hypomagnesemia with secondary hypocalcemia (HSH) caused by 
mutations of TRPM6, autosomal dominant polycystic kidney disease caused by 
mutations of TRPP2, and focal segmental glomerulosclerosis caused by mutations of 
TRPC6 [3, 24-31]. The epithelial Ca2+ channels, TRPV5 and TRPV6 uniquely represent 
two highly homologous members within the TRP superfamily, which are mainly 
expressed in Ca2+-transporting epithelia [13, 32]. The molecular identification of TRPV5 
[17] and TRPV6 [16, 33], boosted the research addressing the molecular mechanism of 
transepithelial Ca2+ transport. TRPV5 primarily fulfills the role as a gatekeeper of 
epithelial Ca2+ transport in the kidney [32], whereas TRPV6 forms the main Ca2+ influx 
pathway in small intestine [34]. These channels convey the rate-limiting step in active 
Ca2+ transport and play, therefore, a pivotal role in Ca2+ homeostasis. The structure of 
TRPV5 and TRPV6 shows the typical topology features shared by all members of the 
TRP family [32]. The amino (N-tail) and carboxyl (C-tail) termini of TRPV5 and TRPV6 
contain several conserved putative regulatory sites (for instance, ankyrin repeats [35] 
and potential internal PDZ motifs [36]) that might be involved in regulation of channel 
trafficking and activity. Particularly, TRPV5 and TRPV6 possess several potential 
phosphorylation sites in their N- and C-tails. Many of these putative phosphorylation 
sites are conserved among species, which suggest an important role in TRPV5 and 
TRPV6 functioning. TRPV5 and TRPV6 form homo- or hetero-tetrameric channel 
complexes with four subunits in a head-to-tail fashion [37]. These two channels contain a 
conserved N-glycosylation site in the extracellular loop between transmembrane (TM) 
region 1 and 2, which is localized at the asparagine residue N358 or N357 in TRPV5 and 
TRPV6, respectively. It has been reported that these channels are complexly 
glycosylated resulting in higher molecular weight proteins with corresponding molecular 
weight of about 85-100 kDa [37]. N-glycosylation of TRPV5 and TRPV6 may play an 
important role in protein folding, intracellular trafficking and channel regulation. 
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Detailed study about the molecular structure and regulation of these epithelial Ca2+ 
channels is crucial for a comprehensive understanding of Ca2+ homeostasis. The activity 
of TRPV5 and TRPV6 can be controlled by different regulatory mechanisms [38], for 
instance, hormone-mediated TRPV5 and TRPV6 expression, pH, intracellular Ca2+ and 
Ca2+ sensors (80K-H and calmodulin)-controlled channel activity and S100A10-mediated 
trafficking regulation. To get deeper insight into the molecular structure and regulation of 
TRPV5 and TRPV6, the studies described in this thesis have been performed. This 
chapter will discuss and summarize the findings of these studies.  
 
Molecular structure of TRPV5 and TRPV6 
 
Heterotetrameric TRPV5 and TRPV6 channels and their assembly domains 
By co-immunoprecipitations and molecular mass determination of TRPV5 and TRPV6 
complexes using sucrose gradient sedimentation it was demonstrated that these two 
channels form homo- and heterotetrameric channel complexes. When concatemeric 
channels are constructed in a head-to-tail fashion consisting of four different TRPV5 
and/or TRPV6 subunits, they display intermediate properties between TRPV5 and 
TRPV6 channels depending on the subunit configuration [37]. Previously, Hellwig and 
co-workers showed by fluorescence resonance energy transfer and co-
immunoprecipitation experiments that TRPV5 and TRPV6 seem to be unique in forming 
heterotetramers [39], whereas the other TRPV channels preferentially form 
homotetramers. Thus, regulation of the relative expression levels of TRPV5 and TRPV6 
may be a mechanism to fine-tune the Ca2+ transport kinetics in TRPV5 and TRPV6 co-
expressing tissues. Indeed, several studies indicated that certain tissues co-expressing 
TRPV5 and TRPV6 would allow oligomerization of these channels in vivo [34, 38, 40]. 
An extensive analysis of TRP channel tissue distribution shows that TRPV5 and TRPV6 
are co-expressed in brain, kidney, pancreas, small intestine, colon, prostate and testis 
[40].  
 
Detailed information concerning protein structure and assembly of ion channels 
containing six TM domains is available for Shaker-like voltage-gated K+ (Kv+) and cyclic 
nucleotide-gated channels (CNG). It has been demonstrated that CNG channel 
assembly requires a trimer-forming C-tail leucine zipper (CLZ) domain [41]. Kv channels 
process a highly conserved N-tail cytoplasmic T1 domain (around 130 amino acids), 
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found to form a tetrameric ring with a narrow, positively charged central pore [42]. This 
designated T1 domain has been shown to spontaneously form tetramers in the absence 
of TM sequences [42, 43]. Crystallization of the T1 domain further verifies the reported 
biochemical and functional properties [42, 44]. The overall structure of TRPV5 and 
TRPV6 is similar to that of voltage-gated Ca2+ (Cav) channels. It has been investigated 
that functional Cav channels are monomeric proteins containing four homologous 
internal repeats, which assemble via an α-interaction domain (AID), β-interaction domain 
(BID) and an extensive, conserved hydrophobic cleft (named the α-binding pocket, ABP) 
[45, 46]. Similarly, TRPV5 and TRPV6 are shown to assemble into homo- and/or 
heterotetrameric complexes. However, the crucial domains involved in the assembly of 
these two channels were until recently poorly understood. Therefore, the identification of 
the precise assembly domains is a prerequisite to better understand TRPV5 and TRPV6 
tetramerization. In chapter 2, the molecular determinants in TRPV5 that play a key role 
in the formation of the functional channel complex were identified. Both the N-tail and C-
tail are critical for TRPV5 channel assembly. Furthermore, functional 45Ca2+ influx study 
in Xenopus laevis oocytes and patch-clamp analysis in HEK293 cells co-expressing 
TRPV5 wild-type and truncated channels lacking either the N-tail or C-tail indicated that 
these N- or C-tail lacking truncants exert dominant-negative effects on channel activity, 
resulted from a disturbed trafficking of TRPV5 to the plasma membrane. Therefore, 
assembly of channel subunits is essential for trafficking of the TRPV5 channel complex 
and subsequent activity at the plasma membrane. Niemeyer et al. [47] identified the third 
ankyrin repeat being a stringent requirement for physical assembly of TRPV6 subunits. 
Our studies in chapter 2 showed that at least two regions in the cytosolic tails (64-77 in 
the N-tail and 596-601 in the C-tail) are involved in channel assembly [48]. Physical 
interactions between the N-tail & N-tail, N-tail & C-tail and C-tail & C-tail of TRPV5 were 
demonstrated by pull-down and co-immunoprecipitations in Xenopus laevis oocytes. 
When these two critical regions in the N-tail (64-77) and C-tail (596-601) involved in 
channel assembly are deleted, the interactions between the tails are abolished. In 
addition, the identified N-tail assembly domain includes an ankyrin repeat, substantiating 
the involvement of these protein–protein binding modules in TRPV5 assembly. The 
importance of both the N- and C-tail in TRPV channel oligomerization, including TRPV5 
and TRPV6, was recently confirmed by Hellwig et al. [39]. Their study provided evidence 
that ankyrin repeats in the N-tail of TRPV5 and TRPV6 are essential for subunit 
assembly [39, 48], which is in line with our results in chapter 2. Deleting or mutating 
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assembly domains could cause a change in the tertiary structure and/or prevent the 
interaction with auxiliary proteins, thereby affecting channel trafficking and activity. For 
instance, the assembly domain in the C-tail (596-601) of TRPV5 is a helical stretch 
containing five amino acids (MLERK), also known to bind the auxiliary proteins Rab11a 
and 80K-H [49-51] (Figure 1). Impaired trafficking observed in the TRPV5 mutant 
lacking the MLERK motif could be explained by the inability to interact with the 
necessary auxiliary proteins that play an essential role in TRPV5 trafficking and 
functioning [50]. Taken together, both N- and C-tail are crucial for TRPV5 assembly. 
Assembly of channel subunits is essential for trafficking of the TRPV5 channel complex 
and subsequent activity at the plasma membrane. In order to get more insight into the 
TRPV5 and TRPV6 assembly, protein crystallography of these channels would be the 
most challenging approach to determine the molecular structure in the near future.  
 
Molecular regulation of TRPV5 and TRPV6 channel 
 
The detailed studies in the molecular regulation of TRPV5 and TRPV6 further extended 
to proteins that act as the putative regulators of these two channels. Our recent findings 
demonstrated that TRPV5 and TRPV6 can be regulated at the trafficking level by 
Rab11a, at the channel activity level at the plasma membrane by NHERF2 / NHERF4, 
FKBP52, BSPRY, calbindin-D28k and RGS2.  In addition, these channels could also be 
regulated by extracellular proteins including klotho, β-glucuronidase, sialidase, peptide 
N-glycosidase F (endoF) and tissue kallikrein (TK). An integrated model of TRPV5 and 
TRPV6 regulation by different proteins and binding sites of channel-associated proteins 
is depicted in Figure 1.   
 
FKBP52, NHERF2/4, BSPRY, calbindin-D28k, and RGS2-mediated channel activity 
regulation 
It has been recently reported [52] that expression of the FKBP52 protein reduces 
TRPV5-mediated Ca2+ and Na+ current, suggesting that FKBP52 decreases the number 
of functional channels at the plasma membrane. Van de Graaf et al. [53] showed the first 
physiology role of novel protein BSPRY in the directly negative regulation of TRPV5, 
which is involved in inhibitory signaling cascades that control the activity of the epithelial 
Ca2+ channels at the cell surface.  In addition, it has been demonstrated that NHERF2 
and NHERF4 hypothetically increase cell-surface TRPV5 abundance and activity in a  
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Figure 1. Integrated model of TRPV5 and TRPV6 regulation by different proteins and binding 
sites of channel-associated proteins. TRPV5 and TRPV6 are synthesized in the endoplasmic 
reticulum (ER) and subsequently transported towards the plasma membrane. Rab11a mediates the 
trafficking of TRPV5 and TRPV6 to the plasma membrane, and it binds to MLERK domain in the C-
tails of TRPV5 and TRPV6. FKBP52 decreases the number of functional channels at the plasma 
membrane. NHERF2 and NHERF4 are hypothesized to enhance the stability of TRPV5 and TRPV6 at 
the plasma membrane. NHERF2 binds to the last amino acids YHE and NHERF4 binds to amino acid 
region 596-617 of TRPV5. In addition, calbindin-D28k and RGS2 regulate TRPV5 or TRPV6 by direct 
association with the channel. Calbindin-D28k binds to both N- and C-tails of TRPV5 in a Ca2+ 
dependent manner, and RGS2 binds to N-tail of TRPV6, however, the exact binding domains of these 
two proteins were not identified. Furthermore, BSPRY is involved in inhibitory signaling cascades that 
control the activity of the epithelial Ca2+ channels at the cell surface, and binds to C-tail of TRPV5 
without identification of binding domains. TRPV5 and TRPV6 have one N-linked glycan at the 
asparagine residue N358 or N357 between transmembrane (TM) segment 1 and 2, respectively. 
Glycosidases - klotho, sialidase and endoF activate TRPV5 from outside by hydrolyzing N-glycan of 
the channel at the site N358. Tissue kallikrein (TK) extracellularly stimulates TRPV5 by activating the 
bradykinin 2 receptor (B2R), which requires the two conserved PKC sites – serine residue S299 and 
S654 in the channel. In total, there are six predicted PKC phosphorylation sites as shown in the figure. 
The tetramerization domains of TRPV5 locate between 64-77 region of N-tail and MLERK region in C-
tail. 64-77 region in the N-tail of TRPV5 located more upstream, overlaps with the first ankyrin repeat. 
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direct fashion via protein-protein interaction [54-56]. Furthermore, Lambers et al. [57] 
showed that calbindin-D28k acts in Ca2+-transporting epithelia as a dynamic Ca2+ buffer, 
regulating Ca2+ concentration in close vicinity to the TRPV5 pore by direct association 
with the channel. More recently, RGS was identified as a protein directly interacting with 
TRPV6 to negatively affect the channel gating properties [58]. 
 
Rab11a-mediated trafficking regulation 
 
A novel function of Rab11a as an associated protein mediating trafficking of TRPV5 and 
TRPV6 to the plasma membrane by direct cargo protein interaction has been 
demonstrated in chapter 3. Rab11a is a small GTPase involved in trafficking via 
recycling endosomes [59, 60]. Rab proteins are known to interact with a large variety of 
effectors [61-63], but only a few studies have demonstrated direct interactions between a 
Rab GTPase and a cargo molecule [64]. The ability to act as molecular switches that 
cycle between GTP- and GDP-bound states, underlies the functionality of the Rab 
GTPase family. Although the role of Rab GTPase in protein trafficking has long been 
recognized, the underlying mechanisms are far from understood. Our study in chapter 3 
describes for the first time cargo proteins that interact directly with Rab11a. As TRPV5 
and TRPV6 preferentially interact with GTP binding-deficient (GDP-locked) mutant 
Rab11a S25N in its GDP-bound configuration, this direct association of TRPV5 and 
TRPV6 with Rab11a could support the translocation of these channels into recycling 
endosomes and thereby constitute the “delivery machinery” destined to transport these 
channels to the apical plasma membrane. Further evidence for a role of Rab11a in 
TRPV5 and TRPV6 regulation is the predominant colocalization of Rab11a with TRPV5 
or TRPV6 along the apical domain of the DCT and CNT cells. At the subcellular level, 
Rab11a shows a significant colocalization with TRPV5 in subapical vesicular structures. 
Previous functional and histological studies have identified Rab11-positive structures as 
(apical) recycling endosomes, which are specialized compartments involved in (polar) 
sorting of endocytosed membrane proteins [59, 60, 65-67]. Furthermore, Rab11 has 
been demonstrated to play a role in transport from the trans-Golgi network to the plasma 
membrane [68, 69]. The unique role of Rab11a in targeting of TRPV5 and TRPV6 to the 
plasma membrane by direct interaction to the channel was further established by 
combined biochemical, functional, and immunocytochemical analyses. The MLERK 
domain in TRPV5 and TRPV6, conserved among all identified species of these two 
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channels, was demonstrated to be required for Rab11a binding. Mutations in this stretch 
induce a significantly diminished TRPV5- and TRPV6-mediated Ca2+ influx, resulted from 
impaired trafficking of the channels.  It indicates an essential role for Rab11a in targeting 
TRPV5 and TRPV6 to the plasma membrane. Moreover, this study further substantiates 
the functional role of Rab11a in the trafficking of TRPV5 and TRPV6 using Rab11a 
mutants by the result that GTP binding-deficient (GDP-locked) Rab11a mutant Rab11a 
S25N expression strongly reduces the TRPV5- and TRPV6-mediated Ca2+ influx. The 
expression of another dominant negative Rab protein (Rab22b S19N) does not inhibit 
TRPV5 and TRPV6 activity indicating the specificity of the Rab11a effect. These data 
indicate that cargo interaction (in the GDP status), as well as subsequent GTP binding, 
is required for Rab11a-mediated TRPV5 and TRPV6 trafficking. Taken together, our 
data provide new insight into the molecular machinery of TRP channel trafficking via 
direct interaction between a Rab GTPase and apically targeted cargo. This association 
is involved in the physiological regulation of TRPV5 and TRPV6 cell-surface abundance, 
a critical component in Ca2+ homeostasis. 
 
 
Klotho, β-glucuronidase, sialidase, endoF and TK–mediated extracellular 
regulation   
 
Klotho 
The klotho gene was originally identified as a gene mutated in a mouse strain that 
developed multiple aging-like phenotypes [70]. Mice defective in klotho gene expression 
(klotho-/- mice) exhibit a syndrome resembling human aging, including short life span, 
hypoactivity, muscle atrophy, skin atrophy, osteopenia, vascular calcification, 
abnormality in phosphate and Ca2+ metabolism [70] . In contrast, overexpression of the 
klotho gene extends life span in mice, by regulating the insulin / insulin-like growth factor 
1 (IGF1) signaling pathway [71]. These observations suggest that the klotho gene may 
function as an aging-suppressor, and klotho could be involved in the regulation of human 
aging and related diseases [72-77]. The klotho gene encodes a single-pass 
transmembrane protein. The extracellular domain of the protein is composed of two 
homologous domains, each having a homology to β-glucosidase of bacteria and plants. 
In addition, β-glucuronidase activity is detected when artificial substrates are added to 
the extracellular domain of klotho [78, 79]. The klotho protein is secreted into serum, 
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urine and cerebrospinal fluid [71, 78, 79]. Intriguingly, the klotho gene is only notably 
expressed in the renal DCT cells and the choroid plexus in the brain, but multiple aging-
like phenotypes of klotho-/- mice are involving almost all organ systems. Therefore, 
klotho itself may function as a humoral factor. 
 
To date, the identification of klotho molecular functions is developing rapidly. Klotho 
appears to regulate the insulin / IGF1 signaling pathway via binding of klotho to the 
putative klotho receptor [71]. This is a mechanism for life span extension, evolutionarily 
conserved from worms to mammals [80]. Further analysis demonstrates that klotho, both 
the full length and secreted forms bind to multiple fibroblast growth factor (FGF23) 
receptors [81], and that FGF23 requires klotho to activate FGF signaling pathway. 
FGF23 was identified as a gene mutated in patients with autosomal dominant 
hypophosphatemic rickets [82], and inhibits phosphate transport in renal proximal 
tubules. This indicates that klotho plays an important role in phosphate metabolism [83, 
84]. It has been recently investigated that klotho also plays a crucial role in the 
maintenance of Ca2+ homeostasis. One of the first signs that klotho regulates Ca2+ 
metabolism is the observation that klotho-/- mice have slightly increased serum levels of 
Ca2+ and develop bone abnormalities including osteoporosis [70]. In addition, klotho may 
play as a negative regulator of active vitamin D synthesis [70]. Appealing evidences of 
the involvement of klotho in Ca2+ homeostasis came with the investigation shown in 
chapter 4 that klotho activates the epithelial Ca2+ channel TRPV5 [85]. Previous studies 
have indicated that the expression of both klotho and TRPV5 is tightly controlled by the 
calciotropic hormone vitamin D, which may suggest a functional link between these 
proteins in the maintenance of the Ca2+ balance [38, 86]. Based on this correlation, the 
significant downregulation of klotho expression in TRPV5-/- mice shown by real-time PCR 
[85], and the conspicuous overlap in the pathophysiology of TRPV5-/- and klotho-/- mice 
(for instance, disturbed Ca2+ and vitamin D metabolism), we hypothesized that TRPV5 is 
a down-stream target of the anti-aging hormone klotho.  
 
The study in chapter 4 further uncovers the relationship between TRPV5 and klotho. Co-
expression of klotho with TRPV5 in HEK293 cells, or application of culture media 
collected from klotho-expressing HEK293 cells (klotho-containing supernatant) to 
TRPV5-transfected HEK293 cells, significantly stimulates TRPV5-mediated 45Ca2+ 
uptake in these cells. Cell-surface biotinylation experiments revealed a significant 
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increase in plasma membrane localization of TRPV5 whereas total expression is not 
affected after klotho treatment. These effects were mimicked by the purified β-
glucuronidase indicating that this enzymatic activity of klotho is responsible for the 
increased TRPV5 activity. Interestingly, the klotho or β-glucuronidase-mediated 
stimulatory effect on TRPV5 was abolished in HEK293 cells expressing the TRPV5 
glycosylation-deficient mutant TRPV5-N358Q without the entire N-glycan. Further, D-[U-
14C]glucose labeling assay demonstrated that klotho exhibits β-glucuronidase activity by 
hydrolyzing the N-glycan of glycosylated TRPV5 channels. Our results indicate that N-
glycosylation plays a crucial role in TRPV5 activation by β-glucuronidase klotho, in 
addition, the N-glycan acts as the target in this stimulation event. We provide a novel 
concept of a regulatory mechanism through which the secreted β-glucuronidase klotho 
hydrolyzes the extracellularly exposed N-glycan of TRPV5 to entrap channels at the 
plasma membrane. The physiological relevance of the aforementioned findings is 
substantiated by the co-localization of klotho with TRPV5 in the renal DCT and CNT cells, 
where klotho activates the channel from the pro-urine side. Klotho is the first example of 
an extracellular enzyme modifying the sugar chains of an ion channel to initiate a 
signaling cascade controlling transport activity. During aging, Ca2+ loss predominates 
Ca2+ intake [64]. As klotho deficiency is associated with a phenotype resembling aging, it 
may well be that impaired klotho activity in the elderly is responsible for reduced Ca2+ 
reabsorption via TRPV5. Future studies will have to corroborate this notion. The 
discovery of klotho-mediated extracellular TRPV5 activation has greatly enhanced our 
comprehension of TRPV5 regulation and klotho functioning, which may prove to be the 
model in unraveling the anti-aging effect of this novel hormone. 
 
Since klotho co-localizes with TRPV5 in renal DCT cells where it activates the channel 
from the pro-urine, it is tempting to explore whether the activities of other renal apically 
localized channels or transporters could be influenced by klotho. The aim of the study in 
chapter 7 was, therefore, to examine whether the klotho effect is restricted to TRPV5 or 
more generally applicable to other renal apically localized proteins in DCT cells. To this 
end, we selected candidates within the TRP channels including TRPV4, TRPV6 and 
TRPM6. These channels have structural similarities with TRPV5 and are permeable to 
Ca2+. Additionally, the thiazide-sensitive Na+-Cl- cotransporter (NCC) was selected as a 
candidate in this study.  Using 45Ca2+ uptake experiments, we were able to demonstrate 
that incubation with klotho-containing supernatant or β-glucuronidase for 16 hours 
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results in a significantly enhanced Ca2+ influx mediated by TRPV6. The immunoblot 
showed identical total expression of TRPV6 in all conditions, indicating that klotho or β-
glucuronidase increases either open probability of the channel or TRPV6 abundance at 
the plasma membrane. The latter is most likely, since a cell-surface biotinylation assay 
has shown a significantly increased TRPV5 expression at the plasma membrane by 
klotho [85]. The study in chapter 7 further substantiates klotho as a regulator of both 
TRPV5 and TRPV6 channels. The tissue distribution of TRPV5 and TRPV6 in humans 
indicates that both channels are co-expressed in several organs that mediate 
transcellular Ca2+ transport [87], such as duodenum, colon, and kidney, but also in 
pancreas, prostate, mammary, sweat and salivary glands. Klotho is predominantly 
expressed in the renal DCT cells and the choroid plexus in the brain, and the 
extracellular domain of klotho is secreted into  serum, urine and cerebrospinal fluid [78, 
85]. Therefore, the secreted klotho may function as a humoral factor extracellularly 
modulating TRPV5 and TRPV6 activity in various target organs where these two 
epithelial Ca2+ channels are expressed. Both TRPV5 and TRPV6 channels contain a 
conserved N-glycosylation site at the asparagine residue N358 (TRPV5) or N357 
(TRPV6) in the extracellular loop between TM region 1 and 2, respectively [85]. 
Immunoblot analysis showed that the intensity of the complex-glycosylated TRPV5 and 
TRPV6 bands is reduced after incubation with endoglycosidase H (endoH) hydrolyzing 
N-linked high mannoses [37]. These bands disappear after treatment with endoF 
removing the entire N-glycan, indicating that both epithelial channels are similarly 
complex glycosylated [37]. N-glycosylation plays a crucial role in TRPV5 regulation by 
klotho [85]. Likely, a comparable function applies to N-glycosylation of TRPV6 in the 
klotho-mediated channel stimulation. 
 
Furthermore, we investigated whether β-glucuronidase activates two other members of 
TRP superfamily, TRPV4 and TRPM6, which share similar molecular structures with 
TRPV5 and TRPV6. TRPV4 and TRPM6 are Ca2+-permeable cation channels [88, 89], 
localized in the renal DCT cells. In general, TRPV4 plays a key role in cell volume 
regulation [90], and is widely expressed including in lung, spleen, kidney, testis, fat, brain, 
cochlea, skin, smooth muscle, liver, and vascular endothelium [91]. TRPM6 has a more 
restricted expression pattern being predominantly present in absorbing epithelia [24], 
and plays a potential role in the maintenance of Mg2+ balance [25]. Our results in chapter 
7 showed that β-glucuronidase incubation does not simulate TRPV4 and TRPM6 
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channel activity. Presumably, the N-oligosaccharides pivotal for TRPV5 and TRPV6 
activation, which are hydrolyzed by β-glucuronidase, are not present in TRPV4 and 
TRPM6. Alternatively, hydrolysis of the N-oligosaccharides is not involved in the 
regulation of TRPV4 and TRPM6. Up to date, detailed information regarding TRPM6 N-
glycosylation remains elusive. Therefore, comprehensive studies about N-glycosylation 
and N-glycan structures of TRPV4 and TRPM6 are a prerequisite to further understand 
regulation of these two channels. 
 
To substantiate the applicability of the effect of β-glucuronidase on other transporters 
besides TRP channels, we investigated whether the thiazide-sensitive NCC can be 
activated by β-glucuronidase. NCC is mainly expressed in the apical membrane of  DCT, 
where it is responsible for the reabsorption of 10% of the filtered NaCl load [92, 93]. 
Interestingly, mutations in NCC have been implicated in the autosomal recessive renal 
tubular disorder Gitelman syndrome, characterized by hypokalemic metabolic alkalosis, 
hypomagnesemia, and hypocalciuria [94]. Our results in chapter 7 demonstrated that the 
thiazide-sensitive Na+ influx mediated by NCC is not influenced by β-glucuronidase 
treatment. Detailed sequence analysis showed that rat NCC contains two potential N-
glycosylation consensus sites, at the asparagine residue N404 and N424. Functional 
expression of NCC in Xenopus laevis oocytes revealed that the glycosylation-deficient 
mutants NCC-N404Q and NCC-N424Q display drastically decreased thiazide-sensitive 
22Na+ uptake, resulting from reduced plasma membrane expression [95]. This 
observation suggests that N-glycosylation is essential for optimal function and cell-
surface expression of NCC [95]. It may suggest a different role of N-glycosylation in 
NCC regulation compared to TRPV5 and TRPV6, explaining why NCC is insensitive to 
β-glucuronidase treatment.  
Taken together, klotho hydrolyzes N-oligosaccharides of TRPV5 to entrap the channel at 
the plasma membrane leading to an increased channel activity. This stimulatory effect of 
klotho is only predominantly applicable to the epithelial Ca2+ channels TRPV5 and 
TRPV6, but not to TRPV4, TRPM6 and NCC. This may result from diverse functions of 
N-glycosylation or various N-glycan structures of the investigated proteins. Therefore, 
detailed studies concerning the N-glycosylation and N-glycan structures of TRPV4, 
TRPV5, TRPV6, TRPM6 and NCC are warranted in the near future. 
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EndoF and sialidase 
The study in chapter 4 about klotho-mediated TRPV5 activation highlights the crucial 
role of the N-glycan in TRPV5 regulation. Thus, we hypothesized that other glycosidases 
that hydrolyze N-glycans may mimic the stimulatory effect of klotho. Therefore, the study 
in chapter 6 aimed to investigate the molecular mechanism underlying the klotho-
mediated TRPV5 activation as well as the specificity of this effect. To this end, we 
investigated the effect of diverse members of the glycosidase superfamily, to which β-
glucuronidase and klotho belong, namely β-glucosidase, β-galactosidase, sialidase, 
endoH, and endoF. These glycosidases hydrolyze various sugar residues including 
glucuronic acid, glucoses, galactoses, sialic acid, high mannoses and the entire N-
glycan.  In general, glycosidases participate in essential steps of synthesis and 
degradation of polysaccharides, which are involved in processes such as pathogen 
defense [96], control of signal transduction [97] and modification of hormones [98]. In 
humans, inheritable deficiencies of glycosidases are known to induce a large variety of 
impairments such as lysosomal storage diseases, Gaucher’s and Krabbe’s disease and 
lactose intolerance [99]. At present, the biological function of glycosidases remains 
scarce. So far, some studies suggested that sialidase and endoF can regulate ion 
channel activity [100]. Sialidase is known to hydrolyze sialic acid residues from 
glycosylated proteins [101]. A novel mechanism has been described through which 
hydrolysis of surface sialic acids by sialidase or removal of the complete surface N-
glycan of voltage-gated Na+ channel (Nav) can directly modulate channel gating, and 
therefore affect cardiac, skeletal muscle, and neuronal excitability [100]. Moreover, it has 
been described that Kv1.1 channels contain significant amounts of sialic acids, which 
appear to be the negative charges at the channel surface sensitive to Ca2+. The data 
suggested that sialidase treatment modifies Kv1.1 function by influencing the channel 
voltage dependence of activation [102]. EndoF is a well-known glycosidase, which 
removes the entire N-glycan of proteins. Glycans participate in many key biological 
processes including cell adhesion, molecular trafficking, receptor activation, signal 
transduction, and endocytosis [103]. It has been reported that N-glycans could serve as 
a signal for degradation by the SCF(Fbx2) ubiquitin ligase complex [104]. The F-box 
protein Fbx2 binds specifically to proteins attached to N-linked high-mannose 
oligosaccharides and subsequently contributes to ubiquitination of N-glycosylated 
proteins. These studies highlight the role of N-glycans in protein degradation besides its 
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typical role in protein folding, quality control, sorting, transport and channel activity [1]. In 
support of the previous findings, our data in chapter 6 showed by 45Ca2+ uptake 
measurements that sialidase or endoF stimulates TRPV5-mediated Ca2+ influx [85]. 
Thereby, we substantially extend the members of glycosidases extracellularly modulating 
TRPV5 activity besides klotho and β-glucuronidase [85]. Interestingly, the complex-
glycosylated TRPV5 band of 85-100 kDa disappeared after endoF treatment, but was 
not changed by the other investigated glycosidases. It indicated that klotho and sialidase 
only hydrolyze specific N-oligosaccharides of TRPV5, not detectable as a shift in 
molecular weight of the channel by SDS-PAGE. However, this hydrolysis can already 
activate TRPV5. In addition, based on the result that β-glucosidase, β-galactosidase and 
endoH do not increase TRPV5-mediated Ca2+ influx, our data revealed that these 
specific N-oligosaccharides, responsible for the channel activation, are β-glucuronic acid 
and sialic acid, hydrolyzed by β-glucuronidase and sialidase, respectively. 
 
Stimulation of Ca2+ influx through TRPV5 upon glycosidase treatment could be the result 
of an increase in either open probability of the channel or in expression of TRPV5 at the 
plasma membrane. Cell-surface biotinylation analysis showed that sialidase, endoF, 
klotho and β-glucuronidase increase TRPV5 channel abundance at the plasma 
membrane. Thereby, TRPV5 activation following the glycosidase application might be 
due to either an enhanced trafficking from the Golgi apparatus to the cell surface or a 
reduction in channel retrieval from the plasma membrane. Metabolic labeling in 
combination with cell-surface biotinylation subsequently revealed that the apparent 
retrieval process of TRPV5 is significantly delayed upon exposure to β-glucuronidase, 
indicating that β-glucuronidase increases TRPV5 activity by stabilizing the channel at the 
plasma membrane. Most likely, this also applies to sialidase and endoF-mediated 
increase in TRPV5 activity. Hereby, our data indicated a novel retrieval pathway 
controlled by the N-glycan of TRPV5, in which N-glycosylation plays a pivotal role. 
  
N-glycosylation 
N-glycosylation of proteins is highly conserved from yeast to human and has a 
significant effect on modulating protein structure and localization to facilitate proper 
folding and trafficking of membrane proteins [105]. The role of N-glycosylation of 
transmembrane proteins has received great attention, and it appears that in some cases 
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it is involved in membrane targeting. To date, several studies have focused on the role of 
N-glycosylation in the variety of ion channels or transporters. It has been conclusively 
demonstrated that prevention of N-glycosylation negatively influences proteins activity 
including the γ-aminobutyric acid (GABA) transporter (GAT1) [106], the voltage-gated 
Ca2+ channels (Cav) [107], cyclic nucleotide-gated ion channel (CNG) [108] and Na+-K+-
2Cl- cotransporter (NKCC2) [109]. Further, Pabon et al. demonstrate that N-glycosylation 
of G-protein-activated inwardly rectifying K+ channel (GIRK1) at the asparagine residue 
N119 and the renal outer-medullary K+ channel (ROMK1) at the asparagine residue 
N117 has different consequences in K+ channel function [110]. In addition, it has been 
demonstrated that the gating, cell-surface trafficking and pH sensitivity of Kv channels 
are regulated by N-glycosylation [111-113]. Moreover, the human ether-à-go-go-related 
gene (HERG) channel without N-glycosylation degrades more rapidly than glycosylated 
channel, resulting in a reduced cell-surface stability [114]. Within the TRP superfamily, N-
glycosylation regulates also TRPV1 channel activity [115]. Understanding the role of N-
glycosylation in protein trafficking, degradation and activity will highlight the different 
posttranslational mechanisms modifying the cell-surface ion channel expression levels 
and possibly their signaling characteristics. However, in addition to the well-known fact 
that deglycosylation negatively influences protein trafficking, stability and activity, Xu and 
co-workers showed that deglycosylation activates TRPV4 channel [116]. They identified 
a consensus N-glycosylation motif at the asparagine residue N651 within the pore-
forming loop between the fifth and sixth TM segments of TRPV4. Mutation of this residue 
results in a glycosylation-deficient mutant TRPV4-N358Q. HEK293 cells expressing 
TRPV4-N651Q display an enhanced Ca2+ entry resulted from an increased plasma 
membrane abundance of TRPV4-N651Q compared to the wild-type channel. The 
structurally related TRP channels share a nearly identically situated and experimentally 
confirmed N-glycosylation site, which promotes rather than limits channel insertion into 
the plasma membrane. Since deglycosylation increases TRPV4 channel activity [116], 
we applied endoF to remove TRPV4 N-glycosylation in order to study the role of N-
glycosylation in the channel regulation. As revealed in chapter 7, 45Ca2+ uptake 
measurements showed that endoF increases TRPV4-mediated Ca2+ influx, indicating an 
enhanced TRPV4 channel activity via deglycosylation. The immunoblotting subsequently 
demonstrated that the complex-glycosylated band of TRPV4, which is around 85-100 
KDa, is diminished after endoF treatment. It supports the previous study that 
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deglycosylation activates TRPV4 channel, indicating a key role of N-glycosylation in 
TRPV4 regulation.  
 
To further clarify the molecular mechanism underlying the N-glycosylation-mediated 
TRPV5 retrieval shown in chapter 6, we investigated the retrieval kinetics of the TRPV5 
glycosylation-deficient mutant (TRPV5-N358Q). Our result corroborates the importance 
of N-glycosylation in TRPV5 stability at the cell surface, since TRPV5-N358Q showed a 
low turnover compared to wild-type channels. In addition, β-glucuronidase did not further 
delay the TRPV5-N358Q retrieval due to absence of the entire N-glycan of this mutant, 
confirming that N-glycosylation plays a key role in the retrieval process of TRPV5, and 
therefore glycosidase-mediated channel activation. Taken together, our findings 
emphasize that deglycosylation increases cell-surface expression of TRPV4 and TRPV5 
channels. Moreover, it adds a new dimension to the traditional effect of N-glycosylation 
on ion channel trafficking and degradation by showing that deglycosylation delays 
TRPV5 retrieval to increase channel stability. Future studies should investigate whether 
the same mechanism applies to other TRP channels.  
  
Tissue kallikrein (TK) 
TK is a serine protease produced in CNT [117], where it co-localizes with TRPV5 [118]. 
Proteolytic enzymes such as TK are synthesized as inactive precursors or zymogens, to 
prevent protein degradation and to enable spatial and temporal regulation of enzymatic 
activity. The precursor of TK is converted to the mature active form before entering the 
luminal tubular compartment [119]. Once activated, TK is excreted and can process low 
molecular weight kininogen to release kinin, which acts through kinin receptors such as 
the bradykinin (BK) 2 receptor (B2R) [120]. Remarkably, recent studies showed that TK 
can directly activate the B2R independently of BK release [121]. Interestingly, mice 
lacking TK (TK-/- mice) exhibit robust hypercalciuria comparable to the Ca2+ leak in 
TRPV5-/- mice. [122]. However, the molecular events that link TK to Ca2+ balance were 
until recently unknown. The study in chapter 5 delineates the molecular mechanism 
through which TK stimulates Ca2+ reabsorption via TRPV5, which explains hypercalciuria 
observed in TK-/- mice. Using TRPV5-expressing primary cultures of rabbit CNT and 
CCD cells, we showed that TK stimulates Ca2+ reabsorption. This stimulatory effect of 
TK is mimicked by BK and could be reversed by application of JE049, a B2R antagonist. 
The effect of these compounds on TRPV5 activity is validated in TRPV5-transfected 
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HEK293 cells by electrophysiological measurement. Furthermore, using a 
phospholipase C (PLC) inhibitor and a cell permeable analog of diacylglycerol (DAG) it 
was demonstrated that TK activates PLC/DAG pathway. The analog of DAG increases 
TRPV5 activity via PKC activation of the channel, since mutation of TRPV5 at the 
putative PKC phosphorylation sites S299 and S654 prevents the stimulatory effect of TK. 
Cell-surface biotinylation revealed that TK enhances the amount of TRPV5 channels at 
the plasma membrane by delaying its retrieval. Therefore, we conclude that TK 
stimulates Ca2+ reabsorption via the BK-activated PLC/DAG/PKC pathway and induces 
the subsequent stabilization of the TRPV5 channel at the plasma membrane. The 
physiological relevance of this finding is substantiated by the co-localization of B2R with 
TK [123] and TRPV5 [118] in DCT and CNT cells. This is the first study demonstrating 
that TRPV5 is activated through PKC phosphorylation sites. Among the six predicted 
phosphorylation sites in the TRPV5 sequence, two serines, S299 and S654 are 
apparently critical for TRPV5 activation by TK. Importantly, TRPV5 closest homologue, 
TRPV6, does not respond to TK. Since the second serine (S654) is not conserved in 
TRPV6, both serines are all critical for stimulation of TRPV5 by TK. Previous studies 
showed that TRP channels can be activated by different signaling molecules of the PLC 
pathway. For example, TRPC3, TRPC6 and TRPC7 are characterized by their sensitivity 
to DAG [124]. Alternatively, TRPV1 [125], TRPV5 [126], TRPM4 [127], TRPM5 [128], 
TRPM7 [129] and TRPM8 [130] can be directly regulated by PIP2. Thus, in vivo TRPV5 
activation by PIP2 [131] or DAG/PKC could adjust TRPV5 activity in response to 
physiological fluctuations. In addition, Ca2+ entering the cell through TRPV5 could 
prevent the electrostatic interaction between the negatively charged PIP2 and the 
channel by screening the negative charge on the lipid head group, as proposed for Mg2+ 
and TRPM7 [132]. 
 
Since cell-surface biotinylation analysis showed that TK increases the amount of TRPV5 
channels at the plasma membrane by delaying channel retrieval. Thus, PKC activation 
of TRPV5 following the TK application would regulate the balance between constitutive 
exocytosis and endocytosis in favor of the former leading to the accumulation of TRPV5 
at the cell surface. The role of the cytoskeleton in this translocation process is presently 
unknown. It is possible that PKC-dependent phosphorylation of TRPV5 leads to 
activation of motor proteins that transport the channels towards the plasma membrane. 
Interestingly, TRPM7 associates to the actomyosin cytoskeleton upon BK stimulation 
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regulating cell adhesion [133]. Remarkably, the protein synaptotagmin has been 
proposed to regulate the exocytosis of TRPC5 [134]. Furthermore, accumulation of 
channels at the cell surface can also occur by increased incorporation into the plasma 
membrane. Indeed, PKC potentiation of TRPV1 promotes the recruitment of a channel 
vesicular pool to the cell surface [135]. This exocytosis process of TRPV1 is dependent 
on the soluble N-ethylmaleimide-sensitive-factor attachment proteins receptor (SNARE) 
[135], known to act as membrane recognition molecules and acceptors for vesicle 
trafficking, docking and fusion [136]. However, the cytoskeletal elements and the motor 
proteins participating in the incorporation of TRPV5 at the plasma membrane remain to 
be identified. It would be intriguing to investigate the role of similar scaffold proteins in 
the assembly of TRPV5 and PKC upon TK treatment, considering that such signaling 
pathways are currently indicated to function in spatially distinct microdomains [137]. 
Taken together, TK-directed translocation of TRPV5 channels constitutes a mechanism 
by which renal cells can fine-tune the Ca2+ reabsorption. 
 
Extracellular regulation of TRPV5 and TRPV6 
Together with the results in chapter 4 on the β-glucuronidase klotho, chapter 5 on the TK, 
and chapter 6 on the endoF and sialidase, our study introduces a new mechanism 
through which Ca2+ reabsorption can be stimulated via extracellular urinary enzymes. To 
date, there is only limited information about extracellular regulation of ion channels and 
transporters. It has been previously described that epithelial Na+ channel (ENaC) is 
extracellularly regulated by the channel activating proteases CAP-1, CAP-2 and CAP-3 
[138-140]. CAPs, which are membrane-bound serine proteases, act directly on the 
channel gating by enhancing the open probability of ENaC to stimulate epithelial Na+ 
absorption [141]. Subsequently, other serine protease - trypsin, prostasin and TMPRSS2 
were subsequently identified to regulate ENaC activity [139, 140, 142]. Similarly, the 
activity of acid-sensing ion channels (ASICs), neuronal Na+ channels, were also found to 
be influenced by serine protease - trypsin [143, 144]. However, unlike the protease CAP, 
TK stimulates TRPV5 indirectly via activation of the B2R, which then induces a 
redistribution of TRPV5 channels towards the plasma membrane. Klotho, β-
glucuronidase, sialidase and endoF directly activate TRPV5 by enzymatic modification of 
the N-glycan to stabilize TRPV5 channels at the plasma membrane resulted from the 
channel retrieval delaying. In future studies, the effect of serine or other proteases on 
epithelial Ca2+ channels TRPV5 and TRPV6 should be investigated. Klotho and TK co-
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localize with TRPV5 at the apical membrane of the distal part of the nephron. Of 
particular interest is that these two proteins are secreted into the pro-urine from which 
they activate the TRPV5 channel, and therefore Ca2+ reabsorption. Thus, it would be 
tempting to explore additional urinary proteins extracellularly influencing TRPV5 activity. 
Urinary secreted glycosidases could be good candidates in maintaining the Ca2+ balance. 
In order to determine potential urinary regulators, urinary proteomics will be a powerful 
tool, which has been used for many years for the diagnosis and monitoring of renal 
disease [145]. Together, unraveling the molecular mechanisms by which extracellular 
calciotropic factors control the activity of TRPV5 involved in hormonal regulation of Ca2+ 
balance is essential in keeping Ca2+ levels within a healthy range.  
 
The N-glycan structure of TRPV5  
In mature glycoproteins, N-glycans are structurally diverse [1]. The sugar composition 
and the number and size of branches in the sugar tree vary among glycans, among 
glycoproteins, and among cell types, tissues, and species [146, 147]. However, when 
initially added in the ER to grow new polypeptides, the glycans do not display such 
diversity. The so-called “core glycans” are homogeneous and relatively simple [1, 146, 
147] (Figure 2).  
  Glucose
Mannose
N-acetylglucosamine
ER
Asn-X-Ser/ThrN C
 
 
 
 
 
 
 
 
 
 
Figure 2. The N-linked core oligosaccharide. N-glycans are added to proteins in the 
endoplasmic reticulum (ER) as “core oligosaccharides” that have the depicted structure. These 
are bound to the polypeptide chain through an N-glycosidic bond with the side chain of an 
asparagine (Asn) residue that is part of the Asn-X-Ser/Thr consensus sequence. Terminal 
glucose and mannose residues are removed in the ER by glucosidases and mannosidases [1]. 
Asn: asparagine; Ser: serine; Thr: threonine; X: any amino acid. 
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Such N-glycan structures remain uniform until the glycoproteins reach the Golgi 
apparatus, where structural diversity is introduced through a series of nonuniform 
modifications [1]. When the glycoprotein moves to the Golgi complex, the glycan chains 
undergo further trimming. In many cases, new sugars are added during terminal 
glycosylation to produce complex N-glycans [146-151]. However, the number of 
branches generated is variable, as are the number and identity of sugars added. This 
biosynthesis pathway is still in puzzle in several respects, for instance, which sugars will 
be added during the final glycosylation pathway, and what are the determinants for the 
different sugar addition?  
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(       )  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic representation of the key features of the N-glycan of mature TRPV5. The 
expected N-glycan is linked to asparagine residue N358 of TRPV5. The dotted lines between the 
brackets indicate the unknown part of the N-glycan. The sugar residues are composed of part of 
“core oligosaccharides” (two GlcNAcs and three mannoses) [1]. Sialic acid and glucuronic acid are 
present at the end. However, number of sugar residues and branches is unknown. In addition, the 
existence of other sugar residues in the sugar tree of TRPV5 is not clear. GlcNAc: N-
acetylglucosamine. 
 
By the present study in chapter 6, it was shown that hydrolysis of the N-glycan stabilizes 
the channel at the plasma membrane, leading to the enhancement of TRPV5 activity. In 
addition, our data elucidated that β-glucuronic acid hydrolyzed by β-glucuronidase and 
sialic acid removed by sialidase are responsible for TRPV5 activity. Thus, based on the 
above findings and the theory of N-glycan biosynthesis [146-151], the potential TRPV5 
N-glycan structure is predicted. In ER, the TRPV5 N-glycan will be the homogeneous 
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and relatively simple “core oligosaccharides” (Figure 2) [146, 147], which is shared by 
nearly all N-glycoproteins. In Golgi complex, high mannoses and other sugars are added 
during terminal glycosylation to produce the complex N-glycan [1, 152]. The N-glycan of 
mature TRPV5 could be composed of part of “core oligosaccharides” (three mannoses 
and two N-acetylglucosamines) [1, 146-151]. Sialic acid and glucuronic acid are present 
at the end of the sugar tree, since these two sugars are responsible for TRPV5 activity. 
Therefore, the speculated N-glycan structure of mature TRPV5 is shown in Figure 3. 
 
Conclusion and future direction  
In this thesis, the studies unraveling the molecular structure and regulation mechanisms 
of TRPV5 and TRPV6 were described. The molecular determinants in TRPV5 were 
identified that play a key role in the formation of the functional channel complex, and 
substantiated that assembly of channel subunits is essential for routing to and 
subsequent activity of TRPV5 at the plasma membrane. In addition, our data provided 
new insight into the molecular machinery of TRPV5 and TRPV6 channel trafficking via 
direct interaction between a Rab GTPase (Rab11a) and apically targeted cargo. Of 
particular interest is that our study introduces a new mechanism through which Ca2+ 
reabsorption can be stimulated via extracellular activation of TRPV5 by urinary enzymes, 
including TK, sialidase, endoF, klotho and β-glucuronidase. TK stimulates TRPV5 
indirectly via activation of the B2R, which then induces a redistribution of TRPV5 
channels towards the plasma membrane. Sialidase, endoF, klotho and β-glucuronidase 
directly activate TRPV5 by enzymatic modification of the N-glycan to stabilize TRPV5 
channels at the plasma membrane. This extracellular control will ensure high Ca2+ 
transport capacity and reduce Ca2+ excretion to preserve normal plasma Ca2+ levels 
during periods of dietary Ca2+ insufficiency and aging. The identification and elucidation 
of TRPV5 and TRPV6 regulation by extracellular proteins have greatly contributed to our 
understanding of the regulation of apical Ca2+ influx in epithelial cells. However, this is 
only the first step in a long endeavor. The major challenges in the near future will be to 
explore additional urinary proteins extracellularly regulating TRPV5 and TRPV6. Urinary 
secreted glycosidases could be potential candidates in this case, and urinary proteomics 
would be a powerful tool, which has been used for many years to diagnose and monitor 
renal disease. We have to obtain further insight into the N-glycosylation process of 
TRPV5, TRPV6 and other TRP channels, in addition, establish a comprehensive view of 
N-glycan structures of TRPV5 and TRPV6, and their contribution to channel regulation. 
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To unravel the molecular mechanisms by which extracellular factors control the activity 
of TRPV5 and TRPV6 is essential in enduring Ca2+ levels within a healthy range. This 
will complete our picture of Ca2+ homeostasis.  
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Summary 
 
Chapter 1. Introduction 
The Transient Receptor Potential (TRP) superfamily of proteins consists of ion channels 
with structural similarities. TRP channels are widely expressed and have diverse 
functions in our body. They are all cation selective, but the selectivity ratio for Ca2+ and 
the monovalent cation Na+ varies extensively. The TRP superfamily is identified on basis 
of homology only, since the mode of activation and ion selectivity is quite different. Some 
TRP channels are activated by ligands, whereas others are regulated by physical stimuli 
(for instance, heat) or yet-unknown mechanisms. Mutations of TRP channels result in 
kidney-related diseases, including hereditary hypomagnesemia with secondary 
hypocalcemia (HSH) caused by mutations of TRPM6, autosomal dominant polycystic 
kidney disease caused by mutations of TRPP2, and focal segmental glomerulosclerosis 
caused by mutations of TRPC6. The epithelial Ca2+ channels, TRPV5 and TRPV6, 
uniquely represent two highly homologous members within the TRP superfamily, which 
are mainly expressed in Ca2+-transporting epithelia. The molecular identification of 
TRPV5 and TRPV6 boosted the research addressing the molecular mechanism of 
transepithelial Ca2+ transport. TRPV5 primarily fulfills the role as a gatekeeper of 
epithelial Ca2+ transport in the kidney, whereas TRPV6 forms the main Ca2+ influx 
pathway in small intestine. These channels convey the rate-limiting step in active Ca2+ 
transport and play, therefore, a pivotal role in Ca2+ homeostasis. The structure of TRPV5 
and TRPV6 shows the typical topology shared by all members of the TRP family, which 
have six transmembrane (TM) segments, intracellularly localized amino (N-tail) and 
carboxyl (C-tail) termini.  The N- and C-tail of TRPV5 and TRPV6 contain several 
conserved putative regulatory sites that are involved in regulation of channel trafficking 
and activity, for instance, ankyrin repeats, potential internal PDZ motifs and protein 
kinase C (PKC) phosphorylation sites. TRPV5 and TRPV6 form homo- and/or 
heterotetrameric channel complexes. When concatemeric channels are constructed in a 
head-to-tail fashion consisting of four different TRPV5 and/or TRPV6 subunits, they 
display intermediate properties between TRPV5 and TRPV6 channels depending on the 
subunit configuration. These two channels contain a conserved N-glycosylation site in 
the extracellular loop between TM region 1 and 2, which is localized at the asparagine 
residue N358 (TRPV5) or N357 (TRPV6). It has been reported that these two channels 
are complex glycosylated resulting in higher molecular weight proteins ranging from 85–
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100 kDa. N-glycosylation of TRPV5 and TRPV6 may play an important role in protein 
folding, intracellular trafficking and channel regulation. TRPV5 and TRPV6 are 
synthesized in the endoplasmic reticulum (ER) and are subsequently modified at 
appropriate asparagine residues through the ER to the Golgi complex, and finally 
transported towards the plasma membrane as their final destination. The activity of 
TRPV5 and TRPV6 can be controlled by different regulatory mechanisms [37], for 
instance, hormone-mediated TRPV5 and TRPV6 expression, pH, intracellular Ca2+ and 
Ca2+ sensors (80K-H and calmodulin)-controlled channel activity and S100A10-mediated 
trafficking regulation. Our recent findings demonstrated that NHERF2 / NHERF4, 
FKBP52, BSPRY, calbindin-D28k and RGS2 could also regulate TRPV5 and TRPV6 
channel activity at the plasma membrane. However, up to date, many aspects of TRPV5 
and TRPV6 regulation remain elusive. The aim of this thesis was, therefore, to unravel 
the molecular structure and regulation mechanisms of TRPV5 and TRPV6. 
 
Chapter 2. Molecular structure of TRPV5 
TRPV5 and TRPV6 were shown to assemble into homo- and/or heterotetrameric 
complexes. However, the crucial domains involved in the assembly of these two 
channels were until recently poorly understood. Here, the molecular determinants in 
TRPV5 that play a key role in the formation of the functional channel complex were 
identified. Both the N-tail and C-tail are critical for TRPV5 channel assembly. Functional 
45Ca2+ influx study in Xenopus laevis oocytes and patch-clamp analysis in human 
embryonic kidney (HEK293) cells co-expressing TRPV5 wild-type and truncated 
channels lacking either the N-tail or C-tail indicated that these N- or C-tail deletion 
truncants exert dominant-negative effects on channel activity, resulted from a disturbed 
trafficking of TRPV5 to the plasma membrane. At least two regions in the cytosolic tails 
(64-77 in the N-tail and 596-601 in the C-tail) are involved in channel assembly. When 
these two critical regions are deleted, physical interactions between the N-tail & N-tail, 
N-tail & C-tail and C-tail & C-tail of TRPV5 are abolished. In addition, the identified N-tail 
assembly domain includes an ankyrin repeat, substantiating the involvement of these 
protein–protein binding modules in TRPV5 assembly. Taken together, both N- and C-tail 
are crucial for TRPV5 assembly. Assembly of channel subunits is essential for trafficking 
of the TRPV5 channel complex and subsequent activity at the plasma membrane.  
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Chapter 3. Rab11a as a novel regulator of TRPV5 and TRPV6 trafficking 
Rab11a is a small GTPase involved in protein trafficking via recycling endosomes. A 
novel function of Rab11a as an associated protein mediating trafficking of TRPV5 and 
TRPV6 to the plasma membrane by direct cargo protein interaction was demonstrated. 
Rab11a predominantly colocalizes with TRPV5 or TRPV6 along the apical domain of the 
renal distal convoluted (DCT) and connecting tubules (CNT). TRPV5 and TRPV6 
preferentially interact with the GTP binding-deficient (GDP-locked) mutant Rab11a S25N 
in its GDP-bound configuration. This direct association could support the translocation of 
these channels into recycling endosomes and thereby constitute the “delivery 
machinery” destined to transport these channels to the apical plasma membrane. The 
amino-acid domain 596-601 (MLERK) in C-tail of TRPV5 or TRPV6, conserved among 
all identified species of these two channels, is required for Rab11a binding. Mutations in 
this stretch induce a significantly diminished TRPV5- and TRPV6-mediated Ca2+ influx, 
resulted from impaired trafficking of the channels. GTP binding-deficient (GDP-locked) 
mutant Rab11a S25N expression strongly reduces the TRPV5- and TRPV6-mediated 
Ca2+ influx. These results indicate an essential role for Rab11a in targeting TRPV5 and 
TRPV6 to the plasma membrane, in which cargo interaction (in the GDP status), as well 
as subsequent GTP binding is required. Taken together, our data provide new insight 
into the molecular machinery of TRPV5 and TRPV6 channel trafficking via direct 
interaction between a Rab GTPase and apically targeted cargo. This association is 
involved in the physiological regulation of TRPV5 and TRPV6 cell-surface abundance, a 
critical component in Ca2+ homeostasis.  
 
Chapter 4 and 7. Klotho as a unique extracellular stimulator of TRPV5 and TRPV6 
The klotho gene was originally identified as a gene mutated in a mouse strain that 
develops multiple aging-like phenotypes. Mice defective in klotho expression (klotho-/- 
mice) exhibit a syndrome resembling human aging. Klotho gene encodes a single-pass 
transmembrane protein, whose extracellular domain is secreted into serum, urine and 
cerebrospinal fluid. The extracellular domain of klotho has a homology to β-glucosidase. 
The recent study suggested that klotho may play a crucial role in the maintenance of 
Ca2+ and phosphate homeostasis. Appealing evidences of the involvement of klotho in 
Ca2+ homeostasis came from the studies described in chapter 4 showing that klotho 
activates the epithelial Ca2+ channel TRPV5. Real-time PCR analysis indicated that 
klotho expression is downregulated in kidneys of TRPV5 knockout (TRPV5-/-) mice. Co-
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expression of klotho with TRPV5 in HEK293 cells, or application of klotho-containing 
supernatant (culture media from klotho-expressing HEK293 cells) to TRPV5-transfected 
HEK293 cells, significantly stimulates TRPV5-mediated 45Ca2+ influx. Cell-surface 
biotinylation experiments revealed a significant increase in TRPV5 channel abundance 
at the plasma membrane. These effects could be mimicked by the purified β-
glucuronidase indicating that the enzymatic activity of klotho is responsible for the 
increased TRPV5 activity. Interestingly, the klotho and β-glucuronidase-mediated 
stimulatory effect on TRPV5 is abolished in HEK293 cells expressing the TRPV5 
glycosylation-deficient mutant TRPV5-N358Q without the entire N-glycan. It indicates 
that N-glycosylation plays a crucial role in TRPV5 activation by β-glucuronidase klotho, 
in addition, the N-glycan acts as the target in this stimulatory event. The physiological 
relevance of the aforementioned findings is substantiated by the co-localization of klotho 
with TRPV5 in the renal DCT and CNT cells, where klotho activates the channel from the 
pro-urine side. Hereby, we provide a new concept of a regulatory mechanism by 
glycosylation in which the secreted urinary β-glucuronidase klotho hydrolyzes the 
extracellular exposed N-linked oligosaccharides of TRPV5 to entrap channels at the 
plasma membrane. 
 
Furthermore, it raises the intriguing question concerning the specificity of klotho 
stimulatory effect on TRPV5. To answer this question, we performed the studies 
described in chapter 7. Here, we selected different ion channels within the TRP 
superfamily, including TRPV4, TRPV6, and TRPM6, in order to examine whether the 
klotho effect is restricted to TRPV5 or may be more generally applicable to other renal 
apically localized channels in DCT cells. These selected channels have structural 
similarities with TRPV5 and are all permeable to Ca2+. Additionally, the Na+-Cl- 
cotransporter (NCC) was chosen as a candidate in this study since it is also expressed 
in DCT. By using 45Ca2+ influx analysis, we showed that klotho-containing supernatant or 
β-glucuronidase incubation results in a significantly enhanced Ca2＋ influx mediated by 
TRPV6, further substantiating klotho as a regulator of both TRPV5 and TRPV6 channels. 
However, β-glucuronidase treatment for 16 hours does not increase the Ca2+ influx 
mediated by TRPV4 or TRPM6. In addition, the thiazide-sensitive Na+ influx mediated by 
NCC was not influenced by β-glucuronidase as shown by 22Na+ uptake experiments. 
Therefore, a unique stimulatory effect of klotho was disclosed that is only applicable to 
the epithelial Ca2+ channels TRPV5 and TRPV6, but not to TRPV4, TRPM6 and NCC.  
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Chapter 5. Tissue kallikrein as a modulator of TRPV5 
Tissue kallikrein (TK) is a serine protease produced in CNT, where it co-localizes with 
TRPV5. Mice lacking TK (TK-/- mice) exhibit robust hypercalciuria, which was also 
observed in TRPV5-/- mice. Our study delineates the molecular mechanism through 
which TK stimulates renal Ca2+ reabsorption via TRPV5. It explains the hypercalciuria 
observed in TK-/- mice. Using TRPV5-expressing primary cultures of rabbit renal CNT 
and cortical collecting duct (CCD) cells, we showed that TK stimulates Ca2+ reabsorption 
in these cells. This stimulatory effect of TK is mimicked by bradykinin (BK) and could be 
reversed by application of JE049, a bradykinin 2 receptor (B2R) antagonist. The effect of 
these compounds on TRPV5 activity is validated in TRPV5-transfected HEK293 cells by 
electrophysiological measurement. Using a phospholipase C (PLC) inhibitor and a cell 
permeable analog of diacylglycerol (DAG) it was demonstrated that TK activates 
PLC/DAG pathway. The analog of DAG increases TRPV5 activity via PKC activation of 
the channel, since mutation of TRPV5 at the putative PKC phosphorylation sites of S299 
and S654 prevents the stimulatory effect of TK. Cell-surface biotinylation revealed that 
TK enhances the amount of TRPV5 channels at the plasma membrane by delaying its 
retrieval. Taken together, TK stimulates Ca2+ reabsorption via the BK-activated 
PLC/DAG/PKC pathway and induces the subsequent stabilization of the TRPV5 channel 
at the plasma membrane. 
Chapter 6. EndoF and sialidase as another two extracellular activators of TRPV5 
Based on the forementioned study on klotho, we hypothesized that other glycosidases 
that hydrolyze N-oligosaccharides of TRPV5 may mimic the stimulatory effect of klotho. 
Therefore, we investigated the effect of diverse members of the glycosidase superfamily, 
to which β-glucuronidase and klotho belong, namely β-glucosidase, β-galactosidase, 
sialidase, endoglycosidase H (endoH) and peptide N-glycosidase F (endoF). 45Ca2+ 
uptake analysis showed that sialidase and endoF increase TRPV5-mediated Ca2+ influx, 
resulted from enhanced TRPV5 channel abundance at the plasma membrane. In 
contrast, β-glucosidase, β-galactosidase and endoH do not stimulate TRPV5 activity. 
Cell-surface biotinylation experiments demonstrated that β-glucuronidase stabilizes 
TRPV5 at the cell surface by significantly delaying channel retrieval. In addition, the 
glycosylation-deficient mutant TRPV5-N358Q shows reduced retrieval kinetics compared 
to wild-type channels. Here, we identified in addition to klotho and β-glucuronidase, 
sialidase and endoF as novel glycosidases extracellularly modulating TRPV5 activity. 
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These glycosidases activate TRPV5 by hydrolyzing the N-oligosaccharides of the 
channel, resulting in the stabilization of the TRPV5 channel units at the plasma 
membrane, in which N-glycosylation plays a crucial role and controls TRPV5 stability at 
the cell surface.  
 
Chapter 8. Conclusion and future perspectives 
In this thesis, the studies unraveling the molecular structure and regulation mechanisms 
of TRPV5 and TRPV6 were described. The molecular determinants in TRPV5 were 
identified that play a key role in the formation of the functional channel complex, and 
substantiated that assembly of channel subunits is essential for routing to and 
subsequent activity of TRPV5 at the plasma membrane. In addition, our data provided 
new insight into the molecular machinery of TRPV5 and TRPV6 channel trafficking via 
direct interaction between a Rab GTPase (Rab11a) and apically targeted cargo. Of 
particular interest is that our study introduces a new mechanism through which Ca2+ 
reabsorption can be stimulated via extracellualr activation of TRPV5 by urinary enzymes, 
including TK, sialidase, endoF, klotho and β-glucoronidase. TK stimulates TRPV5 
indirectly via activation of the B2R, which then induces a redistribution of TRPV5 
channels towards the plasma membrane. Sialidase, endoF, klotho and β-glucoronidase 
directly activate TRPV5 by enzymatic modification of the N-glycan to stabilize TRPV5 
channels at the plasma membrane. This extracellular control will ensure high Ca2+ 
transport capacity and reduce Ca2+ excretion to preserve normal plasma Ca2+ levels 
during periods of dietary Ca2+ insufficiency and aging. The identification and elucidation 
of TRPV5 and TRPV6 regulation by extracellular proteins have greatly contributed to our 
understanding of the regulation of apical Ca2+ influx in epithelial cells. However, this is 
only the first step in a long endeavor. The major challenges in the near future will be to 
explore additional urinary proteins extracellularly regulating TRPV5 and TRPV6. Urinary 
secreted glycosidases could be potential candidates in this case, and urinary proteomics 
would be a powerful tool, which has been used for many years to diagnose and monitor 
renal disease. We have to obtain further insight into the N-glycosylation process of 
TRPV5, TRPV6 and other TRP channels, in addition, establish a comprehensive view of 
N-glycan structures of TRPV5 and TRPV6, and their contribution to channel regulation. 
To unravel the molecular mechanisms by which extracellular factors control the activity 
of TRPV5 and TRPV6 is essential in enduring Ca2+ levels within a healthy range. This 
will complete our picture of Ca2+ homeostasis.  
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Samenvatting 
 
Hoofdstuk 1. Introductie 
De eiwitten van de Transient Receptor Potential (TRP) superfamilie vormen ionkanalen 
die voorkomen in het hele lichaam. TRP-ionkanalen hebben overeenkomsten in 
structuur, maar onderling verschillende functies. Terwijl deze ionkanalen selectief zijn 
voor cationen, varieert de selectiviteitsratio voor calcium en natrium sterk. Bovendien 
wordt een deel van de TRP-kanalen geactiveerd door middel van interactie met een 
ligand, terwijl anderen worden gereguleerd door stimuli zoals temperatuur. Mutaties in 
TRP-kanalen kunnen resulteren in niergerelateerde ziekten, zoals erfelijke 
hypomagnesiëmie met secundaire hypocalciëmie (HSH) dat veroorzaakt wordt door 
mutaties in TRPM6 en focale segmentale glomerulosclerose ten gevolge van mutaties in 
TRPC6. Twee leden van de TRP-superfamilie (TRPV5 en TRPV6) zijn homologe 
calciumkanalen, welke voornamelijk tot expressie komen in calciumtransporterende 
epitheelcellen. De identificatie van TRPV5 en TRPV6 heeft het inzicht in de moleculaire 
mechanismen die betrokken zijn bij het transepitheliaal calciumtransport enorm vergroot. 
TRPV5 vervult de rol van poortwachter bij de epitheliale calciumresorptie in de nier, 
terwijl TRPV6 voornamelijk verantwoordelijk is voor de opname van calcium in de dunne 
darm. De structuur van beide kanalen bestaat uit 6 transmembraanregio’s en 
intracellulair gelegen N- en C-termini, eigenschappen die gedeeld worden met alle leden 
van de TRP-superfamilie. Zowel de N- als de C-terminus van TRPV5 en TRPV6 
bevatten geconserveerde domeinen welke betrokken zijn bij de regulatie van deze 
kanalen. Beide kanalen bevatten bovendien geconserveerde glycosyleringsdomeinen in 
de extracellulaire lus tussen transmembraanregio 1 en 2, welke geïdentificeerd zijn als 
asparagine-residuen N358 in TRPV5 en N357 in TRPV6. N-glycosylering is belangrijk voor 
de vouwing, het transport naar de plasmamembraan en de regulatie van eiwitten. De 
synthese van TRPV5 en TRPV6 vindt plaats in het endoplasmatisch reticulum, waarna 
een modificatie plaatsvindt aan bovengenoemde asparagineresiduen. Via het Golgi-
complex worden de calciumkanalen naar de plasmamembraan getransporteerd. Er zijn 
diverse belangrijke mechanismen die bepalen hoeveel calcium daadwerkelijk via TRPV5 
of TRPV6 een cel instroomt, zoals regulatie door hormonen, transportprocessen in de 
cel, de locale zuurgraad, intracellulaire calciumconcentraties en regulatie via 
geassocieerde eiwitten. Uit recent onderzoek is gebleken dat S100A10, 
NHERF2/NHERF4, FKBP52, BSPRY, calbindin-D28K en RGS2 als geassocieerde 
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eiwitten betrokken zijn bij de regulatie van TRPV5 en TRPV6. Vele moleculaire details 
van de mechanismen die betrokken zijn bij TRPV5- en TRPV6-afhankelijk 
calciumtransport zijn echter nog onbekend. Dit proefschrift beschrijft de moleculaire 
structuur en regulatiemechanismen van TRPV5- en TRPV6-afhankelijk calciumtransport.  
 
Hoofdstuk 2. De moleculaire structuur van TRPV5 
TRPV5 en TRPV6 zijn opgebouwd uit vier individuele subunits die tezamen het 
functionele calciumkanaal vormen. Welke domeinen van TRPV5 betrokken zijn bij de 
formatie van deze complexen wordt beschreven in hoofdstuk 2. De cytosolische N- en 
C-termini zijn cruciaal gebleken in dit proces. In oocyten en humane embryonale 
niercellen (HEK293)  zijn normale (wild-type) TRPV5-kanalen en kanalen zonder N- of 
C-terminus tot expressie gebracht. Deze deleties verstoren het transport van TRPV5 
naar de plasmamembraan. Tenminste twee regio’s (aminozuurdomein 64-77 in de N-
terminus en 596-601 in de C-terminus) zijn betrokken bij de generatie van de 
kanaalcomplexen. Wanneer deze 2 belangrijke regio’s worden verwijderd, is de fysieke 
interactie tussen N- en N-termini, N- en C-termini en C- en C-termini verstoord. De N- en 
C-termini zijn dus van groot belang voor de samenstelling, het transport en uiteindelijk 
de activiteit van TRPV5- en TRPV6-kanaalcomplexen op de plasmamembraan. 
 
Hoofdstuk 3. Rab11a, een nieuwe regulator van TRPV5 en TRPV6 
Rab11a is een GTPase eiwit dat aanwezig is in recycling-endosomen, celorganellen die 
betrokken zijn bij het transport van eiwitten naar de plasmamembraan. Rab11a 
colokaliseert met TRPV5 en TRPV6 in cellen van het distaal convoluut en de 
verbindingsbuis. Aminozuurdomein 596-601 (MLERK) in de C-termini van beide kanalen 
is geconserveerd in diverse species en is verantwoordelijk voor binding aan Rab11a. 
Mutaties in dit domein verlagen de TRPV5- en TRPV6-afhankelijke calciumstroom en dit 
is het resultaat van een verstoord transport van TRPV5- en TRPV6-calciumkanalen naar 
de plasmamembraan. TRPV5 en TRPV6 binden direct aan GDP-gebonden Rab11a, 
terwijl GTP-gebonden Rab11a weinig tot geen associatie met deze kanalen vertoont. 
Expressie van een Rab11a-mutant, welke geblokkeerd is in de GDP-status leidt tot een 
afname van de hoeveelheid TRPV5 op de plasmamembraan. Deze bevindingen 
suggereren dat Rab11a betrokken is bij het transport van TRPV5 en TRPV6 naar de 
plasmamembraan.  
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Hoofdstuk 4 en 7. Klotho, een extracellulaire stimulator van TRPV5 en TRPV6 
Klotho is een transmembraaneiwit dat met één domein de plasmamembraan passeert. 
Het extracellulaire domein van klotho wordt uitgescheiden in bloed, urine en hersenvocht 
en vertoont een functionele overeenkomst met het enzym β-glucosidase. Muizen zonder 
klotho-expressie (klotho knock-out muizen) vertonen symptomen die geassocieerd 
worden met een verstoorde calciumbalans en versnelde veroudering. In hoofdstuk 4 
staat de onderzoeksvraag centraal wat de rol is van klotho bij het behoud van een 
normale calciumhuishouding. Expressie van TRPV5 samen met klotho in HEK293 cellen 
of toediening van klotho-bevattend kweekmedium aan HEK293 cellen waarin TRPV5 tot 
expressie is gebracht, stimuleert het TRPV5-afhankelijk calciumtransport. Een toename 
van het aantal TRPV5-kanalen op de plasmamembraan leidt tot een vergrote 
calciuminflux. Bovengenoemde effecten van klotho kunnen worden nagebootst door 
toediening van β-glucuronidase. Dit suggereert dat de enzymatische activiteit van klotho 
verantwoordelijk is voor het stimulerende effect van klotho op TRPV5. Wanneer de 
TRPV5 glycosyleringsmutant TRPV5-N358Q (zonder N-gebonden suikergroepen) in 
HEK293 cellen tot expressie wordt gebracht, verdwijnen de stimulerende effecten van 
zowel klotho als β-glucuronidase, waaruit blijkt dat N-glycosylering een cruciale rol 
speelt in de activatie van TRPV5 door klotho. De fysiologische relevantie van de 
voorgenoemde bevindingen wordt bevestigd door de apicale colocalisatie van TRPV5 en 
klotho in cellen van het distaal convoluut en de verbindingsbuis van de muizennier. In 
deze nefronsegmenten kan klotho TRPV5 stimuleren vanuit de voorurine. Hiermee is 
een nieuw regulatiemechanisme blootgelegd waarbij klotho extracellulaire N-gebonden 
suikergroepen in TRPV5 hydrolyseert hetgeen leidt tot een verhoogde TRPV5-expressie 
in de plasmamembraan en daardoor stimulatie van het transepitheliaal calciumtransport. 
In hoofdstuk 7 is het onderzoek beschreven waarin de specificiteit van het klotho effect 
wordt aangetoond. Dit heeft geleid tot de identificatie van TRPV6 als tweede TRP-kanaal 
dat gereguleerd wordt door klotho en β-glucuronidase. Er is geen verandering in de 
activiteit van de TRP-kanalen TRPV4, TRPM6 en de thiazide-gevoelige Na+-Cl- 
cotransporteur (NCC) aangetoond na toediening van klotho of β-glucuronidase. Het 
effect van klotho lijkt dus specifiek voor TRPV5 en TRPV6 en speelt geen rol bij de 
regulatie van TRPV4, TRPM6 en NCC.  
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Hoofdstuk 5. Kallikreine, een modulator van TRPV5 
Kallikreine (TK) is een serineprotease die geproduceerd wordt in de 
verbindingsbuiscellen van de nier en hier colocaliseert met TRPV5. Muizen zonder TK 
(TK knock-out muizen) vertonen hypercalciurie, een kenmerk ook aanwezig in TRPV5 
knock-out muizen. Hoofdstuk 5 beschrijft het moleculaire mechanisme waarmee TK de 
TRPV5-afhankelijke calciumresorptie stimuleert. Dit effect is aangetoond in primaire 
cellen van verbindings- en corticale verzamelbuizen, geïsoleerd uit konijnen en 
vervolgens gevalideerd in TRPV5-getransfecteerde HEK293 cellen. Analyse van de 
eiwitexpressie laat zien dat het aantal TRPV5-kanalen op de plasmamembraan 
verhoogd wordt door TK. Dit stimulerende effect van TK kan worden nagebootst met 
bradykinine en wordt daarnaast geblokkeerd met JE049, een antagonist van de  
bradykininereceptor. Door gebruik te maken van een fosfolipase C (PLC) remmer en 
een celpermeabele analoog van diacylglycerol (DAG) is aangetoond dat TK de 
PLC/DAG route activeert. DAG stimuleert het TRPV5-kanaal via PKC-activatie. Een 
TRPV5-kanaal waarin de PKC fosforyleringsplaatsen S299 en S654 zijn gemuteerd is 
ongevoelig geworden voor TK. Samengevat kan gesteld worden dat TK via activering 
van de bradykininereceptor het aantal TRPV5-kanalen dat tot expressie komt op de 
plasmamembraan verhoogt via de PLC/DAG/PKC route. 
Hoofdstuk 6. EndoF en sialidase, twee activatoren van TRPV5 
Gebaseerd op het onderzoek beschreven in hoofdstuk 5, is de hypothese ontstaan dat 
behalve klotho ook andere glycosidases de hydrolyse van N-gebonden oligosacchariden 
in TRPV5 kunnen bewerkstelligen. Hoofdstuk 6 beschrijft de effecten van β-glucosidase, 
β-galactosidase, sialidase, endoglycosidase H (endoH) en peptide N-glycosidase F 
(endoF) op de activiteit van TRPV5. Analyse van de calciumopname in HEK293 cellen 
na toediening van deze enzymen heeft sialidase en endoF geïdentificeerd als 
stimulatoren van het TRPV5-afhankelijk calciumtransport. Behalve klotho en β-
glucuronidase moduleren ook sialidase en endoF de TRPV5-activiteit extracellulair via 
de hydrolyse van de N-gebonden suikergroepen van het kanaal. Dit resulteert in de 
stabilisatie van TRPV5 in de plasmamembraan en een toename van het TRPV5-
afhankelijk calciumtransport. 
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Hoofdstuk 8. Conclusies en toekomstperspectieven 
In dit proefschrift zijn de determinanten geidentificeerd die een rol spelen bij de formatie 
en regulatie van functionele TRPV5- en TRPV6-kanalen. Hiermee zijn nieuwe inzichten 
verkregen in de moleculaire werkingsmechanismen betrokken bij het transport van 
TRPV5 en TRPV6 naar de plasmamembraan zoals de functie van het TRPV5-
geassocieerde eiwit Rab11a. Een nieuw mechanisme is ontdekt waarbij TRPV5 wordt 
gereguleerd door de extracellulaire enzymen TK en glycosidases als klotho, β-
glucuronidase en sialidase. Deze mechanismen verhogen de capaciteit van de 
calciumresorptie en verlagen derhalve de calciumexcretie via de urine. Dit resulteert in 
het behoud van een normale calciumconcentratie in het bloed gedurende perioden van 
een verstoorde calciumbalans door bijvoorbeeld een lage calciuminname of een 
verminderde calciumabsorptie in de darm tijdens veroudering. In de toekomst zal het 
van belang zijn andere extracellulaire eiwitten te identificeren die betrokken zijn bij de 
regulatie van het TRPV5- en TRPV6-afhankelijk calciumtransport. Glycosidases, welke 
uitgescheiden worden in de urine, zijn hiervoor potentiële kandidaten. Toepassing van 
nieuwe eiwitanalysetechnieken in urinemonsters zal hierbij een krachtig hulpmiddel 
kunnen zijn. Inzicht in de N-glycosylering van TRP-kanalen in het algemeen en de 
suikergroepen aanwezig op de TRPV5- en TRPV6-kanalen in het bijzonder zal verdere 
opheldering geven over de betrokkenheid van deze domeinen in de regulatie van 
ionkanalen. Het vergaren van kennis over de extracellulaire factoren die de activiteit van 
ionkanalen kunnen beïnvloeden is essentieel voor het behoud van een goede 
calciumbalans in het lichaam. 
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中文简介 
 
第一章   导言 
TRP（Transient Receptor Potential）家族是一类分子结构具有相似性的离子通道
蛋白。TRP 家族通道蛋白的表达十分广泛，并且功能各异。所有 TRP 家族的通道蛋白都具
阳离子通透性，但是对于二价钙离子与单价钠离子的选择通透性大相径庭，而且具有多种
激活模式。正是如此，所以我们只能从蛋白分子结构的同源性来判断某一蛋白是否属于
TRP 家族。某些 TRP 通道蛋白的突变可导致多种与肾脏有关的疾病，如伴有继发性低钙血
症的遗传性低镁血症【hereditary hypomagnesemia with secondary hypocalcemia 
(HSH)】,多囊肾 （polycystic kidney disease），以及中心肾小球硬化（focal 
segmental glomerulosclerosis） 等。在众多的 TRP 家族蛋白中，上皮钙离子通道 TRPV5
和 TRPV6 是具有高度结构同源性的典型代表，它们主要表达在与钙离子运输相关的上皮细
胞中。TRPV5 和 TRPV6 通道的发现使得对上皮钙离子转运分子机制的研究得到了极大关
注。这两个蛋白有效地控制着上皮钙离子的转运传输，从而在调节钙离子血液平衡方面扮
演着举足轻重的角色。但是 TRPV5 和 TRPV6 在调节钙离子重吸收方面的分工略有不同，
TRPV5 主要在肾脏上皮钙离子运输中起关键作用，而 TRPV6 主要形成小肠里的钙离子流入
通道。TRPV5 和 TRPV6 的分子结构显示出典型的所有 TRP 家族成员共有的拓扑结构特征—
—具有六个跨膜区和胞内的氨基端和羧基端。在 TRPV5 和 TRPV6 的氨基端和羧基端上还包
含着一些特异的高度保守的调节位点，例如 ankyrin 重复片断、内部潜在的 PDZ 序列模式
和磷酸化位点，这些位点可能对于通道活性的调节至关重要。TRPV5 和 TRPV6 都是由四个
亚单位构成的同源或异源性通道复合四聚体，此四聚体以头尾相接的方式结合在一起。当
四个 TRPV5 和 TRPV6 亚单位组成异源通道复合四聚体时，此四聚体显示出介于 TRPV5 和
TRPV6 的特性, 而此特性由四聚体中配置的 TRPV5 和 TRPV6 亚单位数量来决定。TRPV5 和
TRPV6 通道在位于第一和第二跨膜区之间的细胞外环上包含一个高度保守的 N 糖基化位
点。这个 N 糖基化位点在 TRPV5 和 TRPV6 上分别位于第 358 或第 357 个氨基酸残基——天
冬氨酸。我们已经清楚, 这两个通道不仅被翻译为核心蛋白, 并且通过高度复杂的糖基化
形成分子量约为 85-100kDa 的大分子蛋白质。TRPV5 和 TRPV6 的 N 糖基化在蛋白质折叠、
转运以及通道活性调节方面扮演着重要角色。TRPV5 和 TRPV6 在内质网内合成，随后在由
内质网向高尔基体装运的过程中被位于天冬氨酸的单糖所调节，并且最终运往它们的目的
地——血浆膜。TRPV5 和 TRPV6 可被多种机制所调控，包括由各类激素介导的在蛋白转录
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和翻译方面的调控，由 pH 值、细胞内钙离子浓度和钙离子传感蛋白（calmodulin 和 80K-
H）控制的在血浆膜活性方面的调控，由 S100A10/annexin 2 调节的在通道向血浆膜转运
过程中的调控等。我们的最新研究进一步表明 NHERF2/NHERF4、FKBP52、BSPRY、
calbindin-D28k和 RGS2 等蛋白也可调控 TRPV5 或 TRPV6 在血浆膜上的活性。尽管近年来在
TRPV5 和 TRPV6 功能、调控和通道装配等方面的研究已经有了迅速发展，但目前的研究成
果还不能完全解释有关这两个蛋白调控以及分子结构方面的所有机理。因此本论文旨在解
开 TRPV5 和 TRPV6 的分子结构和调控之迷。 
 
第二章   TRPV5 的分子结构 
早先研究已经表明，TRPV5和TRPV6可以装配形成同源或异源四聚体通道，但是此四聚
体的装配位点还不明晰。因此，我们做了大量的研究试图找寻在TRPV5复合四聚体通道形
成过程中起着重要作用的分子。本章的研究表明，氨基端和羧基端在TRPV5通道装配方面
的作用具有同等的重要性。我们在Xenopus laevis的卵母细胞和人类肾脏胚胎细胞
【human embryonic kidney （HEK293）cells】中共表达TRPV5通道与缺失氨基端或羧基
端的通道突变体。功能试验分析表明这些缺失了氨基端、羧基端的突变体表现了对通道活
性的显性抑制作用, 此抑制作用的产生是由于此突变体不能与TRPV5通道装配成四聚体，
从而干扰了TRPV5蛋白向血浆膜的转运。我们的研究还进一步表明, TRPV5蛋白中至少有二
个区域 (位于氨基端第64至77位的氨基酸残基序列和位于羧基端第596至601位的氨基酸残
基序列)在通道装配的过程起决定作用。当缺失这两个重要的区域时，TRPV5通道氨基端与
氨基端，氨基端与羧基端，羧基端与羧基端的物理交互作用将被彻底消除。另外, 位于氨
基端第64至77位的氨基酸残基序列与所谓的ankyrin第一重覆片断重叠, 证实了这些“蛋
白质——蛋白质”互作模块在TRPV5装配中具有重要作用。总结以上观点, 通道亚单位的
装配是决定TRPV5蛋白能否运送到血浆膜以及其在血浆膜上活性大小的根本条件。 
 
第三章   Rab11a——全新的TRPV5和TRPV6转运调节蛋白 
Rab11a是一个小型的GTP酶，它主要作用于由循环内涵体控制的蛋白转运过程。本章
的研究阐明了Rab11a的作用，即可以作为TRPV5和TRPV6的直接互作蛋白从而调节这两个通
道到达血浆膜的过程，继而充当了全新的TRPV5和TRPV6的转运调控器。Rab11a与TRPV5或
TRPV6在肾脏远曲小管【distal convoluted tubule（DCT）】、连接管【connecting 
tubule（CNT）】细胞的顶膜上共同表达，并且TRPV5和TRPV6优先地与Rab11a的突变体
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Rab11a S25N互作。Rab11a S25N缺少了与GTP互作的特性。Rab11a与TRPV5和TRPV6的直接
互作作用能够支持这些通道迁移入循环内涵体，从而构成“传递器”最终运输这些通道到
达血浆膜。Rab11a与TRPV5和TRPV6的互作区域位于通道的羧基端，并且由在所有物种中全
部保守的五个氨基酸残基（595 到601：MLERK)所组成。位于这一互作区域的突变体将阻
碍TRPV5和TRPV6到达血浆膜地转运，从而进一步导致由TRPV5和TRPV6介导的钙离子流入的
显著减少。另外，我们的研究发现GDP锁定的Rab11a突变体Rab11a S25N与TRPV5和TRPV6的
共表达也会导致由TRPV5和TRPV6介导的钙离子流入的衰减，这充分证明了Rab11a在TRPV5
和TRPV6转运至血浆膜过程中的重要作用。综上所述,我们的研究提供了在TRPV5和TRPV6通
道分子转运方面的新模式，进而证明了与Rab11a GTP酶的直接互作将有效地调节TRPV5和
TRPV6通道的转运，此调节机制在控制TRPV5与TRPV6的细胞表面丰盈度及钙离子血液平衡
方面起着至关重要的作用。 
  
第四章，第七章   Klotho——TRPV5和TRPV6特异的细胞外激活因子 
Klotho 基因最早被发现是由于此基因的突变引起了小鼠的衰老化。大量的研究数据进
而证明缺失 Klotho 蛋白表达的小鼠的确表现出一系列与人类衰老极为类似的症状。
Klotho 基因编码一个穿膜蛋白质，此蛋白质位于细胞膜外端的部分经证实将会分泌到血
液、尿液以及脑脊液中，这个被分泌的外端部分与β—葡萄糖苷酶（β－glucosidase）
具有同源性。最新研究揭示 Klotho 在维持钙离子血液平衡方面起着相当重要的作用。第
四章中的研究数据极为有力地证明了 Klotho 在维持钙离子血液平衡方面的重要作用。RT-
PCR 分析表明 Klotho 在 TRPV5 敲除小鼠肾脏中的表达明显降低。TRPV5 与 Klotho 在
HEK293 细胞内的共表达或用含有 Klotho 的细胞培养液处理 TRPV5 表达的 HEK293 细胞都会
明显地刺激由 TRPV5 介导的钙离子吸收。细胞表面生物素标记实验证实了在血浆膜上
TRPV5 的大幅度增加是产生这一现象的原因。β－葡萄糖醛酸酶(β－glucuronidase)可以
模拟该刺激作用，表明 Klotho 所具的葡萄糖醛酸酶的活性对刺激增加 TRPV5 的活性起着
决定作用。有趣的是,由 Klotho 以及葡萄糖醛酸酶引起的对 TRPV5 的刺激作用在表达了
TRPV5 糖基化缺失突变体 TRPV5-N358Q 的 HEK293 细胞里被彻底消除，这个糖基化缺失突变
体被证实没有 N 糖链。通过 D-[U-14C]葡萄糖标志试验我们又进一步阐明了 Klotho 和β－
葡萄糖醛酸酶能够水解位于已经糖基化了的 TRPV5 蛋白表面的糖链。这些数据表明, N 糖
基化在由葡萄糖醛酸酶和 Klotho 介导的对 TRPV5 通道的激活中扮演了关键的角色，而且 N
糖链在此过程中起到了靶子的作用。Klotho 和 TRPV5 在肾脏远曲小管（DCT）以及连接管
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（CNT）中的共表达为此研究发现提供了有力的生理依据，在正常的生理状况下，Klotho
从肾脏与 TRPV5 共表达的细胞内被分泌到原尿中进而调节 TRPV5 的活性。 我们在第四章
的研究提供了一个有关 TRPV5 调控机制的新概念。在此调控机制中，被分泌的 Klotho 蛋
白水解 TRPV5 通道的细胞外 N 糖链引起此通道在血浆膜上表达的增加，从而加大由 TRPV5
引起的钙离子吸收。与此同时，这个研究也提出了一些有关 Klotho 蛋白在 TRPV5 刺激作
用中特异性的问题，我们因此开始了在第七章的研究。在第七章中, 我们选择了一些具有
代表性的蛋白质来进一步研究 Klotho 的刺激作用是否仅限于 TRPV5 或者对其它蛋白亦有
活性，例如，我们选择了位于 TRP 家族之内的 TRPV6、TRPV4 和 TRPM6 通道。这些通道与
TRPV5 具有结构相似性并且对钙离子有选择通透性。另外, 对钠离子有选择通透性的钠离
子氯离子运输蛋白 【Na+-Cl- cotransporter（NCC)】也被了用到了这项研究中。钙离子
吸收试验数据表明,葡萄糖醛酸酶和 Klotho 显著增加了由 TRPV6 介导的钙离子流入，从而
证明了 Klotho 能够作为 TRPV5 和 TRPV6 共同的调节因子来维持钙离子的血液平衡。但
是，葡萄糖醛酸酶并不能刺激 TRPV4 和 TRPM6 的通道活性。而且，钠离子吸收试验还进一
步阐明了由 NCC 介导的对噻嗪类药物敏感的钠离子流入不会受到葡萄糖醛酸酶的影响。因
而, 我们证实了 Klotho 对上皮钙离子通道 TRPV5 和 TRPV6 激活作用的特异性，此作用并
不适用于 TRPV4，TRPM6 和 NCC。此特异作用的产生也许来源于这些蛋白不同的糖基化方式
和它们各样的 N 多聚糖结构。 
 
第五章   组织血管激肽释放酶——TRPV5通道活性的调节器 
组织血管激肽释放酶【Tissue kallikrein（TK）】是在肾脏连接管（CNT）中产生的
丝氨酸蛋白酶。这一蛋白酶在肾脏集合管与TRPV5通道共同表达。TK敲除小鼠表现出明显
的高钙尿症，此症状与在TRPV5敲除小鼠中表现的钙离子流失现象高度相似，我们为解释
这一生理现象展开了大量的研究工作，本章对这些研究做了详尽的描述。通过对野兔肾脏
连接管（CNT）以及皮质集合管（CCD）细胞的培养，我们发现TK能够刺激这些细胞中的钙
离子吸收。TK的这一刺激作用可被血管缓激肽【bradykinin（BK）】所模拟，但是被血管
缓激肽第二受体【bradykinin 2 receptor（B2R）】拮抗剂JE049所阻抗。这些化合物的
活性都能够由在 HEK293 细胞中进行的电生理试验所证实。此外，试验中应用磷脂酶C 
【phospholipase C (PLC)】抑制剂以及具有细胞通透性的甘油二酯【diacylglycerol 
(DAG)】类似物检测到TK激活了PLC/DAG路径。位于TRPV5假定磷酸化位点S299和S654的突
变体阻碍了TK对此通道的刺激作用，此结果表明了甘油二酯类似物可通过激活TRPV5磷酸
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化来增加通道的活性。细胞表面半衰期生物素标记试验揭示了TK凭借延迟TRPV5的回收降
解而提高TRPV5在血浆膜的表达数量。因此, 我们得出结论,即TK通过BK激活的
PLC/DAG/PKC通路来增加TRPV5通道在血浆膜的稳定性，进而刺激钙离子的重吸收。 
 
第六章    缩氨酸N端切割糖苷酶 F 和唾液酸酶——两个新型的TRPV5细胞外激活酶 
基于上述对于Klotho蛋白功能的一系列深入研究，我们假定具有N端糖链切割特性的
其它糖苷酶成员能够模拟Klotho的活性。因此我们进一步展开了对Klotho和葡萄糖醛酸酶
所属糖苷酶家族中其它成员的研究，这些糖苷酶包括β－葡萄糖苷酶（ β-
glucosidase），β-半乳糖苷酶（β-galactosidase）,唾液酸酶（sialidase），内切糖
苷酶H【endoglycosidase H (endoH)】以及缩氨酸N端切割糖苷酶F【peptide N-
glycosidase F （endoF）】。钙离子吸收试验表明唾液酸酶和endoF明显增加了TRPV5通
道在细胞表面的表达，从而刺激了由TRPV5介导的钙离子吸收。但是，其它糖苷酶成员β
－葡萄糖苷酶,β-半乳糖苷酶和endoH并没有显示出对TRPV5的刺激作用。通过细胞表面半
衰期生物素标记试验, 我们证实了β－葡萄糖醛酸酶显著延迟了TRPV5的回收降解, 从而导
致了TRPV5通道在血浆膜上表达数量的增加。此外，我们的研究还发现TRPV5糖基化缺失突
变体TRPV5-N358Q的回收降解明显缓慢于TRPV5通道，从而导致此突变体在细胞表面的稳定
性大大提高，β－葡萄糖醛酸酶也因此不能够再刺激TRPV5-N358Q的活性。我们在本章的研
究进一步证实除Klotho和β－葡萄糖醛酸酶之外，唾液酸酶和endoF也可作为新的糖苷酶于
细胞外调节TRPV5的活性。这四个糖苷酶由于切割TRPV5的N糖链而引起TRPV5降解的延迟，
这一过程将导致TRPV5通道在细胞表面稳定性的提高，从而大幅度的刺激由TRPV5介导的钙
离子吸收。N糖基化控制着TRPV5在细胞表面的稳定性，因而在由糖苷酶介导的TRPV5激活
作用中起着极为重要的作用。 
 
第八章 结论及未来展望 
在本论文中，我们对有关TRPV5和TRPV6分子结构和调节机制方面的研究做了详细的阐
述和全面的总结。我们的研究表明, 位于氨基端第64至77位以及羧基端第596至601位的氨
基酸残基序列对TRPV5通道的装配的作用同等重要，通道亚单位的装配是TRPV5转运至血浆
膜及随后在血浆膜上活性程度的根本决定因素。此外，我们的研究提出了在TRP通道分子
转运方面的新模式，进而证明了与Rab11a GTP酶的直接互作可以有效地调节TRP通道的转
运。此调节机制在控制TRPV5与TRPV6的细胞表面丰盈度及血液钙离子平衡方面起着十分关
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键的作用。我们的研究还阐明了组织血管激肽释放酶（TK）通过血管缓激肽（BK）激活的
PLC/DAG/PKC通路来增加TRPV5通道在血浆膜的稳定性，进而刺激钙离子的重吸收。我们的
研究进一步表明，TRPV5和TRPV6的活性可由细胞外糖苷酶控制。这些糖苷酶包括β－葡萄
糖醛酸酶、Klotho和endoF。最终我们证实了Klotho的激活作用对上皮钙离子通道TRPV5和
TRPV6具有明显的特异性。这里, 我们提供了一个N糖基化调控TRPV5活性的新概念，这一
概念揭示上述糖苷酶由于切割TRPV5 N糖链而引起TRPV5降解的延迟，该过程将导致TRPV5
通道在细胞表面稳定性的提高，从而大幅度的刺激由TRPV5介导的钙离子吸收。这一调节
机制将保持高钙运输容量并减少钙离子在尿中的排泄，从而保证在饮食钙离子不足和衰老
过程中具有正常的血液钙离子平衡。我们的研究结果提出了关于TRPV5和TRPV6生理功能的
新概念，并且基于对细胞外蛋白调节TRPV5和TRPV6过程的进一步阐述，我们指出了全新的
关于上皮细胞顶膜钙离子流入的调节机制，但这只是窥豹一斑。未来工作应主要着眼于对
TRPV5、TRPV6和其它TRP通道N糖基化过程的进一步研究。我们必须建立一个详细的TRPV5
和TRPV6N糖链的结构图, 并且深入研究这些糖链对通道的调控作用。搞清细胞外调钙因子
控制TRPV5和TRPV6活性的分子机制是使肌体在一个健康范围内维持正常的钙离子水平的根
本保证，这同时也有助于我们了解血液钙离子平衡调控的完整机制。 
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1,25(OH)2D3 1,25-dihydroxy-vitamin D3  
[Ca2+]i intracellular Ca2+ concentration 
1α-OHase 25-hydroxyvitamin D3-1α-hydroxylase 
1α-OHase-/- 1α-hydroxylase knock-out mice 
ADPKD autosomal dominant polycystic kidney disease 
ADPLD autosomal dominant polycystic liver disease 
AGE 
AID 
advanced glycosylation end products 
α-interaction domain 
ANOVA 
AR 
ATL 
analysis of variance 
androgen receptor 
ascending thin limb of Henle’s loop 
ATP adenosine 5' –triphosphate 
B2R bradykinin 2 receptor 
BAPTA-AM 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic  
acid acethoxymethylester 
BK Bradykinin 
bp Basepairs 
BSA bovine serum albumin 
Calbindin-D28K-/- calbindin-D28K-/- knock-out mice 
CAP channel activating protease 
CaSR Ca2+-sensing receptor 
CCD 
CD 
cortical collecting duct 
collecting duct 
CFTR cystic fibrosis transmembrane regulator  
CIPP channel-interacting PDZ domain protein 
 
CNT connecting tubule 
CTRL Control 
DAG Diacylglycerol 
DCT 
DTL 
distal convoluted tubule 
descending thin limb of Henle’s loop 
DVF divalent free 
ECaC epithelial Ca2+ channel 
EDTA ethylenediaminetetraacetate 
EGTA ethylene glycol-bis(b-aminoethyl ether)-N,N,N',N'-tetra  
acetic acid 
ENaC epithelial Na+ channel 
ER endoplasmic reticulum  
FGF fibroblast growth factor 
FKBP 
GABA 
FK506-binding protein 
gamma-aminobutyric acid 
GFP 
GIRK 
green fluorescent protein 
G-protein-activated inwardly rectifying K+ channel 
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GPCR G protein-coupled receptor 
GRK G protein-coupled receptor kinase 
GST glutathione S-transferase 
HEK 293 human embryonic kidney 293 
HPRT hypoxanthine-guanine phosphoribosyl transferase 
i unitary channel current 
I 
IMCD 
whole cell current  
inter modular collecting duct 
IP3 inositol triphoshpate  
I-V current-voltage 
MAPK 
MDCK cells 
mitogen-activated protein kinases 
Madin-Darby canine kidney cells 
NCX1 Na+-Ca2+-exchanger 1 
NHE Na+-H+ exchanger 
NHERF 
NMDA 
NHE regulating factor  
N-methyl-D-aspartate  
OAG 
OVX 
1-oleoyl-acetyl-sn-glycerol  
Ovarioectomized 
PAGE polyacrylamide electrophoresis gel 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDDR pseudovitamin D-deficiency rickets  
PDZ PS095/DLG/Z0-1 
PIP2 phosphatidylinositol-4,5-biphosphate 
PKC  protein kinase C 
PKD polycystic kidney disease 
PLC phospholipase C 
PMA phorbol 12-myristate 13-acetate 
PMCA1b Ca2+-ATPase 1b 
Po channel open probability  
PPIase peptidyl-propyl cis-trans isomerase 
PT proximal tubule 
PTH  
PTX 
parathyroid hormone 
parathyroidectomized 
ROMK renal outer medullary K+ 
SDS sodium dodecyl sulphate 
SGK serine/threonine kinase 
siRNA small interference RNA 
SNARE 
 
TAL 
soluble N-ethylmaleimide-sensitive-factor attachment  
proteins receptor 
thick ascending limb of Henle’s loop 
TBS tris buffered saline 
TCA trichloroacetic acid 
TK tissue kallikrein 
TK-/-  tissue kallikrein knock-out mice 
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Tris tris(hydroxyl-methyl)aminomethane 
TRP transient receptor potential  
TRPC TRP canonical  
TRPL TRP like 
TRPM TRP melastatin  
TRPV TRP vanilloid 
TRPV5-/-  TRPV5 knock-out mice 
TRPV5-/-/calbindin-D28K-/- TRPV5/calbindin-D28K double knock-out mice 
VDDR-1 vitamin D-dependent rickets type I 
VDR 
VDR-/- 
vitamin D receptor 
vitamin D receptor knock-out mice 
Y2H yeast two-hybrid 
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